uniquePatientKey,patientId,studyId,AGE,AJCC_METASTASIS_PATHOLOGIC_PM,AJCC_NODES_PATHOLOGIC_PN,AJCC_STAGING_EDITION,AJCC_TUMOR_PATHOLOGIC_PT,BRACHYTHERAPY_TOTAL_DOSE_POINT_A,BRACHYTHERAPY_TYPE,BRACHYTHERAPY_TYPE_OTHER,CERVIX_SUV_RESULTS,CHEMO_CONCURRENT_COURSE,CHEMO_CONCURRENT_DOSE,CHEMO_CONCURRENT_FRACTIONS_TOTAL,CHEMO_CONCURRENT_REASON_NOT_GIVEN,CHEMO_CONCURRENT_REASON_NOT_OTHER,CHEMO_CONCURRENT_TYPE,CHEMO_CONCURRENT_TYPE_OTHER,CLINICAL_STAGE,CORPUS_INVOLVEMENT,CT_SCAN_PREOP_RESULTS,DAYS_TO_DIAGNOSTIC_COMPUTED_TOMOGRAPHY_PERFORMED,DAYS_TO_DIAGNOSTIC_MRI_PERFORMED,DAYS_TO_FDG_OR_CT_PET_PERFORMED,DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS,DAYS_TO_PERFORMANCE_STATUS_ASSESSMENT,DFS,ECOG_SCORE,ETHNICITY,FEDPET_OR_CT_RESULTS,FORM_COMPLETION_DATE,GRADE,HEIGHT,HISTOLOGICAL_DIAGNOSIS,HISTORY_HORMONAL_CONTRACEPTIVES_USE,HISTORY_IMMUNOSUPPRESSIVE_DISEASE,HISTORY_NEOADJUVANT_TRTYN,HISTORY_OTHER_MALIGNANCY,HPV_TYPES_OTHER,HPV_TYPES_POSITIVE,HPV_TYPING_METHOD,HPV_TYPING_METHOD_OTHER,HYSTERECTOMY_TYPE,ICD_10,ICD_O_3_HISTOLOGY,ICD_O_3_SITE,INFORMED_CONSENT_VERIFIED,INITIAL_PATHOLOGIC_DX_YEAR,KERATINIZATION_SQUAMOUS_CELL,LYMPHOVASCULAR_INVOLVEMENT,LYMPH_NODES_EXAMINED,LYMPH_NODES_EXAMINED_HE_COUNT,LYMPH_NODES_EXAMINED_IHC_COUNT,LYMPH_NODES_SUPRACLAVICULAR,LYMPH_NODE_EXAMINED_COUNT,MARGINS_INVOLVED_HYSTERECTOMY,MENOPAUSE_STATUS,METHOD_OF_INITIAL_SAMPLE_PROCUREMENT,METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER,NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT,OS,OTHER_HYSTERECTOMY_TYPE,OTHER_IMMUNOSUPPRESSIVE_DISEASE,OTHER_INVOLVED_MARGINS,OTHER_PATIENT_ID,OTHER_POS_NODE_LOCATION,PATIENT_DEATH_REASON,PCR_PRIMER_PAIRS,PELVIC_EXTENSION_COMMENT,PERFORMANCE_STATUS_OTHER_TIMING,PERFORMANCE_STATUS_TIMING,PHARMACEUTICAL_TX_ADJUVANT,POS_LYMPH_NODE_LOCATION,PREGNANCIES_COUNT_ECTOPIC,PREGNANCIES_COUNT_INDUCED_ABORTION,PREGNANCIES_COUNT_LIVE_BIRTH,PREGNANCIES_COUNT_MISCARRIAGE,PREGNANCIES_COUNT_STILLBIRTH,PREGNANCIES_COUNT_TOTAL,PREGNANT_AT_DIAGNOSIS,PROSPECTIVE_COLLECTION,RACE,RADIATION_THERAPY_DOSE_PARAAORTIC_NODES,RADIATION_THERAPY_XRT_TYPE,RADIATION_TREATMENT_ADJUVANT,RADIATION_TYPE_OTHER,RETROSPECTIVE_COLLECTION,RT_TX_REASON_NOT_COMPLETED,RT_TX_REASON_NOT_COMPLETED_OTHER,RT_TX_TOTAL_DOSE_TO_PELVIS,SAMPLE_COUNT,SEX,SITE_OF_TUMOR_TISSUE,SMOKING_PACK_YEARS,SMOKING_YEAR_STARTED,SMOKING_YEAR_STOPPED,TARGETED_MOLECULAR_THERAPY,TISSUE_SOURCE_SITE,TOBACCO_SMOKING_HISTORY_INDICATOR,TREATMENT_OUTCOME_FIRST_COURSE,TUMOR_RESPONSE,TUMOR_STATUS,WEIGHT,fold_information_5fold-1,fold_information_5fold-2,fold_information_5fold-3,fold_information_5fold-4,fold_information_5fold-5,slide_id,TISSUE_TYPE,SLIDE_TYPE,AJCC_PATHOLOGIC_TUMOR_STAGE_reduced
VENHQS00Si1BQTFKOmNlc2NfdGNnYQ,TCGA-4J-AA1J,cesc_tcga,31.0,M0,N0,2009,T1b2,40.0,HDR,,,,,,,,,,Stage IB2,ABSENT,,,,,0.0,226.0,17.81|0,0.0,NOT HISPANIC OR LATINO,,11/13/14,G3,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,,,15.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cytology (e.g. Peritoneal or pleural fluid),,NO,17.81|0,,,,53EAC147-7EB8-4C54-A982-5E058D6749F8,,,,no extension,,Post-Adjuvant Therapy,NO,,0.0,0.0,4.0,0.0,0.0,4.0,YES,YES,WHITE,,,YES,,NO,,,,1,Female,Cervical,,,,NO,4J,1.0,Complete Remission/Response,,TUMOR FREE,48.0,Train,Train,Train,Train,Val,TCGA-4J-AA1J-01Z-00-DX1.8E768211-46FC-45A4-8689-6DDEA0198D43,WITH TUMOR,DX1,
VENHQS0yVy1BOFlZOmNlc2NfdGNnYQ,TCGA-2W-A8YY,cesc_tcga,51.0,M0,N0,2009,T2a2,1500.0,HDR,,,Once weekly,56mg/56mL,6,,,Cisplatin,,Stage IB2,PRESENT,,,,145.0,0.0,148.0,17.51|0,1.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,5/15/14,G3,160.0,Adenosquamous,Former User,[Not Evaluated],No,No,,,,,Radical Hysterectomy,C53.9,8560/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,,,18.0,Macroscopic parametrial involvement,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,17.51|0,,,,5AEAC31A-176A-4F93-A376-A93A670821BB,,,,,,Post-Adjuvant Therapy,YES,,0.0,0.0,1.0,0.0,0.0,1.0,NO,YES,WHITE,,IMRT,YES,,NO,,,4500.0,1,Female,Cervical,,,2000.0,YES,2W,4.0,Complete Remission/Response,,TUMOR FREE,42.0,Test,Test,Test,Test,Test,TCGA-2W-A8YY-01Z-00-DX1.2BEC2531-DA98-429B-83BB-3428D3B6FB1E,WITH TUMOR,DX1,
VENHQS1CSS1BMFZSOmNlc2NfdGNnYQ,TCGA-BI-A0VR,cesc_tcga,53.0,M0,N1,,T2b,,,,,,,,,,,,Stage IIIB,PRESENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,15.0,,,0.0,,49.44|0,,NOT HISPANIC OR LATINO,,4/1/11,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2006.0,Non-keratinizing squamous cell carcinoma,PRESENT,,1.0,,,43.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),,,49.44|0,,,,39a3120c-0889-4a10-816a-e07528a35f7a,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",1.0,,0.0,2.0,3.0,6.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,20.0,22.0,1995.0,,BI,4.0,,,TUMOR FREE,,Train,Train,Train,Train,Val,TCGA-BI-A0VR-01Z-00-DX1.69847920-5A6E-4318-9AD8-6EC9EECD1B3A,WITH TUMOR,DX1,
VENHQS1CSS1BMFZTOmNlc2NfdGNnYQ,TCGA-BI-A0VS,cesc_tcga,48.0,M0,N0,,T1b1,,,,,,,,,,,,Stage IB,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,12.0,,12.0,0.0,,57.0|0,,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,4/5/11,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2007.0,Non-keratinizing squamous cell carcinoma,ABSENT,,0.0,0.0,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,8.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cytology (e.g. Peritoneal or pleural fluid),,,57.0|0,,,,3923a64a-f8d7-4e3e-9218-cee642da21db,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",1.0,0.0,,0.0,0.0,,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,BI,2.0,,,TUMOR FREE,,Val,Train,Train,Train,Train,TCGA-BI-A0VS-01Z-00-DX1.C1E1F2D2-4F9F-42A2-914F-75ED20A1DB61,WITH TUMOR,DX1,
VENHQS1CSS1BMjBBOmNlc2NfdGNnYQ,TCGA-BI-A20A,cesc_tcga,49.0,M0,N0,7th,T1b1,,,,,,,,,,,,Stage IB1,PRESENT,,,,,0.0,,23.65|0,,NOT HISPANIC OR LATINO,,10/5/11,G3,167.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,,,6.0,Microscopic parametrial involvement,,Cone Biopsy / LEEP,,,23.65|0,,,,f40468de-3b86-4922-9951-f8ae28da6af0,,,,,,,,,,,2.0,,,2.0,,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,BI,,,,TUMOR FREE,59.0,Train,Val,Train,Train,Train,TCGA-BI-A20A-01Z-00-DX1.308DB77E-2A99-4E4F-B231-F88A0E1AA145,WITH TUMOR,DX1,
VENHQS1DNS1BM0hEOmNlc2NfdGNnYQ,TCGA-C5-A3HD,cesc_tcga,51.0,,,1995,,,,,,,,,,,,,Stage IIB,,,,,3.0,0.0,0.0,51.97|0,1.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,4/17/12,G2,170.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2004.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,51.97|0,,,,12427B02-6E3F-461C-B271-6AB230F628E7,,,,,,Preoperative,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,27.0,16.0,1995.0,,C5,4.0,,Complete response,TUMOR FREE,83.0,Test,Test,Test,Test,Test,TCGA-C5-A3HD-01Z-00-DX1.11EECACD-371A-4B16-A21A-8E2A2258D3A9,WITH TUMOR,DX1,
VENHQS1DNS1BM0hFOmNlc2NfdGNnYQ,TCGA-C5-A3HE,cesc_tcga,44.0,M0,N0,1995,T1b2,,,,,,,,,,,,Stage IB2,,,,,,0.0,,8.28|1,,NOT HISPANIC OR LATINO,,1/3/14,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2006.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,"Other Location, specify",,Biopsy (cervical / CT-guided / Other),,YES,18.0|0,,,margins free of tumor,BC63DD2A-B8F6-4B30-A8D7-CE193BCD17F1,,,,,,,NO,,0.0,1.0,0.0,0.0,0.0,1.0,,NO,WHITE,,External beam radiation,YES,,YES,,,,1,Female,Cervical,,,,NO,C5,1.0,,,,,Train,Train,Train,Train,Val,TCGA-C5-A3HE-01Z-00-DX1.9792538B-1DA9-41F0-B1F3-5C13B23AA7E0,WITH TUMOR,DX1,
VENHQS1DNS1BM0hGOmNlc2NfdGNnYQ,TCGA-C5-A3HF,cesc_tcga,24.0,,,1995,,,,,,,,,,,,,Stage IB2,,,,,,0.0,,14.78|1,,NOT HISPANIC OR LATINO,,4/16/12,G2,,Mucinous Adenocarcinoma of Endocervical Type,,,No,No,,,,,,C53.9,8482/3,C53.9,YES,1996.0,,,YES,11.0,,,32.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,17.84|1,,,,085DF27C-9BC2-425A-9A49-547D692EA028,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)|Para-aortic",0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,9.0,16.0,,,C5,2.0,,,WITH TUMOR,,Train,Train,Train,Train,Val,TCGA-C5-A3HF-01Z-00-DX1.2E520845-B9F6-4E56-80C8-2742DE6DF22B,WITH TUMOR,DX1,
VENHQS1DNS1BM0hMOmNlc2NfdGNnYQ,TCGA-C5-A3HL,cesc_tcga,76.0,MX,N0,1995,T1b2,,,,,,,,,,,,Stage IB2,ABSENT,,,,,0.0,,20.4|0,,NOT HISPANIC OR LATINO,,4/17/12,G2,,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2007.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,21.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,20.4|0,,,margins free of tumor,09329A53-D58D-4480-95D8-32043E40DE6E,,,,,,,,,0.0,1.0,4.0,0.0,0.0,5.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,Complete response,TUMOR FREE,,Train,Train,Train,Train,Val,TCGA-C5-A3HL-01Z-00-DX1.324403AE-C1AC-4562-9EC8-9F4287C03FA1,WITH TUMOR,DX1,
VENHQS1DNS1BMFROOmNlc2NfdGNnYQ,TCGA-C5-A0TN,cesc_tcga,21.0,MX,N1,1995,T1b,,,,,,,,,,,,Stage IB2,ABSENT,,,-2.0,,0.0,,2.04|1,,NOT HISPANIC OR LATINO,,8/23/11,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,1997.0,Keratinizing squamous cell carcinoma,PRESENT,YES,2.0,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,10.0,Microscopic parametrial involvement,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",surgery,,11.43|1,,,,14c65927-b9dd-4ef6-9917-db7bc431ff2f,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",,3.0,1.0,,,4.0,,NO,BLACK OR AFRICAN AMERICAN,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,Progression,WITH TUMOR,55.0,Train,Val,Train,Train,Train,TCGA-C5-A0TN-01Z-00-DX1.D5AB52B6-AD7D-494F-B1AC-E3A72EAD9F51,WITH TUMOR,DX1,
VENHQS1DNS1BMU01OmNlc2NfdGNnYQ,TCGA-C5-A1M5,cesc_tcga,53.0,M0,N0,1995,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,,59.26|1,,NOT HISPANIC OR LATINO,,9/19/11,G2,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1996.0,Keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,59.0,"Other Location, specify",Indeterminate (neither Pre or Postmenopausal),Biopsy (cervical / CT-guided / Other),,,67.41|1,,,margins free of tumor,0fec73a1-8d3a-495b-8008-c52f190f4270,,,,,,,,,0.0,0.0,4.0,0.0,0.0,4.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,WITH TUMOR,70.0,Test,Test,Test,Test,Test,TCGA-C5-A1M5-01Z-00-DX1.37D62003-2428-42E7-8396-72C3C04F7E68,WITH TUMOR,DX1,
VENHQS1DNS1BMU02OmNlc2NfdGNnYQ,TCGA-C5-A1M6,cesc_tcga,55.0,,,1995,,,,,,,,,,,,,Stage IIB,,Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,316.0,,,0.0,,10.38|1,,,,9/21/11,G3,165.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,HPV 18,,,,C53.9,8070/3,C53.9,YES,1998.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,31.37|1,,,,825a6fbb-aede-436f-800b-c7f096da0a77,,,,,,,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,WITH TUMOR,77.0,Test,Test,Test,Test,Test,TCGA-C5-A1M6-01Z-00-DX1.13F7405D-AD0E-4A1C-9DF4-00DC90756D28,WITH TUMOR,DX1,
VENHQS1DNS1BMU03OmNlc2NfdGNnYQ,TCGA-C5-A1M7,cesc_tcga,37.0,MX,N0,1995,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,-33.0,46.29|0,1.0,NOT HISPANIC OR LATINO,,1/24/12,G2,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,HPV 18,PCR,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1999.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,30.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",Radical Hysterectomy,,46.29|0,,,margins free of tumor,e8e16aaf-3621-4ce8-b02a-7893dd656e4d,,,GP5+/GP6+,,,Preoperative,,,0.0,0.0,4.0,0.0,1.0,5.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,26.0,16.0,,,C5,2.0,,Complete response,TUMOR FREE,69.0,Val,Train,Train,Train,Train,TCGA-C5-A1M7-01Z-00-DX1.5E02FF3D-8955-4747-A355-A39BBECE42B0,WITH TUMOR,DX1,
VENHQS1DNS1BMU04OmNlc2NfdGNnYQ,TCGA-C5-A1M8,cesc_tcga,43.0,MX,N0,1995,T1b,,,,,,,,,,,,Stage IB1,ABSENT,,,4.0,,0.0,,30.19|0,,NOT HISPANIC OR LATINO,,9/19/11,G2,163.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2001.0,,ABSENT,YES,0.0,0.0,Pelvic Nodes Present,13.0,"Other Location, specify",Indeterminate (neither Pre or Postmenopausal),Cone Biopsy / LEEP,,,30.19|0,,,margins free of tumor,110cd100-5730-4873-9fab-2ae6c8732062,,,,,,,,,0.0,1.0,0.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,TUMOR FREE,75.0,Train,Val,Train,Train,Train,TCGA-C5-A1M8-01Z-00-DX1.E4AA52E6-AC3E-406E-A8FC-66EAD770AA59,WITH TUMOR,DX1,
VENHQS1DNS1BMU05OmNlc2NfdGNnYQ,TCGA-C5-A1M9,cesc_tcga,46.0,M0,N1,1995,T3b,,,,,,,,,,,,Stage IB1,ABSENT,Extra-Pelvic Metastatic Disease Present|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent,5.0,,5.0,0.0,,18.23|1,,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent,9/19/11,G3,155.0,Endocervical Type of Adenocarcinoma,Former User,,No,No,,HPV 16,,,Radical Hysterectomy,C53.9,8140/3,C53.9,YES,2002.0,,PRESENT,YES,14.0,,,19.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,34.99|1,,,margins free of tumor,a3be445a-a592-4073-815b-47ae41f9c4a0,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)|Para-aortic|Supraclavicular",0.0,1.0,0.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,WITH TUMOR,49.0,Train,Val,Train,Train,Train,TCGA-C5-A1M9-01Z-00-DX1.A84760B1-02A8-4380-954A-7A4133E9C763,WITH TUMOR,DX1,
VENHQS1DNS1BMU1FOmNlc2NfdGNnYQ,TCGA-C5-A1ME,cesc_tcga,40.0,M0,N0,1995,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,13.0,,,0.0,,57.69|0,,NOT HISPANIC OR LATINO,,9/19/11,G1,165.0,Endocervical Type of Adenocarcinoma,Former User,,No,No,,HPV 16,,,Radical Hysterectomy,C53.9,8140/3,C53.9,YES,2003.0,,ABSENT,YES,0.0,0.0,,27.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,57.69|0,,,margins free of tumor,a0598331-79e1-418d-b50c-fd945b843506,,,,,,,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,22.0,18.0,2003.0,,C5,4.0,,,TUMOR FREE,69.0,Train,Train,Train,Val,Train,TCGA-C5-A1ME-01Z-00-DX1.44645529-F452-49AD-8044-0C43DDBAE774,WITH TUMOR,DX1,
VENHQS1DNS1BMU1GOmNlc2NfdGNnYQ,TCGA-C5-A1MF,cesc_tcga,49.0,MX,N0,1995,T1b2,,,,,,,,,,,,Stage IB2,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,31.0,,,0.0,34.0,53.12|0,1.0,NOT HISPANIC OR LATINO,,1/25/12,G2,163.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,45,Other HPV type(s),PCR,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2004.0,Keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,40.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,53.12|0,,,margins free of tumor,4f514ed4-3be6-44bc-a531-210027846459,,,GP5+/GP6+,,,Preoperative,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,10.0,20.0,1995.0,,C5,4.0,,Complete response,TUMOR FREE,70.0,Train,Val,Train,Train,Train,TCGA-C5-A1MF-01Z-00-DX1.8C787217-8C11-4296-A955-45DA0B17C2BA,WITH TUMOR,DX1,
VENHQS1DNS1BMU1IOmNlc2NfdGNnYQ,TCGA-C5-A1MH,cesc_tcga,71.0,,,1995,,,,,9.95,,,,,,,,Stage IIIB,,Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,-2.0,,1.0,0.0,,5.85|1,,NOT HISPANIC OR LATINO,Extra-Pelvic Metastatic Disease Absent,9/19/11,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2004.0,Keratinizing squamous cell carcinoma,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,38.96|1,,,,3143822c-66c4-4b58-8d29-e92d065ff049,,,,,,,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,15.0,,2003.0,,C5,3.0,,Progression,WITH TUMOR,,Test,Test,Test,Test,Test,TCGA-C5-A1MH-01Z-00-DX1.3DCE5241-5E79-4FCB-9D98-063F7121CE8D,WITH TUMOR,DX1,
VENHQS1DNS1BMU1JOmNlc2NfdGNnYQ,TCGA-C5-A1MI,cesc_tcga,50.0,M0,N1,1995,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,16.0,,23.0,0.0,,26.45|1,,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,9/19/11,G2,,Cervical Squamous Cell Carcinoma,,"Other, specify",No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2004.0,,PRESENT,YES,1.0,,,17.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,,35.58|1,,Herpes,,941f75a1-fea4-4539-ba69-60bb11608f6d,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",1.0,2.0,2.0,2.0,0.0,7.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,35.0,15.0,,,C5,2.0,,,WITH TUMOR,77.0,Train,Train,Train,Train,Val,TCGA-C5-A1MI-01Z-00-DX1.93D2D53E-C990-4CEE-AF61-A841A3798A74,WITH TUMOR,DX1,
VENHQS1DNS1BMU1KOmNlc2NfdGNnYQ,TCGA-C5-A1MJ,cesc_tcga,61.0,MX,N0,1995,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,,,,,9/21/11,G2,165.0,Endocervical Type of Adenocarcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8140/3,C53.9,YES,2005.0,,PRESENT,YES,0.0,0.0,,18.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,0.46|1,,,margins free of tumor,23f011e2-c025-4494-8016-2140cc8d4bce,,,,,,,,,1.0,2.0,3.0,0.0,0.0,6.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,TUMOR FREE,75.0,Test,Test,Test,Test,Test,TCGA-C5-A1MJ-01Z-00-DX1.727E1B5B-6DBE-4D79-B8D9-0C6C9BFA3204,WITH TUMOR,DX1,
VENHQS1DNS1BMU1LOmNlc2NfdGNnYQ,TCGA-C5-A1MK,cesc_tcga,79.0,,,1995,,,,,,,,,,,,,Stage IIIB,,,,,,0.0,,,,NOT HISPANIC OR LATINO,Paraaortic Nodes Present|Pelvic Nodes Present,10/21/11,G3,155.0,Cervical Squamous Cell Carcinoma,,,No,No,58,Other HPV type(s),,,,C53.9,8070/3,C53.9,YES,2005.0,Keratinizing squamous cell carcinoma,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,2.43|1,,,,b726f18b-b996-4978-9f27-b3a540e06270,,,,,,,,,0.0,2.0,2.0,0.0,1.0,5.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,WITH TUMOR,63.0,Val,Train,Train,Train,Train,TCGA-C5-A1MK-01Z-00-DX1.2C5781B3-C7E1-46CE-8853-E99497A60571,WITH TUMOR,DX1,
VENHQS1DNS1BMU1OOmNlc2NfdGNnYQ,TCGA-C5-A1MN,cesc_tcga,42.0,,,1995,,,,,16.92,,,,,,,,Stage IIIB,,,,,1.0,0.0,875.0,,1.0,NOT HISPANIC OR LATINO,Parametrium Present|Pelvic Nodes Present,10/21/11,G2,165.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2007.0,Keratinizing squamous cell carcinoma,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,40.9|1,,,,287ce10e-31c8-4b10-9858-6e45451dfbe4,,,,,,Post-Adjuvant Therapy,,,0.0,0.0,0.0,0.0,0.0,0.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,25.0,,,,C5,2.0,,Complete response,TUMOR FREE,64.0,Train,Train,Train,Val,Train,TCGA-C5-A1MN-01Z-00-DX1.2D1DE4B8-7463-4708-872E-DA9D8DA2E421,WITH TUMOR,DX1,
VENHQS1DNS1BMU1QOmNlc2NfdGNnYQ,TCGA-C5-A1MP,cesc_tcga,34.0,MX,N1,1995,T1b2,,,,8.7,,,,,,,,Stage IB2,,,7.0,,7.0,0.0,,3.58|0,,NOT HISPANIC OR LATINO,,10/21/11,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2009.0,,PRESENT,YES,6.0,,,54.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,3.58|0,,,margins free of tumor,08a52bcf-d2e9-497b-938a-4660c332e914,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)|Common iliac|Para-aortic",0.0,0.0,3.0,0.0,0.0,3.0,NO,NO,BLACK OR AFRICAN AMERICAN,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,TUMOR FREE,,Train,Val,Train,Train,Train,TCGA-C5-A1MP-01Z-00-DX1.7B976D22-AA7D-45CD-9624-E1BA41D74312,WITH TUMOR,DX1,
VENHQS1DNS1BMU1ROmNlc2NfdGNnYQ,TCGA-C5-A1MQ,cesc_tcga,35.0,M0,N0,1995,T2b,,,,,,,,,,,,Stage IIA,ABSENT,,,,23.0,0.0,,33.87|0,,NOT HISPANIC OR LATINO,,10/21/11,G2,175.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2009.0,,PRESENT,YES,0.0,0.0,,33.0,Microscopic parametrial involvement,,Biopsy (cervical / CT-guided / Other),,,33.87|0,,,,eb59cf69-1997-41b9-bf69-69ad7da292a1,,,,,,,,,0.0,0.0,2.0,2.0,0.0,4.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,TUMOR FREE,116.0,Train,Train,Train,Val,Train,TCGA-C5-A1MQ-01Z-00-DX1.DCC979DF-17B9-4C2C-BF99-84CE0CF13F62,WITH TUMOR,DX1,
VENHQS1DNS1BMUJFOmNlc2NfdGNnYQ,TCGA-C5-A1BE,cesc_tcga,64.0,MX,N1,1995,T1b,,,,,,,,,,,,Stage IB2,PRESENT,,,,,0.0,,54.99|1,,,,9/12/11,G2,149.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2000.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,2.0,,,38.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cone Biopsy / LEEP,,,68.79|1,,,Anterior lower uterine segment,2b6d2c15-8bcc-41ab-84d6-601442f4378b,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",0.0,1.0,4.0,1.0,0.0,6.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,3.0,,,WITH TUMOR,76.0,Train,Train,Train,Val,Train,TCGA-C5-A1BE-01Z-00-DX1.C6EB1805-CF3F-4ECC-8014-ED0AB4AF7911,WITH TUMOR,DX1,
VENHQS1DNS1BMUJGOmNlc2NfdGNnYQ,TCGA-C5-A1BF,cesc_tcga,46.0,MX,N0,1995,TX,,,,,,,,,,,,Stage IB,,Bladder Present|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,13.0,,,0.0,,3.06|1,,,,9/12/11,G1,,Cervical Squamous Cell Carcinoma,,,No,No,,HPV 18,,,,C53.9,8070/3,C53.9,YES,1997.0,Keratinizing squamous cell carcinoma,,YES,0.0,0.0,,33.0,,,Biopsy (cervical / CT-guided / Other),,,18.73|1,,,,262311a0-7a10-4934-8fba-11ee581ad738,,,,,,,,,,,4.0,1.0,,5.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,30.0,,,,C5,2.0,,,WITH TUMOR,76.0,Test,Test,Test,Test,Test,TCGA-C5-A1BF-01Z-00-DX1.293186DB-FB68-4C45-91FC-5C0A789B1D2D,WITH TUMOR,DX1,
VENHQS1DNS1BMUJJOmNlc2NfdGNnYQ,TCGA-C5-A1BI,cesc_tcga,31.0,,,1995,,,,,,,,,,,,,Stage IIIB,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,1.0,,16.0,0.0,,36.53|0,,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,9/12/11,G2,157.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2001.0,,,YES,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",ECC,,36.53|0,,,,91310434-2a99-4e1d-81e6-3d58d097089f,,,,,,,,,0.0,1.0,2.0,0.0,0.0,3.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,15.0,16.0,,,C5,2.0,,,TUMOR FREE,59.0,Train,Train,Train,Train,Val,TCGA-C5-A1BI-01Z-00-DX1.8BDACB17-D5CF-4462-B58F-8C1AF589E093,WITH TUMOR,DX1,
VENHQS1DNS1BMUJKOmNlc2NfdGNnYQ,TCGA-C5-A1BJ,cesc_tcga,34.0,,,1995,,,,,,,,,,,,,Stage IIB,,,,,,0.0,,144.05|0,,,,9/13/11,G2,169.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,1997.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,144.05|0,,,,7941d1c7-5319-4e8d-a15f-60b61cb68a9b,,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,10.0,24.0,1997.0,,C5,4.0,,,TUMOR FREE,49.0,Train,Train,Train,Train,Val,TCGA-C5-A1BJ-01Z-00-DX1.178689C8-25A8-4BE9-B5CF-0D04CCD65CDF,WITH TUMOR,DX1,
VENHQS1DNS1BMUJLOmNlc2NfdGNnYQ,TCGA-C5-A1BK,cesc_tcga,36.0,MX,N0,1988,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,,176.91|0,,NOT HISPANIC OR LATINO,,8/23/11,G2,151.0,Cervical Squamous Cell Carcinoma,,,No,No,52,HPV 16|Other HPV type(s),,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1994.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,20.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",ECC,,176.91|0,,,margins free of tumor,7df6c297-f2d6-43ef-973b-1f95676b0cc4,,,,,,,,,0.0,0.0,4.0,0.0,0.0,4.0,NO,NO,BLACK OR AFRICAN AMERICAN,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,TUMOR FREE,82.0,Train,Val,Train,Train,Train,TCGA-C5-A1BK-01Z-00-DX1.B01FAC89-30CC-4CDB-9104-844DB4069EF8,WITH TUMOR,DX1,
VENHQS1DNS1BMUJMOmNlc2NfdGNnYQ,TCGA-C5-A1BL,cesc_tcga,32.0,,,1988,,,,,,,,,,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,1.0,,,0.0,-5.0,173.16|0,1.0,NOT HISPANIC OR LATINO,,1/24/12,G2,168.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,HPV 16,PCR,,,C53.9,8070/3,C53.9,YES,1994.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,1.0,0.0,,25.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,173.16|0,,,,03c3fe57-ae85-4e45-9657-c3182ab5e124,,,GP5+/GP6+,,,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,12.0,16.0,1988.0,,C5,4.0,,Complete response,TUMOR FREE,78.0,Train,Train,Train,Val,Train,TCGA-C5-A1BL-01Z-00-DX1.E71D7185-85C2-4E08-AA56-006B08FBD630,WITH TUMOR,DX1,
VENHQS1DNS1BMUJNOmNlc2NfdGNnYQ,TCGA-C5-A1BM,cesc_tcga,78.0,MX,N1,1995,T2,,,,,,,,,,,,Stage IB,PRESENT,,22.0,,102.0,0.0,,,,,Extra-Pelvic Metastatic Disease Present,9/21/11,G2,171.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1997.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,8.0,0.0,,23.0,Positive vaginal margin,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,82.79|1,,,,7fb8e7be-4118-41f8-b785-5cbb0afdb8b7,perigastric,,,,,,,"Pelvic (external iliac, internal iliac, obturator)|Other Location, specify",0.0,0.0,2.0,1.0,0.0,3.0,NO,NO,BLACK OR AFRICAN AMERICAN,,,,,YES,,,,1,Female,Cervical,,,,,C5,4.0,,,TUMOR FREE,56.0,Val,Train,Train,Train,Train,TCGA-C5-A1BM-01Z-00-DX1.81ABAED9-1156-4159-BFC7-53FA341FE00F,WITH TUMOR,DX1,
VENHQS1DNS1BMUJOOmNlc2NfdGNnYQ,TCGA-C5-A1BN,cesc_tcga,26.0,,,1995,,,,,17.36,,,,,,,,Stage IB2,,,,,1.0,0.0,,,,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,9/21/11,G3,163.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2007.0,,PRESENT,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,5.45|1,,,,8a4da4f0-30f2-497e-8a7c-988fd6b813cb,,,,,,,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,11.0,15.0,,,C5,2.0,,,WITH TUMOR,68.0,Test,Test,Test,Test,Test,TCGA-C5-A1BN-01Z-00-DX1.75ED1BD9-C458-42D3-8A98-8FE41BB9CC2E,WITH TUMOR,DX1,
VENHQS1DNS1BMUJROmNlc2NfdGNnYQ,TCGA-C5-A1BQ,cesc_tcga,65.0,,,1995,,,HDR,,,Once weekly,,6,,,Cisplatin,,Stage IIIB,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,8/7/12,G2,147.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8071/3,C53.9,YES,2002.0,Keratinizing squamous cell carcinoma,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,19.84|1,,,,E77C3F70-08D1-40D3-B038-F09A519423CC,,Cervical Cancer,,,,,YES,,0.0,0.0,6.0,3.0,1.0,10.0,NO,NO,WHITE,,External beam radiation,YES,,YES,,,,1,Female,Cervical,25.0,12.0,1999.0,YES,C5,4.0,Partial Remission/Response,,TUMOR FREE,69.0,Train,Train,Train,Train,Val,TCGA-C5-A1BQ-01Z-00-DX1.72164F1F-956F-4C46-A7B7-CBF8DBEC2E56,WITH TUMOR,DX1,
VENHQS1DNS1BMk0xOmNlc2NfdGNnYQ,TCGA-C5-A2M1,cesc_tcga,37.0,MX,N0,1995,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,13.0,38.4|0,1.0,NOT HISPANIC OR LATINO,,2/8/12,G2,168.0,Endocervical Type of Adenocarcinoma,Former User,,No,No,,HPV 16,PCR,,Radical Hysterectomy,C53.9,8384/3,C53.9,YES,2005.0,,ABSENT,YES,0.0,0.0,,31.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,38.4|0,,,margins free of tumor,8911C80C-C903-48E4-AF5B-FFEDEF9ABC47,,,GP5+/GP6+,,,Preoperative,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,Complete response,TUMOR FREE,76.0,Test,Test,Test,Test,Test,TCGA-C5-A2M1-01Z-00-DX1.E03FE8EC-002B-4673-ACC5-A32F1CA94A98,WITH TUMOR,DX1,
VENHQS1DNS1BMk0yOmNlc2NfdGNnYQ,TCGA-C5-A2M2,cesc_tcga,56.0,,,2009,,,,,,,,,,,,,Stage IB2,,,,,18.0,0.0,,,,NOT HISPANIC OR LATINO,Bladder Absent|Parametrium Absent|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent,4/4/12,G2,,Endocervical Type of Adenocarcinoma,Former User,,No,No,,,,,,C53.9,8140/3,C53.9,YES,2009.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,33.21|1,,,,77D53D4D-3B07-4C79-86FE-6AC812968F39,,,,,,,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,8.0,24.0,2003.0,,C5,4.0,,,,,Val,Train,Train,Train,Train,TCGA-C5-A2M2-01Z-00-DX1.145589C8-870A-49BD-BC54-A8951E2DEDE3,WITH TUMOR,DX1,
VENHQS1DNS1BMkxTOmNlc2NfdGNnYQ,TCGA-C5-A2LS,cesc_tcga,37.0,M0,N0,1995,T1b2,,,,,,,,,,,,Stage IB2,,,,,,0.0,,44.19|0,,NOT HISPANIC OR LATINO,,1/3/14,G1,173.0,Endocervical Adenocarcinoma of the Usual Type,,,No,No,,,,,Radical Hysterectomy,C53.9,8380/3,C53.9,YES,2005.0,,,YES,0.0,,,41.0,"Other Location, specify",,Biopsy (cervical / CT-guided / Other),,NO,44.19|0,,,margins free of tumor,185E1520-92EE-4AF5-AF15-FBEEFB352C99,,,,,,,NO,,0.0,0.0,2.0,1.0,0.0,3.0,NO,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,11.0,17.0,,NO,C5,2.0,Complete Remission/Response,,TUMOR FREE,92.0,Train,Train,Val,Train,Train,TCGA-C5-A2LS-01Z-00-DX1.9856EC9C-04C8-4784-B294-0D515F20A6AF,WITH TUMOR,DX1,
VENHQS1DNS1BMkxUOmNlc2NfdGNnYQ,TCGA-C5-A2LT,cesc_tcga,38.0,M0,N0,1995,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,14.0,73.13|0,1.0,NOT HISPANIC OR LATINO,,1/24/12,G3,163.0,Cervical Squamous Cell Carcinoma,Current User,,No,No,70,Other HPV type(s),PCR,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2001.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,31.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,73.13|0,,,margins free of tumor,FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781,,,GP5+/GP6+,,,Preoperative,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,19.0,20.0,,,C5,2.0,,Complete response,TUMOR FREE,59.0,Test,Test,Test,Test,Test,TCGA-C5-A2LT-01Z-00-DX1.3976C725-D766-468F-92BF-789D5280C11B,WITH TUMOR,DX1,
VENHQS1DNS1BMkxWOmNlc2NfdGNnYQ,TCGA-C5-A2LV,cesc_tcga,36.0,MX,N1,1995,T1b,,,,,,,,,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,8.0,,,0.0,-1.0,73.39|0,1.0,NOT HISPANIC OR LATINO,,2/8/12,G3,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,HPV 16,PCR,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2003.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,1.0,0.0,,49.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,73.39|0,,,margins free of tumor,00BCA18C-B3D4-45A3-8F19-034CC40449A4,,,GP5+/GP6+,,,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",0.0,2.0,3.0,1.0,0.0,6.0,NO,NO,BLACK OR AFRICAN AMERICAN,,,,,YES,,,,1,Female,Cervical,16.0,20.0,,,C5,2.0,,Complete response,TUMOR FREE,84.0,Test,Test,Test,Test,Test,TCGA-C5-A2LV-01Z-00-DX1.B8C938D3-FCD8-43C9-8520-6645875FCD30,WITH TUMOR,DX1,
VENHQS1DNS1BMkxYOmNlc2NfdGNnYQ,TCGA-C5-A2LX,cesc_tcga,54.0,MX,N1,1995,T2,,,,,,,,,,,,Stage IB1,ABSENT,,,,31.0,0.0,52.0,82.98|0,1.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,2/8/12,G2,165.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,HPV 16,PCR,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2007.0,Keratinizing squamous cell carcinoma,PRESENT,YES,3.0,0.0,,39.0,Positive vaginal margin,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,82.98|0,,,,B82F4C6D-530F-4B0E-8F33-995633CB254A,,,GP5+/GP6+,severe squamous dysplasia (CIN3) extending to the vaginal margin of excision,,Pre-Adjuvant Therapy,,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,4.0,0.0,0.0,4.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,35.0,18.0,,,C5,2.0,,Complete response,TUMOR FREE,65.0,Train,Val,Train,Train,Train,TCGA-C5-A2LX-01Z-00-DX1.6029EAB9-19ED-46AC-BF9A-1754D39E76E9,WITH TUMOR,DX1,
VENHQS1DNS1BMkxZOmNlc2NfdGNnYQ,TCGA-C5-A2LY,cesc_tcga,30.0,M0,N0,1995,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,12.0,,12.0,0.0,15.0,78.29|0,1.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,1/25/12,G2,160.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,HPV 16,PCR,,,C53.9,8070/3,C53.9,YES,2002.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,8.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,78.29|0,,,,E733F289-A0EC-478C-AAD9-1378AD26DDFA,,,GP5+/GP6+,,,Preoperative,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,Complete response,TUMOR FREE,88.0,Train,Train,Train,Train,Val,TCGA-C5-A2LY-01Z-00-DX1.14B39C98-A637-44DB-93F3-7904A7F08182,WITH TUMOR,DX1,
VENHQS1DNS1BMkxaOmNlc2NfdGNnYQ,TCGA-C5-A2LZ,cesc_tcga,65.0,,,1995,,,LDR,,,,,,Not done per treating physicians discretion,,,,Stage IIIB,,,,,,0.0,,95.04|1,,NOT HISPANIC OR LATINO,,7/10/12,G2,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,1998.0,Keratinizing squamous cell carcinoma,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,YES,100.07|1,,,,BE8FA67D-C2D3-4FFF-82FE-A46BA1FA8DF0,,Cervical Cancer,,,,,NO,,0.0,0.0,4.0,1.0,0.0,5.0,NO,NO,WHITE,,External beam radiation,YES,,YES,,,4500.0,1,Female,Cervical,50.0,15.0,,NO,C5,2.0,Complete Remission/Response,,WITH TUMOR,85.0,Val,Train,Train,Train,Train,TCGA-C5-A2LZ-01Z-00-DX1.D5CB77BD-EDA8-4D2E-8041-DFB946A131C1,WITH TUMOR,DX1,
VENHQS1DNS1BN0NHOmNlc2NfdGNnYQ,TCGA-C5-A7CG,cesc_tcga,55.0,MX,N0,1995,T1b,,,,,,,,Not done per treating physicians discretion,,,,Stage IB,,,20.0,,,0.0,,210.51|0,,NOT HISPANIC OR LATINO,,1/3/14,G2,169.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1997.0,Keratinizing squamous cell carcinoma,,YES,0.0,,,47.0,"Other Location, specify",,Biopsy (cervical / CT-guided / Other),,NO,210.51|0,,,margins free of tumor,F2C901D1-2039-4046-89B5-C2D45BCF10C3,,,,,,,NO,,0.0,0.0,5.0,0.0,1.0,6.0,,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,,,,NO,C5,1.0,,,TUMOR FREE,94.0,Val,Train,Train,Train,Train,TCGA-C5-A7CG-01Z-00-DX1.42D2FD26-D8ED-49DA-AEF0-FCAD9DB6B4BD,WITH TUMOR,DX1,
VENHQS1DNS1BN0NIOmNlc2NfdGNnYQ,TCGA-C5-A7CH,cesc_tcga,43.0,,,1995,,,,,,,,,,,,,Stage IIB,,,,,,0.0,,154.2|0,,NOT HISPANIC OR LATINO,,1/3/14,G2,161.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2001.0,Keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,154.2|0,,,,D626A732-AF64-4DEC-B4BF-3CB761BF4C8D,,,,,,,YES,,0.0,1.0,8.0,0.0,0.0,9.0,,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,,,,YES,C5,1.0,,,,104.0,Train,Train,Train,Val,Train,TCGA-C5-A7CH-01Z-00-DX1.135C076E-0B56-415F-9693-74730157730F,WITH TUMOR,DX1,
VENHQS1DNS1BN0NKOmNlc2NfdGNnYQ,TCGA-C5-A7CJ,cesc_tcga,42.0,MX,N1,1995,T2a,,,,,,,,,,Cisplatin,,Stage IIA,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,1/3/14,G2,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2002.0,Keratinizing squamous cell carcinoma,,YES,2.0,,,30.0,"Other Location, specify",,Biopsy (cervical / CT-guided / Other),,NO,101.74|1,,,margins free of tumor,F8F470D2-924F-41DD-92C5-516B0BF68E44,,,,,,,YES,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,2.0,0.0,0.0,2.0,,NO,WHITE,,External beam radiation,YES,,YES,,,,1,Female,Cervical,30.0,22.0,,YES,C5,2.0,,,TUMOR FREE,60.0,Train,Train,Val,Train,Train,TCGA-C5-A7CJ-01Z-00-DX1.BEDCF053-02EE-4A5F-8134-C8E2AB556ED4,WITH TUMOR,DX1,
VENHQS1DNS1BN0NLOmNlc2NfdGNnYQ,TCGA-C5-A7CK,cesc_tcga,58.0,,,1995,,,,,,,,,,,Cisplatin,,Stage IVA,,,,,,0.0,,,,,,1/3/14,G2,165.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2001.0,Keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,134.23|1,,,,1C48393E-7DE9-42F6-A6F0-2CBFB8359316,,,,,,,YES,,0.0,0.0,3.0,0.0,0.0,3.0,,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,40.0,,,YES,C5,5.0,,,TUMOR FREE,55.0,Train,Train,Train,Val,Train,TCGA-C5-A7CK-01Z-00-DX1.F2C3A27B-494E-491F-9E3B-B91B20E50C6C,WITH TUMOR,DX1,
VENHQS1DNS1BN0NMOmNlc2NfdGNnYQ,TCGA-C5-A7CL,cesc_tcga,48.0,,,1995,,,,,,,,,,,Cisplatin,,Stage IIIB,,,,,,0.0,,,,,,1/3/14,G2,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2002.0,Keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,15.47|1,,,,BAE2AF5E-484A-44F7-AD6B-66137CDAE300,,Cervical Cancer,,,,,YES,,0.0,0.0,3.0,0.0,0.0,3.0,,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,20.0,29.0,,YES,C5,2.0,,,WITH TUMOR,103.0,Test,Test,Test,Test,Test,TCGA-C5-A7CL-01Z-00-DX1.AF88B99D-C1BB-489F-BAD4-F65119B1938F,WITH TUMOR,DX1,
VENHQS1DNS1BN0NNOmNlc2NfdGNnYQ,TCGA-C5-A7CM,cesc_tcga,35.0,,,2009,,,HDR,,,,,,,,Cisplatin,,Stage IB2,,,,,,0.0,294.0,20.34|0,0.0,HISPANIC OR LATINO,,1/3/14,G2,168.0,Endocervical Adenocarcinoma of the Usual Type,,,No,No,,,,,,C53.9,8384/3,C53.9,YES,2012.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,20.34|0,,,,D223FF09-B80B-4368-9D80-A59DFBE4D820,,,,,,Post-Adjuvant Therapy,YES,,,,,,,,,NO,WHITE,,External beam radiation,YES,,YES,,,5040.0,1,Female,Cervical,,,1997.0,YES,C5,4.0,Complete Remission/Response,,TUMOR FREE,75.0,Val,Train,Train,Train,Train,TCGA-C5-A7CM-01Z-00-DX1.A1886113-2505-4EE3-8170-389AB304EE6C,WITH TUMOR,DX1,
VENHQS1DNS1BN0NPOmNlc2NfdGNnYQ,TCGA-C5-A7CO,cesc_tcga,68.0,,,1995,,,,,,,,,,,Cisplatin,,Stage IB2,,,,,,0.0,,147.24|0,,NOT HISPANIC OR LATINO,,1/3/14,G2,158.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.0,8070/3,C53.0,YES,2002.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,147.24|0,,,,FF3808E4-EECE-4046-819B-FE1019317F8E,,,,,,,YES,,0.0,0.0,5.0,0.0,0.0,5.0,,NO,WHITE,,External beam radiation,YES,,YES,,,5040.0,1,Female,Cervical,38.0,20.0,1972.0,YES,C5,3.0,,,TUMOR FREE,98.0,Test,Test,Test,Test,Test,TCGA-C5-A7CO-01Z-00-DX1.5768F541-4C7C-4D1C-86F8-8213FEC0AE78,WITH TUMOR,DX1,
VENHQS1DNS1BN1VDOmNlc2NfdGNnYQ,TCGA-C5-A7UC,cesc_tcga,48.0,M0,N0,1995,T1b,,,,,,,,Not done per treating physicians discretion,,,,Stage IB,,,,,,0.0,,,,,,1/3/14,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2002.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,,,27.0,"Other Location, specify",,,,,17.18|1,,,margins free of tumor,5C326E9B-85E2-4673-9033-C11827467E1A,,,,,,,NO,,,,,,,,,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,,,,NO,C5,,,,TUMOR FREE,,Train,Train,Train,Train,Val,TCGA-C5-A7UC-01Z-00-DX1.C2323A50-013C-44B9-92CF-93C1C1D27352,WITH TUMOR,DX1,
VENHQS1DNS1BN1VFOmNlc2NfdGNnYQ,TCGA-C5-A7UE,cesc_tcga,45.0,,,1995,,,HDR,,,,1000 ml,6,,,Cisplatin,,Stage IB1,,,,,,0.0,,155.65|0,,,,1/3/14,G2,160.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2001.0,,,YES,1.0,,,23.0,,,Biopsy (cervical / CT-guided / Other),,NO,155.65|0,,,,DA30A845-C4D3-4C78-B8B0-210239224F8F,,,,,,,YES,"Pelvic (external iliac, internal iliac, obturator)",0.0,1.0,3.0,0.0,0.0,4.0,,NO,WHITE,,,YES,,YES,,,3060.0,1,Female,Cervical,35.0,17.0,,YES,C5,2.0,,,TUMOR FREE,63.0,Train,Val,Train,Train,Train,TCGA-C5-A7UE-01Z-00-DX1.7C6A6BB7-0BA8-47A1-A712-21D889293AFE,WITH TUMOR,DX1,
VENHQS1DNS1BN1VIOmNlc2NfdGNnYQ,TCGA-C5-A7UH,cesc_tcga,55.0,,,1995,,,HDR,,,,,,,,Cisplatin,,Stage IIIB,,,,,,0.0,,131.01|0,,NOT HISPANIC OR LATINO,,1/3/14,G3,163.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2003.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,131.01|0,,,,8328925E-3324-4188-85F1-6FFBF819D9E7,,,,,,,YES,,0.0,0.0,2.0,0.0,0.0,2.0,,NO,WHITE,,External beam radiation,YES,,YES,,,,1,Female,Cervical,,,,YES,C5,1.0,,,TUMOR FREE,56.0,Train,Train,Val,Train,Train,TCGA-C5-A7UH-01Z-00-DX1.861C8F5A-5DDA-43EA-8266-0B134B0FE8EF,WITH TUMOR,DX1,
VENHQS1DNS1BN1VJOmNlc2NfdGNnYQ,TCGA-C5-A7UI,cesc_tcga,42.0,MX,N0,1995,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,4/1/14,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2004.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,,,24.0,"Other Location, specify",,Biopsy (cervical / CT-guided / Other),,NO,94.88|1,,,margins free of tumor,CE5765FB-5221-4CBF-AA76-BB863803DF57,,,,,,,NO,,,,3.0,1.0,,4.0,NO,NO,BLACK OR AFRICAN AMERICAN,,,NO,,YES,,,,1,Female,Cervical,12.0,,,,C5,2.0,,,TUMOR FREE,86.0,Train,Val,Train,Train,Train,TCGA-C5-A7UI-01Z-00-DX1.15F300B4-2C82-4D3E-9011-285AF996A475,WITH TUMOR,DX1,
VENHQS1DNS1BN1g1OmNlc2NfdGNnYQ,TCGA-C5-A7X5,cesc_tcga,72.0,,,1995,,,HDR,,,[Not Available]|[Not Available],[Not Available]|[Not Available],[Not Available]|[Not Available],,,Carboplatin|Other,[Not Applicable]|Taxol,Stage IVB,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,1/3/14,G3,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8071/3,C53.9,YES,2003.0,Keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,13.6|1,,,,AED93A3A-7DCB-4BA9-84C0-BC735CBD545F,,Cervical Cancer,,,,,YES,,,,,,,,,NO,BLACK OR AFRICAN AMERICAN,,,YES,,YES,,,,1,Female,Cervical,,,,YES,C5,,,,WITH TUMOR,59.0,Train,Train,Train,Val,Train,TCGA-C5-A7X5-01Z-00-DX1.C1E65119-AF9B-457E-8864-17A782BBC9D2,WITH TUMOR,DX1,
VENHQS1DNS1BN1g4OmNlc2NfdGNnYQ,TCGA-C5-A7X8,cesc_tcga,35.0,M0,N1,1995,T2a,,HDR,,,,,,,,Cisplatin,,Stage IB1,,,,,,0.0,,2.73|0,,NOT HISPANIC OR LATINO,,1/3/14,G2,170.0,Mucinous Adenocarcinoma of Endocervical Type,,,No,No,,,,,Radical Hysterectomy,C53.9,8482/3,C53.9,YES,2003.0,,PRESENT,YES,1.0,,,27.0,"Other Location, specify",,Biopsy (cervical / CT-guided / Other),,NO,2.73|0,,,margins free of tumor,57902B91-BE42-441D-8807-A5EA9C21B214,,,,,,,YES,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,2.0,1.0,0.0,3.0,,NO,WHITE,,External beam radiation,YES,,YES,,,720.0,1,Female,Cervical,5.0,25.0,,YES,C5,2.0,,,TUMOR FREE,74.0,Train,Train,Train,Val,Train,TCGA-C5-A7X8-01Z-00-DX1.868FD898-B9FA-4A24-AC99-1B81D8A456B4,WITH TUMOR,DX1,
VENHQS1DNS1BN1gzOmNlc2NfdGNnYQ,TCGA-C5-A7X3,cesc_tcga,70.0,,,1995,,,HDR,,,[Not Available]|[Not Available],[Not Available]|[Not Available],[Not Available]|[Not Available],,,Cisplatin|Other,[Not Applicable]|5 fu RTOG protocol,Stage IIIB,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,1/3/14,G2,160.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8072/3,C53.9,YES,1997.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,9.33|1,,,,4ED1616E-8C62-4104-BCBE-26D7059F04D0,,,,,,,YES,,0.0,0.0,7.0,0.0,0.0,7.0,,NO,WHITE,,External beam radiation,YES,,YES,,,3060.0,1,Female,Cervical,,,,YES,C5,1.0,,,TUMOR FREE,79.0,Test,Test,Test,Test,Test,TCGA-C5-A7X3-01Z-00-DX1.70B9752B-0E55-429A-93E8-E3EE8491DDB5,WITH TUMOR,DX1,
VENHQS1DNS1BN1hDOmNlc2NfdGNnYQ,TCGA-C5-A7XC,cesc_tcga,26.0,M0,N0,1995,T1b,,,,,,,,,,,,Stage IB1,,,,,,0.0,,50.95|0,,NOT HISPANIC OR LATINO,,5/7/14,G2,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2004.0,,,YES,0.0,,,42.0,"Other Location, specify",,Biopsy (cervical / CT-guided / Other),,NO,50.95|0,,,margins free of tumor,DEDFD5FB-3C72-40F9-A7EF-52C2176BF662,,,,,,,NO,,,,1.0,,,1.0,NO,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,5.0,,,,C5,2.0,,,TUMOR FREE,53.0,Train,Train,Train,Train,Val,TCGA-C5-A7XC-01Z-00-DX1.C73CA509-2FE4-422A-82F3-851A240AB170,WITH TUMOR,DX1,
VENHQS1DNS1BOFhIOmNlc2NfdGNnYQ,TCGA-C5-A8XH,cesc_tcga,39.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,4/17/14,,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2007.0,Keratinizing squamous cell carcinoma,,YES,0.0,,,33.0,"Other Location, specify",,Biopsy (cervical / CT-guided / Other),,NO,45.8|1,,,margins free of tumor,183E8D87-3476-46BC-A989-ED4B09809227,,,,,,,NO,,,,2.0,,,2.0,NO,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,20.0,,2007.0,,C5,4.0,,,TUMOR FREE,60.0,Train,Train,Train,Train,Val,TCGA-C5-A8XH-01Z-00-DX1.BF77955E-29C9-4D06-8FD4-A14B089B2BCE,WITH TUMOR,DX1,
VENHQS1DNS1BOFhJOmNlc2NfdGNnYQ,TCGA-C5-A8XI,cesc_tcga,69.0,MX,N0,1995,T1b2,,,,,,,,,,,,Stage IB2,,,,,,0.0,,8.34|0,,,,4/17/14,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2008.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,,,10.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,8.34|0,,,margins free of tumor,959FE574-054A-4FEF-9CBE-A801A9A355DE,,,,,,,YES,,,,4.0,1.0,,5.0,,NO,BLACK OR AFRICAN AMERICAN,,,YES,,YES,,,,1,Female,Cervical,57.0,29.0,,,C5,2.0,,,TUMOR FREE,,Train,Val,Train,Train,Train,TCGA-C5-A8XI-01Z-00-DX1.7E8E0C2A-D3D4-4DCA-9B4E-70A8EBC48E67,WITH TUMOR,DX1,
VENHQS1DNS1BOFhKOmNlc2NfdGNnYQ,TCGA-C5-A8XJ,cesc_tcga,74.0,,,1995,,,,,,,,,,,,,Stage IB,,,,,,0.0,,146.75|0,,NOT HISPANIC OR LATINO,,4/17/14,,160.0,Cervical Squamous Cell Carcinoma,,,No,Yes,,,,,,C53.9,8070/3,C53.9,YES,2002.0,,,NO,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,146.75|0,,,,E89D0CB1-6EC2-43EE-A6D9-B922B680AF34,,,,,,,YES,,,,4.0,,,4.0,,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,,,,,C5,1.0,,,TUMOR FREE,114.0,Train,Val,Train,Train,Train,TCGA-C5-A8XJ-01Z-00-DX1.E94CFC7B-A580-4862-BD2E-3F65CF761321,WITH TUMOR,DX1,
VENHQS1DNS1BOFhLOmNlc2NfdGNnYQ,TCGA-C5-A8XK,cesc_tcga,30.0,,,,,,,,,,,,,,,,,,,,,,0.0,,99.84|0,,,,4/1/14,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2000.0,,,NO,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,99.84|0,,,,8AC819B3-4227-4EAE-BE03-8760B197DF9A,,,,,,,YES,,,,,,,,,NO,BLACK OR AFRICAN AMERICAN,,,YES,,YES,,,,1,Female,Cervical,,,,YES,C5,,,,TUMOR FREE,,Train,Train,Train,Train,Val,TCGA-C5-A8XK-01Z-00-DX1.DF0D3695-161F-4873-BAE9-27CEE0D4A7A0,WITH TUMOR,DX1,
VENHQS1DNS1BOFlROmNlc2NfdGNnYQ,TCGA-C5-A8YQ,cesc_tcga,79.0,,,1995,,,,,,,,,,,,,Stage IB1,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,4/17/14,G2,165.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2006.0,,,YES,3.0,,,23.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,23.49|1,,,,DE3CFB81-25C3-4137-8F24-AD8AA607C158,,Cervical Cancer,,,,,YES,,,,1.0,,,2.0,,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,56.0,23.0,,,C5,2.0,,,WITH TUMOR,70.0,Train,Train,Train,Train,Val,TCGA-C5-A8YQ-01Z-00-DX1.7C89A1ED-0C03-4668-9378-FE445AF14F5A,WITH TUMOR,DX1,
VENHQS1DNS1BOFlUOmNlc2NfdGNnYQ,TCGA-C5-A8YT,cesc_tcga,36.0,,,1995,,,,,,,,,,,,,Stage IB1,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,4/17/14,G3,,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2008.0,,,NO,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,20.8|1,,,,CECAECB4-51EF-407D-A882-0E4B444B0A77,,,,,,,YES,,,,3.0,,,3.0,,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,20.0,16.0,,,C5,2.0,,,WITH TUMOR,,Train,Train,Train,Train,Val,TCGA-C5-A8YT-01Z-00-DX1.5609D977-4B7E-4B49-A3FB-50434D6E49F9,WITH TUMOR,DX1,
VENHQS1DNS1BOFpaOmNlc2NfdGNnYQ,TCGA-C5-A8ZZ,cesc_tcga,41.0,,,1995,,,,,,,,,,,,,Stage IIB,,,,,,0.0,,20.89|0,,NOT HISPANIC OR LATINO,,4/17/14,G2,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8071/3,C53.9,YES,2005.0,Keratinizing squamous cell carcinoma,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cone Biopsy / LEEP,,NO,20.89|0,,,,33BC6504-D9AB-4B64-A87C-012915F36644,,,,,,,YES,,0.0,0.0,4.0,0.0,0.0,4.0,,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,20.0,21.0,,,C5,2.0,,,TUMOR FREE,,Val,Train,Train,Train,Train,TCGA-C5-A8ZZ-01Z-00-DX1.DD2D0761-66A0-4823-A922-FDF4ABA0AC34,WITH TUMOR,DX1,
VENHQS1DNS1BOTA1OmNlc2NfdGNnYQ,TCGA-C5-A905,cesc_tcga,37.0,MX,N0,1988,T1b,,,,,,,,,,,,Stage IB,,,,,,0.0,,160.28|0,,NOT HISPANIC OR LATINO,,4/1/14,G2,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1994.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,,,33.0,,,Biopsy (cervical / CT-guided / Other),,NO,160.28|0,,,,C99F476B-E8B1-4CDD-9164-0DA450064886,,,,,,,NO,,,,9.0,,,9.0,NO,NO,BLACK OR AFRICAN AMERICAN,,,NO,,YES,,,,1,Female,Cervical,,,,,C5,,,,TUMOR FREE,73.0,Train,Train,Train,Train,Val,TCGA-C5-A905-01Z-00-DX1.CD4B818F-C70D-40C9-9968-45DF22F1B149,WITH TUMOR,DX1,
VENHQS1DNS1BOTA3OmNlc2NfdGNnYQ,TCGA-C5-A907,cesc_tcga,47.0,,,2009,,,,,,Once weekly,,6,,,Cisplatin,,Stage IB2,,,,,,0.0,,14.72|0,,NOT HISPANIC OR LATINO,,4/1/14,G2,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,,,NO,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,14.72|0,,,,C92696BA-F549-480D-8D4A-5F23B27AA336,,,,,,,YES,,,,3.0,1.0,,4.0,NO,NO,WHITE,,,YES,,YES,,,4860.0,1,Female,Cervical,,17.0,2006.0,YES,C5,4.0,,,TUMOR FREE,95.0,Train,Train,Val,Train,Train,TCGA-C5-A907-01Z-00-DX1.7DEEFC23-B631-419E-B5E0-8F9B8E974D1F,WITH TUMOR,DX1,
VENHQS1DNS1BOTAxOmNlc2NfdGNnYQ,TCGA-C5-A901,cesc_tcga,44.0,MX,N1,5th,TX,,,,,,,,,,,,,,,,,,0.0,,17.02|0,,,,4/1/14,G2,166.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2000.0,Keratinizing squamous cell carcinoma,,YES,2.0,,,19.0,Positive vaginal margin,,Cytology (e.g. Peritoneal or pleural fluid),,NO,17.02|0,,,,E8F07D20-D043-4C69-8898-87D0F0FC5A9A,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)",,,,,,0.0,,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,2.0,,,,C5,5.0,,,TUMOR FREE,54.0,Train,Train,Train,Val,Train,TCGA-C5-A901-01Z-00-DX1.44C62D0E-8DDC-4FF3-9D55-3CA9ED7BFFC0,WITH TUMOR,DX1,
VENHQS1DNS1BOTAyOmNlc2NfdGNnYQ,TCGA-C5-A902,cesc_tcga,35.0,,,2009,,,,,,,,,,,,,Stage IB2,,,,,,0.0,,4.89|0,,NOT HISPANIC OR LATINO,,4/17/14,G3,177.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2008.0,,,NO,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,4.89|0,,,,010A807F-9DC0-4E14-9533-DCF478F3D947,,,,,,,YES,,,,1.0,,,1.0,,NO,BLACK OR AFRICAN AMERICAN,,,YES,,YES,,,,1,Female,Cervical,21.0,14.0,,,C5,2.0,,,TUMOR FREE,83.0,Val,Train,Train,Train,Train,TCGA-C5-A902-01Z-00-DX1.60DE8B66-8381-4218-8CA3-63CDB2EE358E,WITH TUMOR,DX1,
VENHQS1ERy1BMktIOmNlc2NfdGNnYQ,TCGA-DG-A2KH,cesc_tcga,25.0,M0,N0,1995,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,1.12|0,0.0,,,10/11/13,GX,,Adenosquamous,,,No,No,,,,,Radical Hysterectomy,C53.9,8140/3,C53.9,YES,,,ABSENT,YES,0.0,0.0,,12.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,1.12|0,,,,6248F2A3-0DA9-419F-AB77-C3F6F4353EB5,,,,The pelvic nodules show circumscribed area of adipose tissue with local fat necrosis. No evidence of malignancy within this pelvic nodule.,,Pre-Adjuvant Therapy,,,,,1.0,,,,NO,NO,,,,,,YES,,,,1,Female,Cervical,,,,,DG,4.0,,,,,Train,Train,Val,Train,Train,TCGA-DG-A2KH-01Z-00-DX1.A223508A-D3EE-4EB0-9578-C8926FF625E3,WITH TUMOR,DX1,
VENHQS1ERy1BMktKOmNlc2NfdGNnYQ,TCGA-DG-A2KJ,cesc_tcga,50.0,M0,N1,1995,T1b,,,,,,,,,,,,Stage IIIB,ABSENT,Bladder Absent|[Not Available]|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,,,,0.0,,95.04|0,0.0,,,10/10/13,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2006.0,Non-keratinizing squamous cell carcinoma,,YES,1.0,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,23.0,,,"Other method, specify:",endometrial biopsy,,95.04|0,,,,7C93642D-7E05-40F8-B1EF-A014EDCFBA42,,,,,,Pre-Adjuvant Therapy,,"Pelvic (external iliac, internal iliac, obturator)",,,,,,,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,DG,,,,TUMOR FREE,,Train,Val,Train,Train,Train,TCGA-DG-A2KJ-01Z-00-DX1.3BAFB571-9A8B-4757-ABAD-7C44E2FA36AF,WITH TUMOR,DX1,
VENHQS1ERy1BMktLOmNlc2NfdGNnYQ,TCGA-DG-A2KK,cesc_tcga,51.0,M0,N1,1995,T1b1,,,,,,,,,,,,Stage IIIB,ABSENT,Bladder Absent|[Not Available]|Parametrium Absent|[Not Available]|Pelvic Nodes Present,,,,0.0,,82.0|0,0.0,,,10/11/13,G3,157.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8140/3,C53.9,YES,2007.0,,PRESENT,YES,2.0,0.0,Bladder Absent|[Not Available]|Parametrium Absent|[Not Available]|Pelvic Nodes Present|[Not Available],28.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,82.0|0,,,Not involved,8DBCB17D-0396-4FAA-9B32-8E2566424BFF,,,,,,Pre-Adjuvant Therapy,,"Pelvic (external iliac, internal iliac, obturator)",,,,,,0.0,,NO,,,,,,YES,,,,1,Female,Cervical,25.0,27.0,2007.0,,DG,4.0,Complete Remission/Response,,TUMOR FREE,64.0,Train,Train,Val,Train,Train,TCGA-DG-A2KK-01Z-00-DX1.248D92C3-AD5B-4F3C-AE5C-6F8C70C7AE87,WITH TUMOR,DX1,
VENHQS1ERy1BMktMOmNlc2NfdGNnYQ,TCGA-DG-A2KL,cesc_tcga,53.0,M0,N0,1995,T2a,,,,,,,,,,,,Stage IIA,ABSENT,Bladder Absent|[Not Available]|Parametrium Absent|[Not Available]|Pelvic Nodes Absent|[Not Available],,,,0.0,,44.91|0,0.0,,,6/20/14,G1,155.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,,Keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,8.0,Positive vaginal margin,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Dilation and curettage,NO,44.91|0,,,,2DA977FC-8B46-4C40-9636-B12FD36A98E4,,,,,,Pre-Adjuvant Therapy,,,0.0,0.0,5.0,0.0,0.0,5.0,NO,NO,,,,,,YES,,,,1,Female,Cervical,25.0,,,,DG,2.0,Complete Remission/Response,,TUMOR FREE,75.0,Test,Test,Test,Test,Test,TCGA-DG-A2KL-01Z-00-DX1.BB898567-DB9E-45B3-BFF2-EE4EC2B4B5BC,WITH TUMOR,DX1,
VENHQS1ERy1BMktNOmNlc2NfdGNnYQ,TCGA-DG-A2KM,cesc_tcga,46.0,M0,N1,1995,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,,,,0.0,,63.93|0,0.0,,,10/10/13,G2,169.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2008.0,,ABSENT,YES,4.0,0.0,,9.0,,,Biopsy (cervical / CT-guided / Other),,NO,63.93|0,,,,E87FADBE-C58C-41D1-B413-8CF6CE70CE94,,,,,,Pre-Adjuvant Therapy,,"Pelvic (external iliac, internal iliac, obturator)",,,2.0,,,2.0,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,DG,1.0,Complete Remission/Response,,TUMOR FREE,,Test,Test,Test,Test,Test,TCGA-DG-A2KM-01Z-00-DX1.58F88374-0268-4314-B75D-BF04DA186995,WITH TUMOR,DX1,
VENHQS1EUi1BMFpMOmNlc2NfdGNnYQ,TCGA-DR-A0ZL,cesc_tcga,53.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,9.0,,,0.0,,87.68|0,,NOT HISPANIC OR LATINO,,3/28/11,G3,155.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2004.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,24.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,87.68|0,,,,36605f5f-245c-41e5-a9db-705373da7923,,,,,,,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,ASIAN,,,,,YES,,,,1,Female,Cervical,,,,,DR,1.0,,Complete response,TUMOR FREE,57.0,Test,Test,Test,Test,Test,TCGA-DR-A0ZL-01Z-00-DX1.C11BCD07-A8F4-4F1D-9AE2-5A118E8AE95C,WITH TUMOR,DX1,
VENHQS1EUi1BMFpNOmNlc2NfdGNnYQ,TCGA-DR-A0ZM,cesc_tcga,61.0,M0,N0,2009,T2b,,,,,,,,,,,,Stage IIIB,PRESENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,8.0,519.0,521.0,0.0,8.0,58.84|0,0.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,3/28/11,G2,158.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2006.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,58.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cone Biopsy / LEEP,,,58.84|0,,,Patient had clear margins,748aada0-448f-4523-9893-3d9618fdbe18,,,,,,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",,,3.0,1.0,,4.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,15.0,30.0,,,DR,2.0,,Complete response,TUMOR FREE,64.0,Val,Train,Train,Train,Train,TCGA-DR-A0ZM-01Z-00-DX1.74DA4FCA-3876-4C06-85B9-D20456B89903,WITH TUMOR,DX1,
VENHQS1EUy1BM0xROmNlc2NfdGNnYQ,TCGA-DS-A3LQ,cesc_tcga,46.0,M0,N1,2009,T3b,,,,,,,,,,,,Stage IIIB,,,,,,0.0,2.0,22.96|0,1.0,,,4/23/12,G3,163.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,1.0,0.0,,8.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cone Biopsy / LEEP,,,22.96|0,,,,63BFFDB1-BC08-4175-8BE7-D7A056D19816,,,,,,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",,,2.0,,,7.0,NO,YES,,,,,,NO,,,,1,Female,Cervical,,,1978.0,,DS,3.0,,Complete response,,72.0,Val,Train,Train,Train,Train,TCGA-DS-A3LQ-01Z-00-DX1.14D94FE2-60A6-49FD-8E8E-325C2C39B550,WITH TUMOR,DX1,
VENHQS1EUy1BMFZLOmNlc2NfdGNnYQ,TCGA-DS-A0VK,cesc_tcga,45.0,M0,N1,,T1b1,,,,,,,,,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,-1.0,,,0.0,-71.0,6.87|1,1.0,NOT HISPANIC OR LATINO,,2/3/11,G3,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1996.0,Keratinizing squamous cell carcinoma,PRESENT,,1.0,0.0,,16.0,Positive vaginal margin,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",Surgery,,36.73|1,,,,5ed3c95a-10d0-4cd5-a54d-523e81587fb1,,,,,,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",0.0,3.0,1.0,0.0,0.0,4.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,DS,4.0,,Progression,WITH TUMOR,52.0,Train,Val,Train,Train,Train,TCGA-DS-A0VK-01Z-00-DX1.E400810B-7164-4D56-9615-17965C2EEDE2,WITH TUMOR,DX1,
VENHQS1EUy1BMFZNOmNlc2NfdGNnYQ,TCGA-DS-A0VM,cesc_tcga,51.0,M0,N1,,T1b1,,,,,,,,,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,1.0,,,0.0,0.0,28.52|1,1.0,NOT HISPANIC OR LATINO,,1/7/11,G3,163.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2003.0,Non-keratinizing squamous cell carcinoma,PRESENT,,1.0,0.0,,21.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,117.9|0,,,No involved margins. Margins clear as per pathology report.,ed6d989d-da09-4818-8fed-f33d88b628af,Parametrial,,,,,Preoperative,,"Other Location, specify",0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,DS,1.0,,Complete response,TUMOR FREE,69.0,Train,Train,Train,Val,Train,TCGA-DS-A0VM-01Z-00-DX1.9F3A1D5D-297F-42ED-BAB3-AD272B9D3F93,WITH TUMOR,DX1,
VENHQS1EUy1BMFZNOmNlc2NfdGNnYQ,TCGA-DS-A0VM,cesc_tcga,51.0,M0,N1,,T1b1,,,,,,,,,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,1.0,,,0.0,0.0,28.52|1,1.0,NOT HISPANIC OR LATINO,,1/7/11,G3,163.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2003.0,Non-keratinizing squamous cell carcinoma,PRESENT,,1.0,0.0,,21.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,117.9|0,,,No involved margins. Margins clear as per pathology report.,ed6d989d-da09-4818-8fed-f33d88b628af,Parametrial,,,,,Preoperative,,"Other Location, specify",0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,DS,1.0,,Complete response,TUMOR FREE,69.0,Train,Train,Train,Val,Train,TCGA-DS-A0VM-01Z-00-DX2.02913549-89AB-4963-BED2-3E0D8AE414E7,WITH TUMOR,DX2,
VENHQS1EUy1BMFZOOmNlc2NfdGNnYQ,TCGA-DS-A0VN,cesc_tcga,47.0,M0,N0,,T1b2,,,,,,,,,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,8.0,,,0.0,18.0,118.56|0,1.0,NOT HISPANIC OR LATINO,,3/4/11,G2,165.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2002.0,Keratinizing squamous cell carcinoma,ABSENT,,0.0,0.0,,19.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,118.56|0,,,deep cervical,f8d342f5-9b92-42e1-8b0d-0876cc26965d,,,,,,Preoperative,,,0.0,2.0,2.0,0.0,0.0,4.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,DS,1.0,,Complete response,TUMOR FREE,81.0,Train,Train,Train,Train,Val,TCGA-DS-A0VN-01Z-00-DX1.DD5F880D-4BA9-45EB-8023-8BA6B59EF32D,WITH TUMOR,DX1,
VENHQS1EUy1BMU85OmNlc2NfdGNnYQ,TCGA-DS-A1O9,cesc_tcga,75.0,M0,N0,2009,T4,,,,,,,,,,,,Stage IVA,PRESENT,Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,-18.0,,,0.0,10.0,,1.0,NOT HISPANIC OR LATINO,,8/12/11,G3,132.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1999.0,Keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,19.0,Positive vaginal margin,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,8.74|1,,,,b8eae533-2ad6-4dcf-98af-0fe7ff23a879,,,,,,Preoperative,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,DS,2.0,,Complete response,WITH TUMOR,32.0,Val,Train,Train,Train,Train,TCGA-DS-A1O9-01Z-00-DX1.6A00B44C-75A7-4949-8331-645EEA70DE91,WITH TUMOR,DX1,
VENHQS1EUy1BMU9DOmNlc2NfdGNnYQ,TCGA-DS-A1OC,cesc_tcga,47.0,M0,N1,2009,T1b1,,,,,,,,,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,34.0,,,0.0,0.0,12.35|0,1.0,HISPANIC OR LATINO,,8/12/11,G2,140.0,Cervical Squamous Cell Carcinoma,,,No,Yes,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2010.0,Keratinizing squamous cell carcinoma,,YES,2.0,0.0,,19.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,12.35|0,,,,e711b88e-fa0e-4781-8549-7a53ed3a13a1,Left External Iliac/Obturator,,,,,Preoperative,,"Other Location, specify",0.0,0.0,3.0,0.0,0.0,3.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,DS,4.0,,Complete response,TUMOR FREE,78.0,Train,Train,Train,Train,Val,TCGA-DS-A1OC-01Z-00-DX1.D3ECE6F5-90DC-4CF4-A203-AC9F28E89959,WITH TUMOR,DX1,
VENHQS1EUy1BMU9EOmNlc2NfdGNnYQ,TCGA-DS-A1OD,cesc_tcga,49.0,M0,N0,1995,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,2.0,,,0.0,5.0,127.27|0,1.0,NOT HISPANIC OR LATINO,,8/12/11,G3,155.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2003.0,Keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,16.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,127.27|0,,,,ec609ebe-2db9-4b95-a154-512fdfa9038f,,,,,,Preoperative,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,DS,4.0,,Complete response,TUMOR FREE,89.0,Train,Train,Train,Val,Train,TCGA-DS-A1OD-01Z-00-DX1.69DC90EF-A061-4862-A97A-EE184349C079,WITH TUMOR,DX1,
VENHQS1EUy1BN1dGOmNlc2NfdGNnYQ,TCGA-DS-A7WF,cesc_tcga,41.0,MX,N0,1995,T1b2,,Other,,,,,,,,Cisplatin,,Stage IB2,,,,,,0.0,,10.55|1,1.0,HISPANIC OR LATINO,,12/23/13,G3,160.0,Adenosquamous,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8560/3,C53.9,YES,2006.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,23.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,YES,16.16|1,,,,D02FFAA9-0403-4A89-BE01-CCE35C80DD69,,Cervical Cancer,,,,Preoperative,YES,,0.0,1.0,1.0,1.0,0.0,3.0,NO,NO,,,,YES,,YES,,,,1,Female,Cervical,7.0,,,YES,DS,2.0,Partial Remission/Response,,WITH TUMOR,63.0,Test,Test,Test,Test,Test,TCGA-DS-A7WF-01Z-00-DX1.35D29A85-846A-435E-8D51-83381C6D52E6,WITH TUMOR,DX1,
VENHQS1EUy1BN1dIOmNlc2NfdGNnYQ,TCGA-DS-A7WH,cesc_tcga,34.0,MX,N0,2009,T1b1,,,,,Once weekly,40 mg/m2,7,,,Cisplatin,,Stage IB1,,,,,5.0,0.0,,17.51|0,1.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,12/23/12,G2,168.0,Mucinous Adenocarcinoma of Endocervical Type,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8480/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,0.0,,22.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,17.51|0,,,,DADCF6D5-03EB-4090-BCC3-B9E9DC3C7E08,,,,,,Preoperative,YES,,0.0,1.0,0.0,1.0,0.0,2.0,NO,YES,WHITE,,External beam radiation,YES,,NO,,,5040.0,1,Female,Cervical,,,,YES,DS,1.0,Complete Remission/Response,,TUMOR FREE,50.0,Train,Train,Val,Train,Train,TCGA-DS-A7WH-01Z-00-DX1.F743D3D3-671A-4763-AB02-4D1488964EED,WITH TUMOR,DX1,
VENHQS1EUy1BN1dJOmNlc2NfdGNnYQ,TCGA-DS-A7WI,cesc_tcga,43.0,MX,N1,2009,T2a2,,,,,Once weekly,40 mg/m2,5,,,Cisplatin,,Stage IIA2,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,4.0,,,0.0,,6.77|1,1.0,NOT HISPANIC OR LATINO,,12/23/13,G2,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,1.0,0.0,,15.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,YES,8.28|1,,,,C14468EB-E725-4029-96CC-75BB9EBD9DEF,,Cervical Cancer,,,,Preoperative,YES,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,7.0,1.0,0.0,8.0,NO,YES,WHITE,,External beam radiation,YES,,NO,,,5040.0,1,Female,Cervical,,,,YES,DS,1.0,Complete Remission/Response,,WITH TUMOR,57.0,Val,Train,Train,Train,Train,TCGA-DS-A7WI-01Z-00-DX1.0B562A1C-1C0A-46B1-8F40-BE134929D036,WITH TUMOR,DX1,
VENHQS1FQS1BM0hROmNlc2NfdGNnYQ,TCGA-EA-A3HQ,cesc_tcga,60.0,M0,N0,2009,T2a,,,,,,,,,,,,Stage II,ABSENT,,,,,0.0,,37.32|0,,NOT HISPANIC OR LATINO,,2/17/12,G2,160.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,13.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,37.32|0,,,,6BF00B63-89F8-420C-8D36-F680FB0908B1,,,,,,,,,0.0,2.0,2.0,0.0,0.0,4.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,Complete response,TUMOR FREE,88.0,Val,Train,Train,Train,Train,TCGA-EA-A3HQ-01Z-00-DX1.13225BE1-091D-41DA-8B4D-C91B1A0CC9D6,WITH TUMOR,DX1,
VENHQS1FQS1BM0hSOmNlc2NfdGNnYQ,TCGA-EA-A3HR,cesc_tcga,57.0,M0,N0,2009,T2a,,,,,,,,,,,,Stage II,ABSENT,,,,,0.0,,30.88|0,,NOT HISPANIC OR LATINO,,12/20/11,G2,146.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,11.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),,,30.88|0,,,,638035F6-2909-4A44-980F-468AC5D74E18,,,,,,,,,,13.0,2.0,0.0,,15.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,Complete response,TUMOR FREE,86.0,Train,Train,Train,Val,Train,TCGA-EA-A3HR-01Z-00-DX1.E3ED09EE-1667-42DD-A1F5-F430CE9A2A25,WITH TUMOR,DX1,
VENHQS1FQS1BM0hTOmNlc2NfdGNnYQ,TCGA-EA-A3HS,cesc_tcga,35.0,M0,N0,2009,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,,31.5|0,,NOT HISPANIC OR LATINO,,12/20/11,G1,169.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,10.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cytology (e.g. Peritoneal or pleural fluid),,,31.5|0,,,,753EE373-FBCF-4349-B9B2-5A41936E27E9,,,,,,,,,0.0,1.0,1.0,0.0,0.0,2.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,Complete response,TUMOR FREE,54.0,Train,Train,Train,Val,Train,TCGA-EA-A3HS-01Z-00-DX1.F74FF288-29EB-4AEF-BC63-71A0839E5874,WITH TUMOR,DX1,
VENHQS1FQS1BM0hUOmNlc2NfdGNnYQ,TCGA-EA-A3HT,cesc_tcga,68.0,M0,N0,2009,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,,31.34|0,,NOT HISPANIC OR LATINO,,12/20/11,G1,163.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,9.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),,,31.34|0,,,,3C5B2452-014B-495F-B86A-F522ED84BC3B,,,,,,,,,0.0,2.0,1.0,0.0,0.0,3.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,Complete response,TUMOR FREE,83.0,Train,Train,Train,Val,Train,TCGA-EA-A3HT-01Z-00-DX1.6B374081-2ECB-4973-8AE7-BF8FA9F00BBC,WITH TUMOR,DX1,
VENHQS1FQS1BM0hVOmNlc2NfdGNnYQ,TCGA-EA-A3HU,cesc_tcga,43.0,M0,N0,2009,T2a2,,,,,,,,,,,,Stage II,ABSENT,,,,,0.0,,33.28|0,,NOT HISPANIC OR LATINO,,2/17/12,G2,162.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,14.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cytology (e.g. Peritoneal or pleural fluid),,,33.28|0,,,,9912432E-74BC-4846-93B4-FA2BF8070BD1,,,,,,,,,0.0,10.0,2.0,0.0,0.0,12.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,Complete response,TUMOR FREE,68.0,Val,Train,Train,Train,Train,TCGA-EA-A3HU-01Z-00-DX1.74B5BF15-FB92-4426-99F3-C3D58CD9FE18,WITH TUMOR,DX1,
VENHQS1FQS1BM1FEOmNlc2NfdGNnYQ,TCGA-EA-A3QD,cesc_tcga,59.0,M0,N1,2009,T1b1,,,,,,,,,,,,Stage IIIB,,,,,,0.0,33.0,13.04|0,0.0,NOT HISPANIC OR LATINO,,4/30/12,G3,163.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,1.0,0.0,,6.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),,,13.04|0,,,,9E2E29E8-D94A-499F-A98A-5B53B2C38F3B,,,,,,Preoperative,,,0.0,0.0,5.0,1.0,0.0,6.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,Complete response,TUMOR FREE,105.0,Train,Val,Train,Train,Train,TCGA-EA-A3QD-01Z-00-DX1.247BDFE4-6352-4531-83CC-D30D5945CAE2,WITH TUMOR,DX1,
VENHQS1FQS1BM1FFOmNlc2NfdGNnYQ,TCGA-EA-A3QE,cesc_tcga,45.0,M0,N0,2009,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,,25.0|0,,NOT HISPANIC OR LATINO,,5/9/12,G2,154.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,,,,14.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,25.0|0,,,,A4E444B5-BBCA-4EF0-B92F-908D608CBB91,,,,,,,,,0.0,4.0,1.0,0.0,0.0,5.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,Complete response,TUMOR FREE,73.0,Train,Train,Train,Val,Train,TCGA-EA-A3QE-01Z-00-DX1.7BCDA7C3-5A22-450D-AE15-7D5E79CC87DA,WITH TUMOR,DX1,
VENHQS1FQS1BM1k0OmNlc2NfdGNnYQ,TCGA-EA-A3Y4,cesc_tcga,40.0,M0,N0,2009,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,35.0,36.86|0,1.0,NOT HISPANIC OR LATINO,,9/24/12,G3,167.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Simple Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,12.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,36.86|0,,,,3AC62513-B5F4-4063-AABD-DAD08A1F56FB,,,,,,Pre-Adjuvant Therapy,,,0.0,2.0,1.0,0.0,0.0,3.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,99.0,Train,Train,Train,Train,Val,TCGA-EA-A3Y4-01Z-00-DX1.05FCBE75-3B24-4905-96D7-E9676EF69003,WITH TUMOR,DX1,
VENHQS1FQS1BMVFTOmNlc2NfdGNnYQ,TCGA-EA-A1QS,cesc_tcga,46.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,39.52|0,,NOT HISPANIC OR LATINO,,7/6/12,G2,164.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,18.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,39.52|0,,,,6F9D21C0-3B88-450D-A249-3E9BAFBA2DFA,,,,,,,,,0.0,4.0,2.0,0.0,0.0,6.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,60.0,Val,Train,Train,Train,Train,TCGA-EA-A1QS-01Z-00-DX1.7BB98DFE-C3C5-459A-BEE8-6ECCEC27B223,WITH TUMOR,DX1,
VENHQS1FQS1BMVFUOmNlc2NfdGNnYQ,TCGA-EA-A1QT,cesc_tcga,47.0,M0,N0,2009,T1b,,,,,,,,,,,,Stage IB,ABSENT,,,,,0.0,,40.83|0,,NOT HISPANIC OR LATINO,,8/3/11,G2,163.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,18.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),,,40.83|0,,,,970b619f-2eb5-4557-a7b8-5def35943c58,,,,,,,,,0.0,3.0,2.0,0.0,0.0,5.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,,,68.0,Test,Test,Test,Test,Test,TCGA-EA-A1QT-01Z-00-DX1.3CF9DD48-AC8F-4DE1-A155-5F2DE5A58976,WITH TUMOR,DX1,
VENHQS1FQS1BNDEwOmNlc2NfdGNnYQ,TCGA-EA-A410,cesc_tcga,51.0,M0,N0,2009,T2a2,,,,,,,,,,,,Stage IIA2,ABSENT,,,,,0.0,,26.38|0,,NOT HISPANIC OR LATINO,,9/24/12,G2,160.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,14.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,26.38|0,,,,7B356C12-B226-4E58-BE7F-44E50E3EEFBE,,,,,,,,,0.0,4.0,2.0,0.0,0.0,6.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,80.0,Val,Train,Train,Train,Train,TCGA-EA-A410-01Z-00-DX1.40217EF9-3F9A-4669-A78E-AC851F62E532,WITH TUMOR,DX1,
VENHQS1FQS1BNDExOmNlc2NfdGNnYQ,TCGA-EA-A411,cesc_tcga,50.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,24.54|0,,NOT HISPANIC OR LATINO,,9/24/12,G2,176.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,13.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),,NO,24.54|0,,,,84CB84D0-7C7E-453C-8CC5-65B5AF941028,,,,,,,,,0.0,3.0,2.0,0.0,0.0,5.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,74.0,Train,Train,Val,Train,Train,TCGA-EA-A411-01Z-00-DX1.F166825A-38D6-4846-883F-74719F578A94,WITH TUMOR,DX1,
VENHQS1FQS1BNDM5OmNlc2NfdGNnYQ,TCGA-EA-A439,cesc_tcga,50.0,M0,N0,2009,T2a1,,,,,,,,,,,,Stage IIA1,PRESENT,Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent,12.0,,,0.0,,10.38|1,,NOT HISPANIC OR LATINO,,11/20/12,G3,160.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,PRESENT,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,31.7|0,,,,3EDB62C1-25AD-4DEB-A005-E881A887D06A,,,,No pelvic spread,,,NO,,,,2.0,,,2.0,NO,YES,ASIAN,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,47.0,Train,Train,Val,Train,Train,TCGA-EA-A439-01Z-00-DX1.0E3C5FDD-D68A-4B1C-A858-9F2ED2BF293F,WITH TUMOR,DX1,
VENHQS1FQS1BNDNCOmNlc2NfdGNnYQ,TCGA-EA-A43B,cesc_tcga,43.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,36.0,,,0.0,53.0,25.99|0,0.0,NOT HISPANIC OR LATINO,,11/20/12,G2,164.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2012.0,Keratinizing squamous cell carcinoma,,YES,0.0,,,24.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,25.99|0,,,,3265F9C1-7242-4C7D-B4AD-B6519EE94F84,,,,,,Preoperative,,,,,2.0,,,2.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,72.0,Test,Test,Test,Test,Test,TCGA-EA-A43B-01Z-00-DX1.4EC03006-C4D1-41E2-A003-99F816F21981,WITH TUMOR,DX1,
VENHQS1FQS1BNDRTOmNlc2NfdGNnYQ,TCGA-EA-A44S,cesc_tcga,31.0,M0,N1,2009,T2a2,,,,,,,,,,,,Stage IIIB,ABSENT,,,,,0.0,9.0,12.12|0,1.0,NOT HISPANIC OR LATINO,,12/19/12,G2,182.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,4.0,,,10.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,12.12|0,,,,CFB61FD8-0BCA-40B4-878C-CC914A289792,,,,,,Preoperative,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,,TUMOR FREE,83.0,Train,Val,Train,Train,Train,TCGA-EA-A44S-01Z-00-DX1.7AE8EECF-A35D-4111-990C-2819B20F79F6,WITH TUMOR,DX1,
VENHQS1FQS1BNEJBOmNlc2NfdGNnYQ,TCGA-EA-A4BA,cesc_tcga,49.0,M0,N0,2009,T1b2,,,,,,,,,,,,Stage IB2,ABSENT,,,,,0.0,7.0,24.8|0,1.0,NOT HISPANIC OR LATINO,,2/5/13,G2,162.0,Endocervical Type of Adenocarcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8384/3,C53.9,YES,2012.0,,ABSENT,YES,0.0,,,10.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,24.8|0,,,,9E79059F-3453-4AA6-9849-55A267C711A4,,,,,,Preoperative,,,,2.0,2.0,,,4.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,96.0,Test,Test,Test,Test,Test,TCGA-EA-A4BA-01Z-00-DX1.7EB090B2-E79E-417F-A871-247353679D7B,WITH TUMOR,DX1,
VENHQS1FQS1BNTBFOmNlc2NfdGNnYQ,TCGA-EA-A50E,cesc_tcga,45.0,M0,N1,2009,T4,,,,,,,,,,,,Stage IVA,PRESENT,,-1.0,,,0.0,,6.83|1,,NOT HISPANIC OR LATINO,,2/27/13,G2,152.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,6.0,,,6.0,Positive bladder margin,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,7.46|1,,,,6A18D184-D3A2-49C2-BD4B-9C18F91B98C7,,,,Pelvic spread,,,,"Pelvic (external iliac, internal iliac, obturator)",,,2.0,,,2.0,NO,YES,ASIAN,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,,WITH TUMOR,45.0,Test,Test,Test,Test,Test,TCGA-EA-A50E-01Z-00-DX1.47E4FA53-C268-4859-ADC3-82B4BDE6BEF1,WITH TUMOR,DX1,
VENHQS1FQS1BNTU2OmNlc2NfdGNnYQ,TCGA-EA-A556,cesc_tcga,38.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,-1.0,14.88|0,1.0,NOT HISPANIC OR LATINO,,4/22/13,G3,160.0,Endometrioid Adenocarcinoma of Endocervix,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8380/3,C53.9,YES,2012.0,,,YES,0.0,,,7.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cytology (e.g. Peritoneal or pleural fluid),,NO,14.88|0,,,,2D34E9A3-298C-4365-B7A1-A507C7F069CD,,,,,,Preoperative,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,20.0,18.0,,,EA,2.0,,,TUMOR FREE,62.0,Val,Train,Train,Train,Train,TCGA-EA-A556-01Z-00-DX1.08D384ED-C0AF-429B-8E7E-0B2BEAB2E90A,WITH TUMOR,DX1,
VENHQS1FQS1BNU85OmNlc2NfdGNnYQ,TCGA-EA-A5O9,cesc_tcga,39.0,M0,N0,2009,T1b2,,,,,,,,,,,,Stage IB2,ABSENT,,,,,0.0,26.0,25.89|0,1.0,NOT HISPANIC OR LATINO,,5/22/13,G2,160.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.1,8070/3,C53.1,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,10.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,25.89|0,,,,1636242C-12DA-412E-A362-914A20ADD708,,,,,,Preoperative,NO,,0.0,7.0,4.0,0.0,0.0,11.0,NO,YES,WHITE,,,YES,,NO,,,,1,Female,Cervical,,,,NO,EA,1.0,Complete Remission/Response,,TUMOR FREE,99.0,Val,Train,Train,Train,Train,TCGA-EA-A5O9-01Z-00-DX1.9694E52A-60A4-4044-90B5-64C11460CAD2,WITH TUMOR,DX1,
VENHQS1FQS1BNUZPOmNlc2NfdGNnYQ,TCGA-EA-A5FO,cesc_tcga,59.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,45.0,26.77|0,1.0,NOT HISPANIC OR LATINO,,5/22/13,G2,162.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,21.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,26.77|0,,,,ED17685C-B706-41E4-8A76-11CB0E6700CD,,,,,,Preoperative,,,,,2.0,,,,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,,TUMOR FREE,58.0,Train,Val,Train,Train,Train,TCGA-EA-A5FO-01Z-00-DX1.202FDE15-12C5-4AA6-B431-213BA1551866,WITH TUMOR,DX1,
VENHQS1FQS1BNVpEOmNlc2NfdGNnYQ,TCGA-EA-A5ZD,cesc_tcga,40.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,27.27|0,,NOT HISPANIC OR LATINO,,5/24/13,G2,154.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,27.27|0,,,,35D677B6-0487-44D3-BBBA-651EAC7E0635,,,,,,,NO,,,,2.0,1.0,,3.0,NO,YES,ASIAN,,,NO,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,,TUMOR FREE,47.0,Val,Train,Train,Train,Train,TCGA-EA-A5ZD-01Z-00-DX1.0F22F099-E562-4AF5-9DE9-46667A4B25B0,WITH TUMOR,DX1,
VENHQS1FQS1BNVpFOmNlc2NfdGNnYQ,TCGA-EA-A5ZE,cesc_tcga,54.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,13.96|1,,NOT HISPANIC OR LATINO,,5/24/13,G3,153.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,NO,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,27.23|0,,,,5E39485A-AC6B-496D-9984-2EA8075F6A9B,,,,,,,NO,,,,3.0,,,3.0,NO,YES,ASIAN,,,NO,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,55.0,Train,Train,Val,Train,Train,TCGA-EA-A5ZE-01Z-00-DX1.A448B9F5-E8DB-453A-BC88-4797A6DE9860,WITH TUMOR,DX1,
VENHQS1FQS1BNVpGOmNlc2NfdGNnYQ,TCGA-EA-A5ZF,cesc_tcga,56.0,M0,NX,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,14.45|1,,NOT HISPANIC OR LATINO,,5/24/13,G2,151.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,NO,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,27.2|0,,,,0C6BB7DC-45A6-4190-A7C9-B080D49FD58A,,,,,,,NO,,,,3.0,,,3.0,NO,YES,ASIAN,,,NO,,NO,,,,1,Female,Cervical,,,,,EA,1.0,Complete Remission/Response,,TUMOR FREE,51.0,Train,Train,Train,Val,Train,TCGA-EA-A5ZF-01Z-00-DX1.DEEAB916-6C01-46A5-9B20-B07C0C30F349,WITH TUMOR,DX1,
VENHQS1FQS1BNlFYOmNlc2NfdGNnYQ,TCGA-EA-A6QX,cesc_tcga,49.0,M0,N1,2009,T1b1,,,,,,,,,,,,Stage IIIB,ABSENT,,,,,0.0,,23.98|0,,NOT HISPANIC OR LATINO,,10/16/13,G3,154.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,2.0,,,3.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,23.98|0,,,,A300DB40-E0B8-4C45-ABBD-D7AA06211E9C,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",,2.0,2.0,,,4.0,NO,YES,ASIAN,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,,TUMOR FREE,49.0,Test,Test,Test,Test,Test,TCGA-EA-A6QX-01Z-00-DX1.2290FFB1-4195-4A70-8472-AE7F22A64FAA,WITH TUMOR,DX1,
VENHQS1FQS1BNzhSOmNlc2NfdGNnYQ,TCGA-EA-A78R,cesc_tcga,54.0,M0,NX,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,13.47|0,,NOT HISPANIC OR LATINO,,11/21/13,G2,160.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,PRESENT,NO,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,13.47|0,,,,79AE5209-F476-4D65-A6C0-EBC18D7C8942,,,,,,,,,,,3.0,,,3.0,NO,YES,ASIAN,,,,,NO,,,,1,Female,Cervical,,,,,EA,1.0,,,TUMOR FREE,63.0,Val,Train,Train,Train,Train,TCGA-EA-A78R-01Z-00-DX1.B8A8BFEC-B584-4804-BF9B-08A377238482,WITH TUMOR,DX1,
VENHQS1FQS1BOTdOOmNlc2NfdGNnYQ,TCGA-EA-A97N,cesc_tcga,38.0,M0,N0,2009,T1b2,,,,,,,,,,,,Stage IB2,ABSENT,,,,,0.0,11.0,0.36|0,1.0,NOT HISPANIC OR LATINO,,4/18/14,G2,160.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,10.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,0.36|0,,,,87E701AB-ACFD-45F2-A12E-323C94E5F3D5,,,,,,Preoperative,NO,,,3.0,2.0,,,5.0,NO,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,NO,EA,1.0,Complete Remission/Response,,TUMOR FREE,60.0,Test,Test,Test,Test,Test,TCGA-EA-A97N-01Z-00-DX1.EC5C1041-2180-47C8-9C17-38694B8B00EE,WITH TUMOR,DX1,
VENHQS1FWC1BM0wxOmNlc2NfdGNnYQ,TCGA-EX-A3L1,cesc_tcga,32.0,M0,N0,2009,T2a1,,,,,,,,,,,,Stage IIA1,ABSENT,,,,,0.0,,15.21|0,,NOT HISPANIC OR LATINO,,4/19/12,G3,160.0,Cervical Squamous Cell Carcinoma,Current User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,22.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,15.21|0,,,,F5D90810-8C4B-4CED-9360-383E42CB54B3,,,,,,,,,,,3.0,,,3.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EX,1.0,,Complete response,TUMOR FREE,57.0,Train,Val,Train,Train,Train,TCGA-EX-A3L1-01Z-00-DX1.F533D7B4-4E0C-48F0-B0E0-36F96006F4CC,WITH TUMOR,DX1,
VENHQS1FWC1BMUg1OmNlc2NfdGNnYQ,TCGA-EX-A1H5,cesc_tcga,58.0,MX,N1,2009,T2b,,,,,,,,,,,,Stage IIB,ABSENT,,,,,0.0,,20.34|0,,NOT HISPANIC OR LATINO,,4/21/11,G3,167.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,4.0,,,21.0,Microscopic parametrial involvement,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cone Biopsy / LEEP,,,20.34|0,,,,6b74c07a-9932-4a80-8296-9db08d0c6964,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",,,4.0,,,4.0,,YES,BLACK OR AFRICAN AMERICAN,,,,,NO,,,,1,Female,Cervical,12.0,33.0,,,EX,2.0,,Complete response,TUMOR FREE,67.0,Train,Train,Val,Train,Train,TCGA-EX-A1H5-01Z-00-DX1.B82669F8-69A2-414F-872F-F51CF3B2E34A,WITH TUMOR,DX1,
VENHQS1FWC1BMUg2OmNlc2NfdGNnYQ,TCGA-EX-A1H6,cesc_tcga,38.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent,24.0,,,0.0,,7.92|0,,,,6/25/12,G1,158.0,Endocervical Type of Adenocarcinoma,Current User,,No,No,,,,,,C53.9,8140/3,C53.9,YES,2009.0,,ABSENT,YES,0.0,,,20.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cone Biopsy / LEEP,,NO,7.92|0,,,,1FE594D9-4240-49EE-8AFD-C7D16A377181,,,,,,,NO,,,1.0,2.0,,,3.0,NO,NO,WHITE,,,NO,,YES,Not done per treating physician discretion,,,1,Female,Cervical,,,,,EX,1.0,Complete Remission/Response,,TUMOR FREE,74.0,Test,Test,Test,Test,Test,TCGA-EX-A1H6-01Z-00-DX1.C7BFF24E-B6DD-41D9-BACF-CE64989FC10A,WITH TUMOR,DX1,
VENHQS1FWC1BNDQ5OmNlc2NfdGNnYQ,TCGA-EX-A449,cesc_tcga,42.0,M1,NX,7th,T1b1,,,,,,,,,,,,Stage IVB,ABSENT,Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent,-12.0,,,0.0,,14.68|0,,NOT HISPANIC OR LATINO,,11/1/12,G1,168.0,Endocervical Type of Adenocarcinoma,,,No,Yes,,,,,Other,C53.9,8384/3,C53.9,YES,2012.0,,ABSENT,NO,,,,,Macroscopic parametrial involvement,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",Total Abdominal Hysterectomy,,14.68|0,Total Abdominal,,,EB0EB159-732E-43FF-A402-7F2D9F67DAA8,,,,,,,,,,1.0,1.0,,1.0,3.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,EX,,,,WITH TUMOR,107.0,Test,Test,Test,Test,Test,TCGA-EX-A449-01Z-00-DX1.5B2B2644-D7DB-4309-BF64-F40EADFA21ED,WITH TUMOR,DX1,
VENHQS1FWC1BNjlMOmNlc2NfdGNnYQ,TCGA-EX-A69L,cesc_tcga,41.0,M0,N0,2009,T1b1,,,,,,,,Not done per treating physicians discretion,,,,Stage IB1,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|[Not Available],11.0,,,0.0,,19.78|0,,NOT HISPANIC OR LATINO,,6/19/13,G3,163.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,,,26.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,19.78|0,,,,6DCA2A6F-7F2C-4524-B528-396A889B2A3F,,,,,,,NO,,,,1.0,1.0,,2.0,NO,YES,ASIAN,,,NO,,NO,Participant refusal,,,1,Female,Cervical,,,,NO,EX,1.0,Complete Remission/Response,,TUMOR FREE,73.0,Train,Val,Train,Train,Train,TCGA-EX-A69L-01Z-00-DX1.7A625731-6D1B-4A86-A3EC-C449CF4D9590,WITH TUMOR,DX1,
VENHQS1FWC1BNjlNOmNlc2NfdGNnYQ,TCGA-EX-A69M,cesc_tcga,62.0,M0,N0,2009,T1b2,,,,,,,,Not done per treating physicians discretion,,,,Stage IB2,,,,,18.0,0.0,,2.53|1,1.0,,Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,6/19/13,G3,158.0,Cervical Squamous Cell Carcinoma,Never Used,,No,Yes,HPV 63,HPV 16|Other HPV type(s),"Other, specify",Immunostain,,C53.9,8072/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,,,11.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),,YES,8.31|1,,,,1E4D7755-B971-4C6E-A2B9-DD83D92BC4C9,,,,,,Preoperative,NO,,1.0,,3.0,,,4.0,NO,YES,WHITE,,,NO,,NO,Not done per treating physician discretion,,,1,Female,Cervical,,,2012.0,NO,EX,4.0,Complete Remission/Response,,TUMOR FREE,58.0,Train,Val,Train,Train,Train,TCGA-EX-A69M-01Z-00-DX1.D0875AD8-BB8D-4CED-BAE8-B54312297A53,WITH TUMOR,DX1,
VENHQS1FWC1BOFlGOmNlc2NfdGNnYQ,TCGA-EX-A8YF,cesc_tcga,44.0,M0,N0,2009,T2a1,,,,,,,,,,,,Stage IB1,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,21.0,,,0.0,,13.01|1,,,,3/13/14,G3,168.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,,,37.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,15.54|0,,,,1DFB4565-81E1-4A1B-BB59-9B5629D6C447,,,,,,,,,,,2.0,,,3.0,NO,YES,WHITE,,,YES,,NO,,,,1,Female,Cervical,,,,,EX,1.0,Complete Remission/Response,,TUMOR FREE,57.0,Train,Train,Train,Val,Train,TCGA-EX-A8YF-01Z-00-DX1.79A4FEAD-3D6A-4D15-BDA8-CD100A411302,WITH TUMOR,DX1,
VENHQS1GVS1BM05JOmNlc2NfdGNnYQ,TCGA-FU-A3NI,cesc_tcga,45.0,MX,N1,2009,T1b1,,,,,,,,,,,,Stage IB1,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,14.0,,,0.0,,,,NOT HISPANIC OR LATINO,,4/17/12,G2,162.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2010.0,Keratinizing squamous cell carcinoma,PRESENT,YES,2.0,,,29.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,20.96|1,,,,DAC27C24-CDBF-4527-9214-178FDE3D098A,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",,,2.0,,,,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,FU,2.0,,Complete response,TUMOR FREE,57.0,Val,Train,Train,Train,Train,TCGA-FU-A3NI-01Z-00-DX1.C613997B-55E7-4B49-BF62-B961606B5CF2,WITH TUMOR,DX1,
VENHQS1GVS1BM0VPOmNlc2NfdGNnYQ,TCGA-FU-A3EO,cesc_tcga,55.0,MX,N0,2009,T2b,,,,,,,,,,,,Stage IIB,ABSENT,,,,,0.0,14.0,16.1|0,1.0,NOT HISPANIC OR LATINO,,2/15/12,G2,165.0,Endocervical Type of Adenocarcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8140/3,C53.9,YES,2011.0,,ABSENT,YES,0.0,0.0,,23.0,Positive vaginal margin,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,16.1|0,,,,B7F2958F-256E-4C30-9C61-11E76DDB36BA,,,,,,Preoperative,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,40.0,15.0,,,FU,2.0,,Complete response,TUMOR FREE,64.0,Train,Train,Val,Train,Train,TCGA-FU-A3EO-01Z-00-DX1.55528543-84AF-49EE-8986-6519F2BFF0E1,WITH TUMOR,DX1,
VENHQS1GVS1BM0hZOmNlc2NfdGNnYQ,TCGA-FU-A3HY,cesc_tcga,47.0,MX,N1,2009,T1b2,,,,,,,,,,,,Stage IB2,,,,,,0.0,,31.34|0,,NOT HISPANIC OR LATINO,,4/16/12,G2,170.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,1.0,,,39.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,31.34|0,,,,674E010C-7AD4-4DC2-86B0-284CD4560633,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,6.0,0.0,0.0,6.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,5.0,16.0,,,FU,2.0,,Complete response,TUMOR FREE,74.0,Train,Train,Val,Train,Train,TCGA-FU-A3HY-01Z-00-DX1.246D4D7B-7656-431E-A9EA-336F9FADF36E,WITH TUMOR,DX1,
VENHQS1GVS1BM0haOmNlc2NfdGNnYQ,TCGA-FU-A3HZ,cesc_tcga,64.0,M0,N0,2009,T2a2,,,,,,,,,,,,Stage IIA2,PRESENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Pelvic Nodes Absent,-7.0,,,0.0,,36.24|0,,NOT HISPANIC OR LATINO,,4/16/12,G3,165.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,9.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",curettage,,36.24|0,,,,6FF12A54-10DA-4941-BFEA-7B66E19B4BE9,,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,FU,1.0,,Complete response,TUMOR FREE,66.0,Test,Test,Test,Test,Test,TCGA-FU-A3HZ-01Z-00-DX1.1E78D8EF-B1FF-49AC-9EC4-D6CC2CD5D170,WITH TUMOR,DX1,
VENHQS1GVS1BM1RROmNlc2NfdGNnYQ,TCGA-FU-A3TQ,cesc_tcga,55.0,MX,N1,2009,T2b,,,,,,,,,,,,Stage IIIB,PRESENT,,,,,0.0,,26.12|0,,NOT HISPANIC OR LATINO,,8/6/12,G2,152.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,2.0,,,12.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cone Biopsy / LEEP,,,26.12|0,,,,7218AA6F-3345-484F-A329-A3B6169A67C7,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,3.0,0.0,0.0,3.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,50.0,30.0,,,FU,2.0,,,TUMOR FREE,59.0,Val,Train,Train,Train,Train,TCGA-FU-A3TQ-01Z-00-DX1.8A9BD5E8-CBFF-4AFB-848C-6F44F8F46129,WITH TUMOR,DX1,
VENHQS1GVS1BM1RYOmNlc2NfdGNnYQ,TCGA-FU-A3TX,cesc_tcga,78.0,M0,N0,2009,T1b2,,,,,,,,,,,,Stage IB2,,[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available],8.0,,8.0,0.0,,1.48|0,,,,8/6/12,G3,,Cervical Squamous Cell Carcinoma,,,No,Yes,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,30.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),,NO,1.48|0,,,,B75644C2-B515-41CE-9B03-842EF5208A17,,,,,,,,,,,3.0,,,3.0,NO,YES,,,,,,NO,,,,1,Female,Cervical,,20.0,1993.0,,FU,4.0,,,,67.0,Train,Train,Train,Train,Val,TCGA-FU-A3TX-01Z-00-DX1.EE303173-5102-4633-92AA-A4C18AB1D251,WITH TUMOR,DX1,
VENHQS1GVS1BM1dCOmNlc2NfdGNnYQ,TCGA-FU-A3WB,cesc_tcga,43.0,MX,N0,2009,T2a2,,,,,,,,,,,,Stage IIA2,ABSENT,,,,,0.0,0.0,16.13|0,2.0,NOT HISPANIC OR LATINO,,9/24/12,G2,167.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,,,43.0,,,"Other method, specify:",D&C,NO,16.13|0,,,,6868BA1D-B612-454C-8146-74AF2F573D76,,,,,,Preoperative,,,,,1.0,,,3.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,25.0,16.0,2012.0,,FU,4.0,Complete Remission/Response,,TUMOR FREE,89.0,Train,Val,Train,Train,Train,TCGA-FU-A3WB-01Z-00-DX1.692AD3D1-6605-46CC-A899-48E952C6F80A,WITH TUMOR,DX1,
VENHQS1GVS1BM1lROmNlc2NfdGNnYQ,TCGA-FU-A3YQ,cesc_tcga,35.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,28.29|0,,NOT HISPANIC OR LATINO,,10/4/12,G1,160.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,,,24.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,28.29|0,,,,6E01248B-C551-4F52-8066-CB2D26EB6394,,,,,,,,,,,3.0,1.0,,4.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,10.0,23.0,,,FU,2.0,,,,101.0,Train,Train,Train,Train,Val,TCGA-FU-A3YQ-01Z-00-DX1.6ABB4FDF-5335-48DF-8B0B-B167E673D52B,WITH TUMOR,DX1,
VENHQS1GVS1BMjNLOmNlc2NfdGNnYQ,TCGA-FU-A23K,cesc_tcga,28.0,MX,N1,2009,T1b1,,,,,,,,,,,,Stage IIIB,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,6.0,,,0.0,,12.22|0,,,,7/18/11,G3,165.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8083/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,1.0,,,24.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,12.22|0,,,,85abfd69-cf72-43f6-a7dd-97056f22c91b,,,,,,,,Common iliac,,,2.0,,,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,FU,1.0,,,TUMOR FREE,91.0,Val,Train,Train,Train,Train,TCGA-FU-A23K-01Z-00-DX1.DC2AFA87-14DE-456D-8900-52F91846EC96,WITH TUMOR,DX1,
VENHQS1GVS1BMjNMOmNlc2NfdGNnYQ,TCGA-FU-A23L,cesc_tcga,60.0,MX,N0,2009,T2a1,,,,,,,,,,,,Stage IIA1,PRESENT,,,,,0.0,,23.82|0,,,,7/18/11,G3,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2010.0,,ABSENT,YES,0.0,,,11.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,23.82|0,,,,86731af9-2d33-4521-9cf9-5f6152ca15d7,,,,,,,,,,,4.0,,,,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,FU,1.0,,,,56.0,Train,Val,Train,Train,Train,TCGA-FU-A23L-01Z-00-DX1.8E5867F8-C381-443A-9FDB-1BA352CCCBAE,WITH TUMOR,DX1,
VENHQS1GVS1BMlFHOmNlc2NfdGNnYQ,TCGA-FU-A2QG,cesc_tcga,29.0,,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,19.02|0,1.0,NOT HISPANIC OR LATINO,,10/18/11,G2,170.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2011.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,32.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,,19.02|0,,,,D5D8A818-D689-4C6F-96B0-13F2CB10C3CA,,,,,,Preoperative,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,15.0,14.0,2011.0,,FU,4.0,,,TUMOR FREE,138.0,Train,Val,Train,Train,Train,TCGA-FU-A2QG-01Z-00-DX1.C3250B28-88A1-4EEC-9854-22FA371DB9AA,WITH TUMOR,DX1,
VENHQS1GVS1BNDBKOmNlc2NfdGNnYQ,TCGA-FU-A40J,cesc_tcga,38.0,MX,N1,2009,T2a1,,,,,,,,,,,,Stage IIIB,ABSENT,,,10.0,,0.0,,13.99|0,,NOT HISPANIC OR LATINO,,10/4/12,G3,160.0,Endocervical Type of Adenocarcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8384/3,C53.9,YES,2012.0,,PRESENT,YES,4.0,,Extra-Pelvic Metastatic Disease Absent|Parametrium Absent,28.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,13.99|0,,,,63DCFA32-C69E-45AD-BEA3-AE672ACB11C6,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",,,3.0,,,3.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,FU,1.0,,,TUMOR FREE,78.0,Train,Train,Val,Train,Train,TCGA-FU-A40J-01Z-00-DX1.E75FB5CE-00E2-4566-894E-566D73CF5DF0,WITH TUMOR,DX1,
VENHQS1GVS1BNTdHOmNlc2NfdGNnYQ,TCGA-FU-A57G,cesc_tcga,49.0,MX,N0,2009,T1b2,,,,,,,,,,,,Stage IB2,ABSENT,,,,,0.0,40.0,35.41|0,1.0,NOT HISPANIC OR LATINO,,5/31/13,G2,160.0,Endocervical Type of Adenocarcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.0,8384/3,C53.0,YES,2011.0,,ABSENT,YES,0.0,,,26.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,35.41|0,,,,968BD652-786C-4DDB-A937-DC480CB821FC,,,,,,Preoperative,,,,,2.0,1.0,,3.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,,,FU,1.0,,,TUMOR FREE,57.0,Train,Train,Train,Val,Train,TCGA-FU-A57G-01Z-00-DX1.3007337B-A044-4831-B957-F8740E9ACB4E,WITH TUMOR,DX1,
VENHQS1GVS1BNVhWOmNlc2NfdGNnYQ,TCGA-FU-A5XV,cesc_tcga,32.0,MX,N1,2009,T1b2,,,,,,,,,,,,Stage IIIB,,,,,,0.0,55.0,10.55|0,1.0,NOT HISPANIC OR LATINO,,7/12/13,G3,157.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,2.0,,,63.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cone Biopsy / LEEP,,NO,10.55|0,,,,9DBA5A81-3587-4F5A-8D19-E0B0AED0A677,,,,,,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",1.0,,2.0,,,,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,18.0,14.0,,,FU,2.0,,,,69.0,Train,Train,Val,Train,Train,TCGA-FU-A5XV-01Z-00-DX1.42E46204-02C8-4BD4-B14C-4A77895EECA5,WITH TUMOR,DX1,
VENHQS1GVS1BNzcwOmNlc2NfdGNnYQ,TCGA-FU-A770,cesc_tcga,33.0,MX,N1,2009,T2a2,,,,,,,,,,,,Stage IIIB,ABSENT,,,,0.0,0.0,30.0,1.12|0,1.0,NOT HISPANIC OR LATINO,,2/26/14,G2,175.0,Endocervical Adenocarcinoma of the Usual Type,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8384/3,C53.9,YES,2013.0,,ABSENT,YES,1.0,,,10.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",D&C,NO,1.12|0,,,,128FD280-9A04-4038-9269-9A945B9A4DC9,,,,Tumor extends 1.0cm into 1.3 cm thick cervical/lower uterine segment wall,,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,1.0,1.0,0.0,2.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,7.0,16.0,,,FU,2.0,,,TUMOR FREE,67.0,Train,Train,Val,Train,Train,TCGA-FU-A770-01Z-00-DX1.67C6E3B1-22BC-41C6-B841-2C01DF1D5071,WITH TUMOR,DX1,
VENHQS1HSC1BOURBOmNlc2NfdGNnYQ,TCGA-GH-A9DA,cesc_tcga,27.0,MX,N0,2009,T1b,,,,11.6,,,,Not done per treating physicians discretion,,,,Stage IB1,ABSENT,,,,42.0,0.0,,17.74|0,,NOT HISPANIC OR LATINO,Pelvic Nodes Present,5/7/14,G3,170.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,15.0,,,Biopsy (cervical / CT-guided / Other),,NO,17.74|0,,,,67195401-9099-4CA9-9790-F42BCB815289,,,,,,,NO,,,,3.0,2.0,,5.0,NO,YES,WHITE,,,NO,,NO,Not done per treating physician discretion,,,1,Female,Cervical,6.5,14.0,,NO,GH,2.0,Complete Remission/Response,,TUMOR FREE,,Train,Val,Train,Train,Train,TCGA-GH-A9DA-01Z-00-DX1.14102CF2-DFD2-4A7C-9394-AEE0A25DEEA9,WITH TUMOR,DX1,
VENHQS1IRy1BMlBBOmNlc2NfdGNnYQ,TCGA-HG-A2PA,cesc_tcga,38.0,M0,N0,2009,T1b2,,,,,,,,,,,,Stage IB2,PRESENT,Bladder Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,2.0,,,0.0,21.0,,0.0,NOT HISPANIC OR LATINO,,12/23/11,G2,164.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2009.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,,,30.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,25.39|1,,,,E2FF7CFD-A101-45B9-895F-26F403E7BDFB,,,,,,Preoperative,,,0.0,0.0,4.0,1.0,0.0,5.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,HG,2.0,,Partial response,WITH TUMOR,95.0,Train,Train,Val,Train,Train,TCGA-HG-A2PA-01Z-00-DX1.CA661EA3-16E7-4DA6-A791-193DCA5A819C,WITH TUMOR,DX1,
VENHQS1IRy1BOVNDOmNlc2NfdGNnYQ,TCGA-HG-A9SC,cesc_tcga,49.0,MX,N0,2009,T2b,,,,,Once weekly,40mg/m2,5,,,Cisplatin,,Stage IIB,,,3.0,,,0.0,21.0,16.56|0,0.0,NOT HISPANIC OR LATINO,,6/19/14,G3,173.0,Adenosquamous,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8560/3,C53.9,YES,2013.0,,PRESENT,YES,,,,21.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,16.56|0,,,,CF87812F-6DB6-4592-9842-C62B3E4FF03F,,,,,,Preoperative,YES,,,,,,,0.0,,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,,,,YES,HG,1.0,Complete Remission/Response,,TUMOR FREE,68.0,Train,Train,Train,Val,Train,TCGA-HG-A9SC-01Z-00-DX1.7C75026C-7A7B-4129-87AF-643B68857837,WITH TUMOR,DX1,
VENHQS1ITS1BM0pKOmNlc2NfdGNnYQ,TCGA-HM-A3JJ,cesc_tcga,40.0,MX,N1,2009,T1b1,,,,,,,,,,,,Stage IB1,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,13.0,,,0.0,26.0,12.65|1,0.0,NOT HISPANIC OR LATINO,,3/12/13,G3,173.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,"18,31,33,35,39,45,51,52,56,58,59,68",Other HPV type(s),,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,4.0,,,41.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cone Biopsy / LEEP,,,21.65|1,,,,F150D999-CDEC-427E-B8B2-00731C648989,,,,,,Preoperative,,,,1.0,5.0,,,6.0,NO,YES,BLACK OR AFRICAN AMERICAN,,,,,NO,,,,1,Female,Cervical,,,,,HM,,,Complete response,WITH TUMOR,72.0,Train,Train,Train,Train,Val,TCGA-HM-A3JJ-01Z-00-DX1.13577649-8FC2-474C-8402-CAF702270254,WITH TUMOR,DX1,
VENHQS1ITS1BM0pLOmNlc2NfdGNnYQ,TCGA-HM-A3JK,cesc_tcga,64.0,MX,N1,2009,T2b,,,,13.8,,,,,,,,Stage IIA2,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,17.0,,17.0,0.0,21.0,20.76|0,0.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,2/17/12,G3,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,,ABSENT,YES,1.0,,,51.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,20.76|0,,,,7C4CD55F-750E-4941-A9F3-0632A75D6531,,,,"carcinoma involves all sections of the cervix with direct extension into the myometrial wall, parametrial tissues and upper vagina.",,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,0.0,0.0,0.0,0.0,NO,YES,WHITE,,,,,NO,,,,1,Female,Cervical,,,2008.0,,HM,4.0,,,TUMOR FREE,94.0,Train,Train,Val,Train,Train,TCGA-HM-A3JK-01Z-00-DX1.D7DFD54D-DF9F-4279-A0FD-760290759C24,WITH TUMOR,DX1,
VENHQS1ITS1BNFM2OmNlc2NfdGNnYQ,TCGA-HM-A4S6,cesc_tcga,51.0,MX,N1,2009,T1b2,,,,,,,,Other,Concurent chemo RT Ongoing-treatment delayed due to postoperative complications.,,,Stage IIIB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|[Not Available],11.0,,24.0,0.0,38.0,14.91|0,0.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,2/27/13,G3,152.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,,PRESENT,YES,2.0,,,13.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",Tissue in the cervix during pelvic exam was passed ans sent for pathology,NO,14.91|0,,,Squamous cell carcinoma in situ focallly extends to the cervical cuff margin(6-9 o'clock,6BCF8B41-7ABC-4B6F-899A-1F67B4ADA765,,,,,,Preoperative,YES,"Pelvic (external iliac, internal iliac, obturator)",,,5.0,1.0,,6.0,NO,YES,WHITE,,,YES,,NO,Other,Radiation currently ongoing- treatment delayed due to postoperative complication,,1,Female,Cervical,10.0,14.0,1995.0,YES,HM,3.0,,,TUMOR FREE,101.0,Train,Train,Train,Train,Val,TCGA-HM-A4S6-01Z-00-DX1.B1F46381-4FBC-46D1-A8AA-729D136AB2ED,WITH TUMOR,DX1,
VENHQS1ITS1BNlcyOmNlc2NfdGNnYQ,TCGA-HM-A6W2,cesc_tcga,34.0,M1,N0,2009,T2a,,,,,Once weekly,70mg,6,,,Cisplatin,,Stage IVB,,[Not Available]|Paraaortic Nodes Absent|Pelvic Nodes Absent,9.0,,62.0,0.0,28.0,9.43|0,0.0,NOT HISPANIC OR LATINO,Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,10/18/13,G3,160.0,Adenosquamous,Former User,,No,No,,,,,Radical Hysterectomy,C56.9,8070/3,C56.9,YES,2013.0,,PRESENT,YES,,,,7.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,9.43|0,,,,929505F7-0270-475E-A9D6-00BF38DC78BA,,,,Metastases to Right Ovary,,Preoperative,YES,,,,2.0,,,2.0,NO,YES,BLACK OR AFRICAN AMERICAN,,IMRT,YES,,NO,,,4500.0,2,Female,Cervical,8.0,27.0,,YES,HM,2.0,,,,89.0,Train,Train,Train,Train,Val,TCGA-HM-A6W2-01Z-00-DX2.DD08024A-D7A2-4730-96CA-2D494AA90D2F,WITH TUMOR,DX2,
VENHQS1ITS1BNlcyOmNlc2NfdGNnYQ,TCGA-HM-A6W2,cesc_tcga,34.0,M1,N0,2009,T2a,,,,,Once weekly,70mg,6,,,Cisplatin,,Stage IVB,,[Not Available]|Paraaortic Nodes Absent|Pelvic Nodes Absent,9.0,,62.0,0.0,28.0,9.43|0,0.0,NOT HISPANIC OR LATINO,Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,10/18/13,G3,160.0,Adenosquamous,Former User,,No,No,,,,,Radical Hysterectomy,C56.9,8070/3,C56.9,YES,2013.0,,PRESENT,YES,,,,7.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,9.43|0,,,,929505F7-0270-475E-A9D6-00BF38DC78BA,,,,Metastases to Right Ovary,,Preoperative,YES,,,,2.0,,,2.0,NO,YES,BLACK OR AFRICAN AMERICAN,,IMRT,YES,,NO,,,4500.0,2,Female,Cervical,8.0,27.0,,YES,HM,2.0,,,,89.0,Train,Train,Train,Train,Val,TCGA-HM-A6W2-01Z-00-DX1.462A81C4-C865-4617-A1F0-5A4EDA176A61,WITH TUMOR,DX1,
VENHQS1JUi1BM0w3OmNlc2NfdGNnYQ,TCGA-IR-A3L7,cesc_tcga,37.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,147.27|0,,,,4/13/12,G3,177.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2000.0,,PRESENT,YES,0.0,0.0,,20.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cone Biopsy / LEEP,,,147.27|0,,,,66229DD6-C771-4455-A90C-C66FB40CF7FE,,,,,,,,,0.0,0.0,3.0,0.0,0.0,3.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,10.0,17.0,1990.0,,IR,4.0,,Complete response,TUMOR FREE,89.0,Test,Test,Test,Test,Test,TCGA-IR-A3L7-01Z-00-DX1.BE6A5DA0-E30B-4D27-ADA3-26E99845D2F0,WITH TUMOR,DX1,
VENHQS1JUi1BM0xBOmNlc2NfdGNnYQ,TCGA-IR-A3LA,cesc_tcga,60.0,M0,N0,2009,T1b1,,,,,[Not Available]|[Not Available],70 mg/m2|750 mg/m2,4|4,,,Cisplatin|Other,[Not Applicable]|Fluorouracil (5-FU),Stage IB1,ABSENT,,,,,0.0,,137.06|0,,,,1/24/13,G3,157.0,Endometrioid Adenocarcinoma of Endocervix,Never Used,,No,No,,,,,Simple Hysterectomy,C53.9,8384/3,C53.9,YES,2002.0,,PRESENT,YES,0.0,0.0,,18.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Dilation & curettage,NO,137.06|0,,,,7B8C04D7-824D-493D-8F2C-9ED87A907192,,,,,,,YES,,,,0.0,,,2.0,NO,NO,WHITE,0.0,External beam radiation,YES,,YES,,,5040.0,1,Female,Cervical,,,,YES,IR,1.0,Complete Remission/Response,,TUMOR FREE,101.0,Val,Train,Train,Train,Train,TCGA-IR-A3LA-01Z-00-DX1.D468114A-B28D-4F61-9582-2D0FC9BDA922,WITH TUMOR,DX1,
VENHQS1JUi1BM0xCOmNlc2NfdGNnYQ,TCGA-IR-A3LB,cesc_tcga,53.0,M0,N0,2009,T1b1,,,,,[Not Available]|[Not Available],70mg/m2|1000mg/m2,4|4,,,Cisplatin|Other,[Not Applicable]|Fluorouracil (5-FU),Stage IB1,ABSENT,,,,,0.0,,10.41|1,,NOT HISPANIC OR LATINO,,1/24/13,G3,168.0,Endocervical Type of Adenocarcinoma,Never Used,,No,No,,,,,Other,C53.9,8384/3,C53.9,YES,2002.0,,PRESENT,YES,0.0,0.0,,29.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,YES,66.75|1,Radical trachelectomy,,,E7C7783C-1D0F-4F42-A4CF-518825E91D91,,,,,,,YES,,,,2.0,,,4.0,NO,NO,WHITE,0.0,External beam radiation,YES,,YES,,,5040.0,1,Female,Cervical,2.5,17.0,1972.0,YES,IR,3.0,Complete Remission/Response,,WITH TUMOR,94.0,Train,Train,Val,Train,Train,TCGA-IR-A3LB-01Z-00-DX1.E1DAA5F8-0906-4F6C-B241-E8144ADB50F5,WITH TUMOR,DX1,
VENHQS1JUi1BM0xDOmNlc2NfdGNnYQ,TCGA-IR-A3LC,cesc_tcga,40.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,129.27|0,,,,4/13/12,G3,160.0,Cervical Squamous Cell Carcinoma,Current User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2003.0,,PRESENT,YES,0.0,0.0,,48.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,129.27|0,,,,58BDCACE-0047-456E-A225-68953EDAFE5E,,,,,,,,,0.0,0.0,3.0,0.0,0.0,3.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,IR,1.0,,Complete response,TUMOR FREE,64.0,Train,Val,Train,Train,Train,TCGA-IR-A3LC-01Z-00-DX1.D5E87530-B079-4374-9DFE-4100CE6A4CDA,WITH TUMOR,DX1,
VENHQS1JUi1BM0xGOmNlc2NfdGNnYQ,TCGA-IR-A3LF,cesc_tcga,64.0,M0,N0,2009,T1b1,2500.0,HDR,,,,,,Not done per treating physicians discretion,,,,Stage IB1,ABSENT,,,,,0.0,,96.88|0,,,,1/24/13,G2,155.0,Endocervical Adenocarcinoma of the Usual Type,Never Used,,No,No,,,,,Simple Hysterectomy,C53.9,8384/3,C53.9,YES,2004.0,,ABSENT,YES,0.0,0.0,,16.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,96.88|0,,,,785DDEA1-399D-47D8-B2B0-39E95EAA24B5,,,,,,,NO,,0.0,0.0,2.0,1.0,0.0,3.0,NO,NO,WHITE,0.0,External beam radiation,YES,,YES,,,4500.0,1,Female,Cervical,,,,NO,IR,1.0,Complete Remission/Response,,TUMOR FREE,86.0,Train,Val,Train,Train,Train,TCGA-IR-A3LF-01Z-00-DX1.ADFB9764-F018-47F5-B6BA-6EFF1079F88E,WITH TUMOR,DX1,
VENHQS1JUi1BM0xIOmNlc2NfdGNnYQ,TCGA-IR-A3LH,cesc_tcga,49.0,M0,N0,2009,T2a1,,,,,,,,,,,,Stage IIA1,ABSENT,,,,,0.0,,78.65|0,,,,4/13/12,G4,154.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2005.0,,ABSENT,YES,0.0,0.0,,40.0,Positive vaginal margin,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,78.65|0,,,,F24ED9C0-92BB-4003-86D2-42AB26617A05,,,,,,,,,1.0,0.0,1.0,0.0,0.0,2.0,NO,NO,BLACK OR AFRICAN AMERICAN,,,,,YES,,,,1,Female,Cervical,20.0,24.0,2000.0,,IR,4.0,,Complete response,TUMOR FREE,74.0,Train,Train,Val,Train,Train,TCGA-IR-A3LH-01Z-00-DX1.38CF2E11-DE1E-4E24-964C-34861E76F9CC,WITH TUMOR,DX1,
VENHQS1JUi1BM0xJOmNlc2NfdGNnYQ,TCGA-IR-A3LI,cesc_tcga,48.0,M1,N1,2009,T2b,,,,,,,,,,,,Stage IVB,ABSENT,,,,,0.0,,81.9|0,,,,4/13/12,G2,169.0,Endocervical Type of Adenocarcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8384/3,C53.9,YES,2005.0,,PRESENT,YES,1.0,0.0,,25.0,Microscopic parametrial involvement,Peri (6-12 months since last menstrual period),"Other method, specify:",Surgical resection,,81.9|0,,,,75BC22D8-738D-45F8-B6C0-C664F5FEF47C,,,,,,,,"Pelvic (external iliac, internal iliac, obturator)",0.0,2.0,2.0,0.0,0.0,4.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,IR,1.0,,Complete response,TUMOR FREE,71.0,Train,Train,Val,Train,Train,TCGA-IR-A3LI-01Z-00-DX1.D8DFF41A-2F52-416D-99A6-241EEEB42B7A,WITH TUMOR,DX1,
VENHQS1JUi1BM0xLOmNlc2NfdGNnYQ,TCGA-IR-A3LK,cesc_tcga,69.0,M0,N0,2009,T1b2,,,,,,,,,,,,Stage IB2,ABSENT,,,,,0.0,,18.86|1,,,,4/13/12,G3,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2009.0,,,YES,0.0,0.0,,17.0,Microscopic parametrial involvement,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,29.83|1,,,,B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E,,,,,,,,,0.0,0.0,1.0,0.0,0.0,1.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,IR,1.0,,Complete response,WITH TUMOR,96.0,Test,Test,Test,Test,Test,TCGA-IR-A3LK-01Z-00-DX1.5BD14F93-80DE-47A5-9582-611BA43D81B3,WITH TUMOR,DX1,
VENHQS1JUi1BM0xMOmNlc2NfdGNnYQ,TCGA-IR-A3LL,cesc_tcga,60.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,36.33|0,,,,4/13/12,G2,157.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2010.0,,PRESENT,YES,0.0,0.0,,15.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,36.33|0,,,,7C4AB1CA-4BDD-4EF7-9A42-F6C0C7136D26,,,,,,,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,IR,1.0,,Complete response,TUMOR FREE,92.0,Test,Test,Test,Test,Test,TCGA-IR-A3LL-01Z-00-DX1.FBAC6F9B-CFA0-45F6-BBDD-10D69D5DB975,WITH TUMOR,DX1,
VENHQS1KVy1BNVZHOmNlc2NfdGNnYQ,TCGA-JW-A5VG,cesc_tcga,35.0,MX,NX,2009,T2a,4500.0,LDR,,,Once weekly,40 mg/m2,5,,,Cisplatin,,Stage IIA,,Pelvic Nodes Present,-8.0,,,0.0,439.0,27.4|0,0.0,HISPANIC OR LATINO,,6/3/13,G3,158.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,27.4|0,,,,0BD52D75-5113-4EF1-BC75-509F59EAEF2B,,,,,,Post-Adjuvant Therapy,NO,,0.0,0.0,5.0,0.0,0.0,5.0,NO,NO,AMERICAN INDIAN OR ALASKA NATIVE,0.0,External beam radiation,NO,,YES,,,4500.0,1,Female,Cervical,,,,YES,JW,1.0,Complete Remission/Response,,TUMOR FREE,110.0,Train,Val,Train,Train,Train,TCGA-JW-A5VG-01Z-00-DX1.59D9AE20-FE48-44E4-B139-91BF9FD3CBD1,WITH TUMOR,DX1,
VENHQS1KVy1BNVZIOmNlc2NfdGNnYQ,TCGA-JW-A5VH,cesc_tcga,53.0,M1,NX,2009,T4,,,,,Once weekly,,2,Not done per treating physicians discretion,,Carboplatin,,Stage IVB,,Extra-Pelvic Metastatic Disease Present|Pelvic Nodes Present,7.0,,,0.0,5.0,3.09|1,2.0,HISPANIC OR LATINO,,5/31/13,G2,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,YES,3.29|1,,,,6813C53C-B256-4115-AD90-24D75328779E,,Cervical Cancer,,,,Other,NO,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,AMERICAN INDIAN OR ALASKA NATIVE,0.0,External beam radiation,NO,,YES,Other,Brain and Pulmonary Metastases leading to death,1900.0,1,Female,Cervical,,,,NO,JW,1.0,Progressive Disease,,WITH TUMOR,80.0,Train,Val,Train,Train,Train,TCGA-JW-A5VH-01Z-00-DX1.1A81423C-5E6B-4766-947B-E7E32A7CDBA6,WITH TUMOR,DX1,
VENHQS1KVy1BNVZLOmNlc2NfdGNnYQ,TCGA-JW-A5VK,cesc_tcga,43.0,MX,NX,2009,T1b2,4725.0,LDR,,,Once weekly,40 mg/m2,5,,,Cisplatin,,Stage IB2,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,16.0,,,0.0,9.0,20.47|0,1.0,NOT HISPANIC OR LATINO,,5/31/13,G3,158.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8052/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,20.47|0,,,,BBB96B5A-80E8-4542-80B4-2444CF1FE51E,,,,,,,NO,,0.0,0.0,1.0,0.0,0.0,1.0,NO,YES,BLACK OR AFRICAN AMERICAN,4500.0,External beam radiation,NO,,NO,,,5500.0,1,Female,Cervical,1.0,33.0,,YES,JW,3.0,Complete Remission/Response,,TUMOR FREE,68.0,Train,Train,Train,Train,Val,TCGA-JW-A5VK-01Z-00-DX1.828A50C3-1C95-4552-8C37-CA9556DF4B94,WITH TUMOR,DX1,
VENHQS1KVy1BNVZMOmNlc2NfdGNnYQ,TCGA-JW-A5VL,cesc_tcga,37.0,MX,NX,2009,T1b2,4620.0,LDR,,,Once weekly,40 mg/m2,4,,,Cisplatin,,Stage IB2,,Pelvic Nodes Present,14.0,,,0.0,-4.0,15.57|0,1.0,HISPANIC OR LATINO,,5/31/13,G1,160.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,15.57|0,,,,D1A5B028-EC79-456B-81A1-69838E2922DF,,,,,,Other,NO,,0.0,0.0,2.0,0.0,0.0,2.0,NO,YES,AMERICAN INDIAN OR ALASKA NATIVE,540.0,External beam radiation,NO,,NO,,,4500.0,1,Female,Cervical,,,,YES,JW,1.0,Complete Remission/Response,,TUMOR FREE,71.0,Val,Train,Train,Train,Train,TCGA-JW-A5VL-01Z-00-DX1.93E521AE-1E55-4FBF-A298-78C08ABCB076,WITH TUMOR,DX1,
VENHQS1KVy1BNjlCOmNlc2NfdGNnYQ,TCGA-JW-A69B,cesc_tcga,44.0,MX,NX,2009,T1b2,4631.0,LDR,,,Once weekly,40 mg/m2,5,Scheduling problems,,Cisplatin,,Stage IB2,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,34.0,,,0.0,34.0,28.35|0,1.0,HISPANIC OR LATINO,,2/10/14,GX,155.0,Endocervical Type of Adenocarcinoma,Never Used,,No,No,,,,,,C53.9,8384/3,C53.9,YES,2012.0,,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,28.35|0,,,,FB4AF6B2-4BED-4DBE-9309-29F59ED30FB2,,,,,,Preoperative,NO,,0.0,0.0,3.0,1.0,0.0,4.0,NO,YES,WHITE,0.0,External beam radiation,NO,,NO,,,4500.0,1,Female,Cervical,,,,YES,JW,1.0,Complete Remission/Response,,TUMOR FREE,69.0,Train,Train,Val,Train,Train,TCGA-JW-A69B-01Z-00-DX1.1C01BC3B-4DC2-4589-8940-10DFCCB2CF22,WITH TUMOR,DX1,
VENHQS1KVy1BQVZIOmNlc2NfdGNnYQ,TCGA-JW-AAVH,cesc_tcga,46.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,Bladder Present|Extra-Pelvic Metastatic Disease Absent|Pelvic Nodes Present,21.0,,,0.0,170.0,18.13|0,2.0,HISPANIC OR LATINO,,4/3/14,G2,155.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,15.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,18.13|0,,,,1C0B5C18-8760-4483-A88C-1D1D89F61998,,,,,,Pre-Adjuvant Therapy,NO,,,,4.0,6.0,,10.0,NO,YES,WHITE,,,NO,,NO,Adverse event/complications,,,1,Female,Cervical,20.0,16.0,,,JW,2.0,,,TUMOR FREE,165.0,Train,Train,Train,Val,Train,TCGA-JW-AAVH-01Z-00-DX1.7E15119B-59A5-48EC-8BEC-987F394CD004,WITH TUMOR,DX1,
VENHQS1KWC1BM1BaOmNlc2NfdGNnYQ,TCGA-JX-A3PZ,cesc_tcga,25.0,M0,N0,1995,T1b,,,,,,,,Not done per treating physicians discretion,,,,Stage IB,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|[Not Available],-1.0,,,0.0,538.0,20.27|1,0.0,,,4/17/14,G2,175.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,1995.0,Keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,22.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,YES,21.09|1,,,,3DF6ABE2-2123-4BFA-A4E4-88DF5F940C04,,Cervical Cancer,,,,Pre-Adjuvant Therapy,NO,,0.0,0.0,0.0,0.0,0.0,0.0,NO,NO,WHITE,,,NO,,YES,Not done per treating physician discretion,,,1,Female,Cervical,,,,NO,JX,1.0,Complete Remission/Response,,WITH TUMOR,58.0,Test,Test,Test,Test,Test,TCGA-JX-A3PZ-01Z-00-DX1.B5104E52-828E-49E1-9467-AC506EC5D551,WITH TUMOR,DX1,
VENHQS1KWC1BM1E4OmNlc2NfdGNnYQ,TCGA-JX-A3Q8,cesc_tcga,40.0,MX,N0,2009,T1b1,,,,7.1,,,,,,,,Stage IB1,ABSENT,,,,32.0,0.0,6.0,44.58|0,0.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,4/17/14,G3,158.0,Endocervical Type of Adenocarcinoma,Former User,,No,No,"31.33, 35.39, 45.51, 52.56.58.59.68",HPV 16|HPV 18|Other HPV type(s),PCR,,Radical Hysterectomy,C53.9,8384/3,C53.9,YES,2011.0,,ABSENT,YES,0.0,0.0,,14.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,44.58|0,,,,34629EB8-0C5E-4910-8E13-BF7D6A1E337F,,,,,Post operative visit,Other,NO,,0.0,1.0,1.0,1.0,0.0,3.0,NO,NO,ASIAN,,,NO,,YES,,,,1,Female,Cervical,,,,,JX,1.0,Complete Remission/Response,,TUMOR FREE,68.0,Train,Train,Val,Train,Train,TCGA-JX-A3Q8-01Z-00-DX1.4995F70C-BDBE-4435-B57B-C6ACC27B0E91,WITH TUMOR,DX1,
VENHQS1KWC1BM1EwOmNlc2NfdGNnYQ,TCGA-JX-A3Q0,cesc_tcga,63.0,M0,N0,1995,T3,3300.0,Other,Implants-tandem and ovoids,,,,,Not done per treating physicians discretion,,,,Stage III,,Extra-Pelvic Metastatic Disease Present,-1.0,,,0.0,89.0,209.43|0,1.0,NOT HISPANIC OR LATINO,,4/17/14,G2,166.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,1997.0,Keratinizing squamous cell carcinoma,,NO,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,209.43|0,,,,20280122-A66A-4C83-8F25-0B9D97558DC2,,,,,,Post-Adjuvant Therapy,NO,,0.0,0.0,2.0,0.0,0.0,2.0,NO,NO,BLACK OR AFRICAN AMERICAN,,Other,YES,Whole pelvis split field,YES,,,3060.0,1,Female,Cervical,20.0,24.0,1997.0,NO,JX,4.0,Complete Remission/Response,,TUMOR FREE,57.0,Train,Train,Train,Train,Val,TCGA-JX-A3Q0-01Z-00-DX1.F848EB8C-256B-4205-B34A-9461E16F6744,WITH TUMOR,DX1,
VENHQS1KWC1BNVFWOmNlc2NfdGNnYQ,TCGA-JX-A5QV,cesc_tcga,37.0,M0,N0,2009,T1b1,2400.0,LDR,,,,,,,,,,Stage IB1,ABSENT,,,,8.0,0.0,7.0,20.89|0,0.0,NOT HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,6/11/14,G3,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2012.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,13.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,20.89|0,,,,ACF5CBF3-09CA-4F4D-A44E-1792613190FC,,,,,,Preoperative,NO,,0.0,0.0,4.0,1.0,0.0,5.0,NO,NO,WHITE,,IMRT,YES,,YES,,,5120.0,1,Female,Cervical,,,,NO,JX,1.0,Complete Remission/Response,,TUMOR FREE,61.0,Train,Train,Train,Val,Train,TCGA-JX-A5QV-01Z-00-DX1.90769414-2C5C-4BAA-A432-9FC0A15EEF5A,WITH TUMOR,DX1,
VENHQS1MUC1BN0hVOmNlc2NfdGNnYQ,TCGA-LP-A7HU,cesc_tcga,53.0,M0,N0,2009,T2,,,,,,,,,,,,Stage II,ABSENT,,,,,0.0,,13.34|0,1.0,NOT HISPANIC OR LATINO,,1/3/14,G3,155.0,Endocervical Type of Adenocarcinoma,Never Used,,No,No,,,,,Simple Hysterectomy,C53.9,8384/3,C53.9,YES,2013.0,,ABSENT,YES,0.0,,,2.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,13.34|0,,,,7067B7DA-FB1B-4827-8FE6-9433ED672D3B,,,,,,Preoperative,,"Pelvic (external iliac, internal iliac, obturator)",,,2.0,,,3.0,NO,YES,ASIAN,,,,,NO,,,,1,Female,Cervical,,,,,LP,1.0,,,TUMOR FREE,58.0,Train,Train,Val,Train,Train,TCGA-LP-A7HU-01Z-00-DX1.AE8E0ECD-C300-4260-A418-F86EED790E0F,WITH TUMOR,DX1,
VENHQS1MUC1BNEFVOmNlc2NfdGNnYQ,TCGA-LP-A4AU,cesc_tcga,35.0,M0,N1,2009,T2,,,,,[Not Available]|[Not Available],75 mg/m2|750 MG/M2,[Not Available]|[Not Available],,,Cisplatin|Other,[Not Applicable]|5FU,Stage IIIB,,,,,,0.0,,11.27|0,,NOT HISPANIC OR LATINO,,3/12/13,G3,153.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Simple Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,,,YES,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,11.27|0,,,,E15D92A1-6925-4B58-A494-D6F665F67B83,,,,,,,YES,,,,1.0,,,1.0,NO,YES,ASIAN,,External beam radiation,YES,,NO,,,6500.0,1,Female,Cervical,,,,YES,LP,1.0,,,TUMOR FREE,49.0,Val,Train,Train,Train,Train,TCGA-LP-A4AU-01Z-00-DX1.6E74590D-7AE0-451B-A340-D6C0B1C46E05,WITH TUMOR,DX1,
VENHQS1MUC1BNEFWOmNlc2NfdGNnYQ,TCGA-LP-A4AV,cesc_tcga,63.0,M0,N0,2009,T1b,,,,,,,,,,,,Stage IB,,,,,,0.0,,0.0|0,,NOT HISPANIC OR LATINO,,3/12/13,G2,153.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2011.0,,,YES,,,,3.0,,,Biopsy (cervical / CT-guided / Other),,NO,0.0|0,,,,F241D6B1-2C32-4478-8F8D-8C746464F7D1,,,,,,,NO,,,,4.0,,,4.0,NO,YES,ASIAN,,,NO,,NO,,,,1,Female,Cervical,,,,,LP,1.0,,,TUMOR FREE,42.0,Train,Train,Val,Train,Train,TCGA-LP-A4AV-01Z-00-DX1.42D4222F-9534-48B5-8478-2BA6E25F32BA,WITH TUMOR,DX1,
VENHQS1MUC1BNEFXOmNlc2NfdGNnYQ,TCGA-LP-A4AW,cesc_tcga,52.0,M0,N0,2009,T1b,,,,,,,,,,,,Stage IA,,,,,,0.0,,0.89|0,,NOT HISPANIC OR LATINO,,3/12/13,G1,158.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2011.0,Keratinizing squamous cell carcinoma,,YES,,,,3.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,0.89|0,,,,74E47DED-2C00-4455-AAA6-CD662DFBF05E,,,,,,,NO,,,,2.0,,,2.0,NO,YES,ASIAN,,,NO,,NO,,,,1,Female,Cervical,,,,,LP,1.0,,,TUMOR FREE,52.0,Val,Train,Train,Train,Train,TCGA-LP-A4AW-01Z-00-DX1.EBEB0F74-3F52-4A55-8633-08B3DBA3D731,WITH TUMOR,DX1,
VENHQS1MUC1BNEFYOmNlc2NfdGNnYQ,TCGA-LP-A4AX,cesc_tcga,45.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,12.48|0,,NOT HISPANIC OR LATINO,,3/12/13,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Simple Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,,,YES,0.0,,,2.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,12.48|0,,,,3223FEC6-1D35-419A-8EE9-7C5885B8BE1E,,,,,,,NO,,,,2.0,,,2.0,NO,YES,ASIAN,,,NO,,NO,,,,1,Female,Cervical,,,,,LP,1.0,,,TUMOR FREE,,Test,Test,Test,Test,Test,TCGA-LP-A4AX-01Z-00-DX1.63D0B7FC-8A6C-40F8-95A4-1F5D9C6FB5D2,WITH TUMOR,DX1,
VENHQS1MUC1BNVUyOmNlc2NfdGNnYQ,TCGA-LP-A5U2,cesc_tcga,30.0,MX,N1,2009,T2a,,,,,,,,,,,,Stage IIIB,ABSENT,,,,,0.0,6.0,0.3|0,1.0,NOT HISPANIC OR LATINO,,7/3/14,G3,160.0,Endocervical Adenocarcinoma of the Usual Type,Never Used,,No,No,,,,,,C53.9,8384/3,C53.9,YES,2012.0,,PRESENT,YES,2.0,,,7.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,0.3|0,,,,1EF20703-3684-4B43-A31F-892073208377,,,,,,Preoperative,NO,"Pelvic (external iliac, internal iliac, obturator)",,1.0,,,,1.0,YES,YES,ASIAN,,,NO,,NO,,,,1,Female,Cervical,,,,,LP,1.0,Complete Remission/Response,,TUMOR FREE,51.0,Test,Test,Test,Test,Test,TCGA-LP-A5U2-01Z-00-DX1.5D32288C-4472-4B5A-B3F6-93D31A8E6E52,WITH TUMOR,DX1,
VENHQS1MUC1BNVUzOmNlc2NfdGNnYQ,TCGA-LP-A5U3,cesc_tcga,40.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,,0.82|0,1.0,NOT HISPANIC OR LATINO,,1/3/14,G3,160.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,0.82|0,,,,1399D31D-9D5E-441A-B400-8B8A92A6FF8B,,,,,,Preoperative,,,,,3.0,,,3.0,NO,YES,ASIAN,,,,,NO,,,,1,Female,Cervical,,,,,LP,1.0,Complete Remission/Response,,TUMOR FREE,50.0,Test,Test,Test,Test,Test,TCGA-LP-A5U3-01Z-00-DX1.709B6010-A1E5-48DF-A994-40816B1825FC,WITH TUMOR,DX1,
VENHQS1NQS1BQTNXOmNlc2NfdGNnYQ,TCGA-MA-AA3W,cesc_tcga,54.0,M0,N1,2009,T1b1,,,,0.0,Once weekly,70,5,,,Cisplatin,,Stage IB1,PRESENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,5.0,,65.0,0.0,7.0,22.5|0,1.0,HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,7/15/14,G3,155.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,YES,1.0,0.0,,40.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,22.5|0,,,,FC2BCE29-4685-49F5-B901-2117BF673BB8,left parametrium,,,negative,,Preoperative,YES,"Other Location, specify",1.0,,4.0,1.0,,6.0,NO,YES,WHITE,,IMRT,YES,,NO,,,4500.0,1,Female,Cervical,5.7,18.0,,YES,MA,2.0,Complete Remission/Response,,TUMOR FREE,84.0,Train,Train,Train,Train,Val,TCGA-MA-AA3W-01Z-00-DX1.40AA8BB7-17A1-4D8F-8F20-CBEDCCD67CAA,WITH TUMOR,DX1,
VENHQS1NQS1BQTNYOmNlc2NfdGNnYQ,TCGA-MA-AA3X,cesc_tcga,50.0,MX,NX,2009,T3b,2900.0,HDR,,,Once weekly,70,5,,,Cisplatin,,Stage IIIB,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,83.0,1.0,77.0,0.0,0.0,20.27|0,1.0,NOT HISPANIC OR LATINO,Bladder Absent|[Not Available]|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|[Not Available],7/15/14,G2,170.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,NO,,,[Not Available]|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,20.27|0,,,,ADB7C5C8-4AFD-40DC-89F1-571FBD88E4F9,,,,,,Pre-Adjuvant Therapy,YES,,,,2.0,1.0,,3.0,NO,YES,BLACK OR AFRICAN AMERICAN,,3D conformal,YES,,NO,,,5040.0,1,Female,Cervical,9.5,12.0,,YES,MA,2.0,Complete Remission/Response,,TUMOR FREE,73.0,Train,Train,Train,Train,Val,TCGA-MA-AA3X-01Z-00-DX1.44657CDB-53F1-4DED-AE54-2251118565EA,WITH TUMOR,DX1,
VENHQS1NQS1BQTNZOmNlc2NfdGNnYQ,TCGA-MA-AA3Y,cesc_tcga,48.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,20.0,,,0.0,22.0,17.81|0,1.0,HISPANIC OR LATINO,,7/16/14,G3,156.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2012.0,Keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,29.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,17.81|0,,,,2F261704-D600-4226-90D5-D51BA416B55C,,,,negative,,Preoperative,NO,,,,,1.0,,1.0,NO,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,NO,MA,1.0,Complete Remission/Response,,TUMOR FREE,65.0,Train,Train,Train,Train,Val,TCGA-MA-AA3Y-01Z-00-DX1.4540E042-94A5-4D83-8349-96457E8BEE27,WITH TUMOR,DX1,
VENHQS1NQS1BQTNaOmNlc2NfdGNnYQ,TCGA-MA-AA3Z,cesc_tcga,43.0,M0,N0,2009,T1b2,2800.0,HDR,,28.8,Once weekly,70,6,,,Cisplatin,,Stage IB2,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,41.0,,52.0,0.0,36.0,19.55|0,1.0,HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,7/16/14,GX,160.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,There are several types of HPV the patient could be positive for.,Other HPV type(s),"Other, specify",HPV Hybrid Capture II,,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,19.55|0,,,,BC2003B9-D489-4559-8672-D9FD2D82F2E8,,,,,,Pre-Adjuvant Therapy,YES,,,,5.0,,,5.0,NO,YES,WHITE,,3D conformal,YES,,NO,,,5040.0,1,Female,Cervical,,,,YES,MA,1.0,Complete Remission/Response,,TUMOR FREE,84.0,Test,Test,Test,Test,Test,TCGA-MA-AA3Z-01Z-00-DX1.5A2321A9-7174-4B3E-9A2D-C4790E5EECBC,WITH TUMOR,DX1,
VENHQS1NQS1BQTQxOmNlc2NfdGNnYQ,TCGA-MA-AA41,cesc_tcga,33.0,M1,N1,2009,T2,6817.0,Other,pulse dose rate,,Once weekly|Once weekly|Once weekly|[Not Available],57|AUC/5|175mg/m2; 135mg/m2|15mg/kg,2|6|6|5,,,Cisplatin|Carboplatin|Other|Other,[Not Applicable]|[Not Applicable]|Paclitaxel|Bevacizumab,Stage IIB,,,,,15.0,0.0,0.0,9.17|0,1.0,HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,7/16/14,G2,159.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,9.17|0,,,,81658CE6-D4A9-4EE0-AE8F-CF2FA8485701,,,,,,Pre-Adjuvant Therapy,YES,,,,3.0,,,3.0,NO,YES,WHITE,,3D conformal,YES,,NO,,,3420.0,1,Female,Cervical,5.0,14.0,,YES,MA,2.0,Progressive Disease,,WITH TUMOR,47.0,Train,Train,Val,Train,Train,TCGA-MA-AA41-01Z-00-DX1.0BF79910-1A5B-49DB-96B9-53BE450371CE,WITH TUMOR,DX1,
VENHQS1NQS1BQTQyOmNlc2NfdGNnYQ,TCGA-MA-AA42,cesc_tcga,75.0,M0,N0,2009,T2b,3100.0,HDR,,18.5,Once weekly,62,5,,,Cisplatin,,Stage IIB,,,,14.0,19.0,0.0,0.0,8.51|0,1.0,HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,7/22/14,G3,140.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,NO,,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,8.51|0,,,,DA5FCB99-16B4-4F9E-8602-D6A6192875EF,,,,,,Pre-Adjuvant Therapy,YES,,,,6.0,2.0,,8.0,NO,YES,WHITE,,3D conformal,YES,,NO,,,5040.0,1,Female,Cervical,,,,YES,MA,1.0,Complete Remission/Response,,TUMOR FREE,63.0,Train,Train,Train,Val,Train,TCGA-MA-AA42-01Z-00-DX1.060491AB-E11F-44DC-91CA-0AE68DE8C900,WITH TUMOR,DX1,
VENHQS1NQS1BQTQzOmNlc2NfdGNnYQ,TCGA-MA-AA43,cesc_tcga,48.0,MX,NX,2009,T3b,8239.0,Other,pulse dose rate,,Once weekly,68,2,,,Cisplatin,,Stage IIIB,,,,70.0,66.0,0.0,39.0,11.37|0,1.0,HISPANIC OR LATINO,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,7/22/14,G3,152.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,NO,,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,11.37|0,,,,ED74703A-6838-4F4E-9524-D6FB7B208687,,,,,,Pre-Adjuvant Therapy,YES,,,,6.0,,,6.0,NO,YES,WHITE,4500.0,3D conformal,YES,,NO,,,11400.0,1,Female,Cervical,11.6,16.0,2013.0,YES,MA,4.0,Complete Remission/Response,,TUMOR FREE,72.0,Train,Train,Train,Train,Val,TCGA-MA-AA43-01Z-00-DX1.ABDB39DC-D3A5-4B34-B573-C918D9783FFA,WITH TUMOR,DX1,
VENHQS1NVS1BNTFZOmNlc2NfdGNnYQ,TCGA-MU-A51Y,cesc_tcga,27.0,MX,N0,2009,T2a1,,,,6.47,,,,,,,,Stage IIA1,,,,,52.0,0.0,,28.06|0,,,,9/14/12,G2,,Cervical Squamous Cell Carcinoma,,,No,No,High risk,Other HPV type(s),"Other, specify",Hybrid Capture 2,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,0.0,,17.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cone Biopsy / LEEP,,NO,28.06|0,,,uninvolved margins,77DA506B-E726-409F-B3EB-D41242862982,,,,,,,NO,,,3.0,1.0,,,,,YES,WHITE,,,NO,,NO,Not done per treating physician discretion,,,1,Female,Cervical,,,,,MU,1.0,Complete Remission/Response,,TUMOR FREE,31.0,Train,Val,Train,Train,Train,TCGA-MU-A51Y-01Z-00-DX1.EC146E16-85BA-4817-A2BE-37BDE4349B5C,WITH TUMOR,DX1,
VENHQS1NVS1BNVlJOmNlc2NfdGNnYQ,TCGA-MU-A5YI,cesc_tcga,60.0,MX,NX,2009,T1a1,,,,,,,,,,,,Stage IA1,,,,,,0.0,,20.7|1,,NOT HISPANIC OR LATINO,,5/23/13,G2,175.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,,,18.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Hysterectomy,NO,34.59|0,,,,5E972E96-7271-439A-905C-6E308C1EF29E,,,,,,,NO,,,,,,,,,YES,BLACK OR AFRICAN AMERICAN,,,NO,,NO,,,,1,Female,Cervical,10.0,37.0,1991.0,,MU,3.0,,,TUMOR FREE,101.0,Train,Val,Train,Train,Train,TCGA-MU-A5YI-01Z-00-DX1.9A120E91-4345-45D5-BF51-C2D6F9612632,WITH TUMOR,DX1,
VENHQS1NVS1BOEpNOmNlc2NfdGNnYQ,TCGA-MU-A8JM,cesc_tcga,46.0,MX,N0,2009,T1b,,,,6.0,,,,,,,,Stage IB1,,,,,28.0,0.0,,19.94|0,,NOT HISPANIC OR LATINO,[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available],10/9/13,G2,165.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,,,29.0,Microscopic parametrial involvement,,Cone Biopsy / LEEP,,NO,19.94|0,,,,1D730565-FFA9-4CC7-A713-C4B5B7BBB29F,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)|Common iliac",,,1.0,1.0,,2.0,NO,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,30.0,16.0,2012.0,NO,MU,4.0,Complete Remission/Response,,TUMOR FREE,86.0,Train,Train,Val,Train,Train,TCGA-MU-A8JM-01Z-00-DX1.6B02B6FD-5D8A-41C0-8936-D7B63CD6B552,WITH TUMOR,DX1,
VENHQS1NWS1BNUJEOmNlc2NfdGNnYQ,TCGA-MY-A5BD,cesc_tcga,62.0,M0,N0,2009,T2b,,,,,,,,,,,,Stage IIB,PRESENT,,,,,0.0,,54.76|0,,HISPANIC OR LATINO,,5/20/13,G1,157.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,PRESENT,YES,0.0,0.0,,26.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,54.76|0,,,,CEF2EFB2-93CC-4BDF-A343-9965E7E0432C,,,,,,,NO,,,,,,,,,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,91.0,Train,Train,Train,Val,Train,TCGA-MY-A5BD-01Z-00-DX1.E7DFAEEE-649B-47F5-A9E0-F0EE85680E45,WITH TUMOR,DX1,
VENHQS1NWS1BNUJFOmNlc2NfdGNnYQ,TCGA-MY-A5BE,cesc_tcga,42.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,35.02|0,,NOT HISPANIC OR LATINO,,5/20/13,G3,157.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,ABSENT,YES,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,35.02|0,,,,F8AB17EC-C365-41A6-A4BC-36653E84BCE5,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)|Common iliac",,,,,,,,NO,BLACK OR AFRICAN AMERICAN,,,NO,,YES,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,84.0,Train,Train,Val,Train,Train,TCGA-MY-A5BE-01Z-00-DX4.FEB6720A-6D9C-4EE7-9251-1BE636EA5269,WITH TUMOR,DX4,
VENHQS1NWS1BNUJFOmNlc2NfdGNnYQ,TCGA-MY-A5BE,cesc_tcga,42.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,35.02|0,,NOT HISPANIC OR LATINO,,5/20/13,G3,157.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,ABSENT,YES,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,35.02|0,,,,F8AB17EC-C365-41A6-A4BC-36653E84BCE5,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)|Common iliac",,,,,,,,NO,BLACK OR AFRICAN AMERICAN,,,NO,,YES,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,84.0,Train,Train,Val,Train,Train,TCGA-MY-A5BE-01Z-00-DX2.7152FFD0-9DD2-4B1A-AADC-8C00B156EBE0,WITH TUMOR,DX2,
VENHQS1NWS1BNUJFOmNlc2NfdGNnYQ,TCGA-MY-A5BE,cesc_tcga,42.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,35.02|0,,NOT HISPANIC OR LATINO,,5/20/13,G3,157.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,ABSENT,YES,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,35.02|0,,,,F8AB17EC-C365-41A6-A4BC-36653E84BCE5,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)|Common iliac",,,,,,,,NO,BLACK OR AFRICAN AMERICAN,,,NO,,YES,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,84.0,Train,Train,Val,Train,Train,TCGA-MY-A5BE-01Z-00-DX1.C345ACDE-83AF-4EB1-9B4C-EBA16F89CB9F,WITH TUMOR,DX1,
VENHQS1NWS1BNUJFOmNlc2NfdGNnYQ,TCGA-MY-A5BE,cesc_tcga,42.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,,35.02|0,,NOT HISPANIC OR LATINO,,5/20/13,G3,157.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,ABSENT,YES,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,35.02|0,,,,F8AB17EC-C365-41A6-A4BC-36653E84BCE5,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)|Common iliac",,,,,,,,NO,BLACK OR AFRICAN AMERICAN,,,NO,,YES,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,84.0,Train,Train,Val,Train,Train,TCGA-MY-A5BE-01Z-00-DX3.6DA5EAD4-BB7C-42ED-BE81-CEF2FAE7A11C,WITH TUMOR,DX3,
VENHQS1NWS1BNUJGOmNlc2NfdGNnYQ,TCGA-MY-A5BF,cesc_tcga,68.0,MX,N0,2009,T2a2,,,,,,,,,,,,Stage IIA2,,,,,,0.0,,20.83|0,,NOT HISPANIC OR LATINO,,5/20/13,G1,170.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Other,C53.9,8071/3,C53.9,YES,2012.0,,PRESENT,YES,0.0,6.0,,6.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Lymph node sampling or dissection,,NO,20.83|0,robotic,,,4F4E8834-A716-42E6-BD51-60D80A619202,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)",,,,,,,,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,74.0,Train,Val,Train,Train,Train,TCGA-MY-A5BF-01Z-00-DX1.EBA36CA2-14D7-45C5-BE6D-FF35B69079FF,WITH TUMOR,DX1,
VENHQS1NWS1BNUJGOmNlc2NfdGNnYQ,TCGA-MY-A5BF,cesc_tcga,68.0,MX,N0,2009,T2a2,,,,,,,,,,,,Stage IIA2,,,,,,0.0,,20.83|0,,NOT HISPANIC OR LATINO,,5/20/13,G1,170.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Other,C53.9,8071/3,C53.9,YES,2012.0,,PRESENT,YES,0.0,6.0,,6.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Lymph node sampling or dissection,,NO,20.83|0,robotic,,,4F4E8834-A716-42E6-BD51-60D80A619202,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)",,,,,,,,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,74.0,Train,Val,Train,Train,Train,TCGA-MY-A5BF-01Z-00-DX3.CF669DE8-217E-47A6-839F-ABE9657BA566,WITH TUMOR,DX3,
VENHQS1NWS1BNUJGOmNlc2NfdGNnYQ,TCGA-MY-A5BF,cesc_tcga,68.0,MX,N0,2009,T2a2,,,,,,,,,,,,Stage IIA2,,,,,,0.0,,20.83|0,,NOT HISPANIC OR LATINO,,5/20/13,G1,170.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Other,C53.9,8071/3,C53.9,YES,2012.0,,PRESENT,YES,0.0,6.0,,6.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Lymph node sampling or dissection,,NO,20.83|0,robotic,,,4F4E8834-A716-42E6-BD51-60D80A619202,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)",,,,,,,,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,74.0,Train,Val,Train,Train,Train,TCGA-MY-A5BF-01Z-00-DX4.48F35F8C-450B-4851-95D0-642B2A700671,WITH TUMOR,DX4,
VENHQS1NWS1BNUJGOmNlc2NfdGNnYQ,TCGA-MY-A5BF,cesc_tcga,68.0,MX,N0,2009,T2a2,,,,,,,,,,,,Stage IIA2,,,,,,0.0,,20.83|0,,NOT HISPANIC OR LATINO,,5/20/13,G1,170.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Other,C53.9,8071/3,C53.9,YES,2012.0,,PRESENT,YES,0.0,6.0,,6.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Lymph node sampling or dissection,,NO,20.83|0,robotic,,,4F4E8834-A716-42E6-BD51-60D80A619202,,,,,,,NO,"Pelvic (external iliac, internal iliac, obturator)",,,,,,,,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,,MY,1.0,,,TUMOR FREE,74.0,Train,Val,Train,Train,Train,TCGA-MY-A5BF-01Z-00-DX2.B9688F0E-42A9-4328-BB22-6446636EFF0F,WITH TUMOR,DX2,
VENHQS1NWS1BOTEzOmNlc2NfdGNnYQ,TCGA-MY-A913,cesc_tcga,28.0,M1,N0,2009,Tis,50.0,HDR,,26.1,Once weekly,40mg,5,,,Cisplatin,,Stage IIA,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,166.0,21.0,-7.0,0.0,152.0,17.21|0,0.0,HISPANIC OR LATINO,Bladder Absent|[Not Available]|[Not Available]|[Not Available]|Pelvic Nodes Present|[Not Available],4/23/14,G3,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,,,NO,,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,17.21|0,,,,C9F519B6-73F1-4737-83CB-F5EF208592CD,,,,,,Post-Adjuvant Therapy,YES,,,1.0,5.0,1.0,,7.0,NO,YES,BLACK OR AFRICAN AMERICAN,,External beam radiation,YES,,NO,,,50.0,1,Female,Cervical,,,,YES,MY,5.0,Complete Remission/Response,,TUMOR FREE,76.0,Train,Train,Train,Train,Val,TCGA-MY-A913-01Z-00-DX1.7A19D2C6-CC5F-4DF5-AFF8-B390C0291C0E,WITH TUMOR,DX1,
VENHQS1NWS1BOTEzOmNlc2NfdGNnYQ,TCGA-MY-A913,cesc_tcga,28.0,M1,N0,2009,Tis,50.0,HDR,,26.1,Once weekly,40mg,5,,,Cisplatin,,Stage IIA,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,166.0,21.0,-7.0,0.0,152.0,17.21|0,0.0,HISPANIC OR LATINO,Bladder Absent|[Not Available]|[Not Available]|[Not Available]|Pelvic Nodes Present|[Not Available],4/23/14,G3,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,,,NO,,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,17.21|0,,,,C9F519B6-73F1-4737-83CB-F5EF208592CD,,,,,,Post-Adjuvant Therapy,YES,,,1.0,5.0,1.0,,7.0,NO,YES,BLACK OR AFRICAN AMERICAN,,External beam radiation,YES,,NO,,,50.0,1,Female,Cervical,,,,YES,MY,5.0,Complete Remission/Response,,TUMOR FREE,76.0,Train,Train,Train,Train,Val,TCGA-MY-A913-01Z-00-DX2.F5233D58-09FE-44ED-8F08-66A1BB6B33DB,WITH TUMOR,DX2,
VENHQS1NWS1BOTEzOmNlc2NfdGNnYQ,TCGA-MY-A913,cesc_tcga,28.0,M1,N0,2009,Tis,50.0,HDR,,26.1,Once weekly,40mg,5,,,Cisplatin,,Stage IIA,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,166.0,21.0,-7.0,0.0,152.0,17.21|0,0.0,HISPANIC OR LATINO,Bladder Absent|[Not Available]|[Not Available]|[Not Available]|Pelvic Nodes Present|[Not Available],4/23/14,G3,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,,,NO,,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,17.21|0,,,,C9F519B6-73F1-4737-83CB-F5EF208592CD,,,,,,Post-Adjuvant Therapy,YES,,,1.0,5.0,1.0,,7.0,NO,YES,BLACK OR AFRICAN AMERICAN,,External beam radiation,YES,,NO,,,50.0,1,Female,Cervical,,,,YES,MY,5.0,Complete Remission/Response,,TUMOR FREE,76.0,Train,Train,Train,Train,Val,TCGA-MY-A913-01Z-00-DX3.19ACBF59-9114-4980-A44C-5ACF414A09CF,WITH TUMOR,DX3,
VENHQS1QTi1BOE1BOmNlc2NfdGNnYQ,TCGA-PN-A8MA,cesc_tcga,43.0,M0,N0,2009,T2b,,,,,Once weekly,50mg,3,,,Cisplatin,,Stage IIB,,,,,,0.0,90.0,2.96|0,1.0,NOT HISPANIC OR LATINO,,3/25/14,G3,167.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,,2.96|0,,,,55ADD854-E63F-4335-BEA9-23C3EB1E766A,,,,,during adjuvant therapy,Other,YES,,,,8.0,1.0,,9.0,NO,YES,BLACK OR AFRICAN AMERICAN,,External beam radiation,YES,,NO,Adverse event/complications,,,1,Female,Cervical,,,,YES,PN,,Stable Disease,,WITH TUMOR,71.0,Val,Train,Train,Train,Train,TCGA-PN-A8MA-01A-01-DX1.978164EB-6260-45BA-A874-FC795B72FA8C,WITH TUMOR,DX1,
VENHQS1RMS1BNVIxOmNlc2NfdGNnYQ,TCGA-Q1-A5R1,cesc_tcga,32.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,6.0,15.57|0,0.0,NOT HISPANIC OR LATINO,,4/26/13,G2,183.0,Mucinous Adenocarcinoma of Endocervical Type,Current User,,No,No,,,,,Radical Hysterectomy,C53.9,8482/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,4.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cytology (e.g. Peritoneal or pleural fluid),,NO,15.57|0,,,,F93CCD2D-3C77-4BD3-8CAC-5203BD57735F,,,,,Post-op,Other,NO,,,,1.0,,,2.0,NO,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,NO,Q1,1.0,Complete Remission/Response,,TUMOR FREE,92.0,Test,Test,Test,Test,Test,TCGA-Q1-A5R1-01Z-00-DX1.25DCB2F6-6F57-4D78-A801-38910AFF6564,WITH TUMOR,DX1,
VENHQS1RMS1BNVIyOmNlc2NfdGNnYQ,TCGA-Q1-A5R2,cesc_tcga,64.0,MX,NX,7th,TX,300.0,HDR,,,Once weekly,,6,,,Cisplatin,,,,,,,,0.0,105.0,16.39|0,0.0,NOT HISPANIC OR LATINO,,4/26/13,G3,160.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,16.39|0,,,,F3CBADB3-3B83-47CD-B8A0-B0E10343A295,,,,,,Post-Adjuvant Therapy,YES,,,,2.0,,,2.0,NO,YES,WHITE,,,YES,,NO,,,,1,Female,Cervical,,,,YES,Q1,1.0,,,WITH TUMOR,76.0,Train,Val,Train,Train,Train,TCGA-Q1-A5R2-01Z-00-DX1.FED4C720-A758-4C81-ABC0-48B9F995506A,WITH TUMOR,DX1,
VENHQS1RMS1BNVIzOmNlc2NfdGNnYQ,TCGA-Q1-A5R3,cesc_tcga,56.0,MX,NX,7th,TX,3000.0,HDR,,,,,,,,Cisplatin,,,,,,,,0.0,178.0,15.93|0,0.0,NOT HISPANIC OR LATINO,,4/26/13,G2,162.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,15.93|0,,,,73AA428A-4288-45F8-8A53-CEC173DCC61F,,,,,,Post-Adjuvant Therapy,YES,,,,3.0,,,5.0,NO,YES,WHITE,,,YES,,NO,,,,1,Female,Cervical,,,,YES,Q1,1.0,Complete Remission/Response,,TUMOR FREE,50.0,Train,Train,Train,Val,Train,TCGA-Q1-A5R3-01Z-00-DX1.8A313239-8F5E-4F78-BBB5-640BF6079FF2,WITH TUMOR,DX1,
VENHQS1RMS1BNkRUOmNlc2NfdGNnYQ,TCGA-Q1-A6DT,cesc_tcga,55.0,MX,NX,2009,TX,,,,,,,,,,,,Stage I,,,,,,0.0,,,,NOT HISPANIC OR LATINO,,8/20/13,GX,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,9.03|1,,,,46ADFBBE-3ADD-41CD-A388-B1EE0790BF62,,,,,,,NO,,,,,,,,NO,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,,Q1,1.0,,,WITH TUMOR,,Train,Train,Val,Train,Train,TCGA-Q1-A6DT-01Z-00-DX1.4790D582-87FA-4684-AA0B-81C294FBF522,WITH TUMOR,DX1,
VENHQS1RMS1BNkRWOmNlc2NfdGNnYQ,TCGA-Q1-A6DV,cesc_tcga,36.0,M0,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,-12.0,16.13|0,0.0,NOT HISPANIC OR LATINO,,8/20/13,G2,152.0,Mucinous Adenocarcinoma of Endocervical Type,Current User,,No,No,,,,,Radical Hysterectomy,C53.0,8482/3,C53.0,YES,2013.0,Non-keratinizing squamous cell carcinoma,ABSENT,YES,0.0,0.0,,2.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",Hysterectomy,NO,16.13|0,,,,C80F777E-D150-40F3-9FA9-02EF9A6D7692,,,,,,Preoperative,NO,,,,,,,0.0,NO,YES,ASIAN,,,NO,,NO,,,,1,Female,Cervical,,,,NO,Q1,1.0,,,,60.0,Train,Train,Train,Train,Val,TCGA-Q1-A6DV-01Z-00-DX1.A31CD86F-703A-462F-8608-E7729607A325,WITH TUMOR,DX1,
VENHQS1RMS1BNkRXOmNlc2NfdGNnYQ,TCGA-Q1-A6DW,cesc_tcga,44.0,MX,NX,2009,TX,2900.0,HDR,,,Once weekly,40mg,5,,,Cisplatin,,Stage I,ABSENT,,,,,0.0,114.0,17.54|0,0.0,NOT HISPANIC OR LATINO,,8/20/13,GX,160.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,ABSENT,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,17.54|0,,,,5DBD5436-696E-40FA-881B-C2386573AC68,,,,,,Post-Adjuvant Therapy,YES,,,,1.0,,,1.0,NO,YES,WHITE,,,YES,,NO,,,,1,Female,Cervical,2.5,35.0,2009.0,YES,Q1,4.0,,,,62.0,Test,Test,Test,Test,Test,TCGA-Q1-A6DW-01Z-00-DX1.5F92312A-1AAF-419F-9D1A-196A6C0D5337,WITH TUMOR,DX1,
VENHQS1RMS1BNzNPOmNlc2NfdGNnYQ,TCGA-Q1-A73O,cesc_tcga,37.0,MX,NX,2009,TX,,,,,Once weekly,40mg/m2,6,,,Cisplatin,,Stage IB2,ABSENT,,,,,0.0,146.0,14.06|0,0.0,HISPANIC OR LATINO,,10/31/13,GX,152.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,ABSENT,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,14.06|0,,,,D0CBE668-5C95-4261-A1E8-CEF55093A0F7,,,,,,Post-Adjuvant Therapy,YES,,,,,,,,NO,YES,,,,YES,,NO,,,,1,Female,Cervical,,,,YES,Q1,1.0,,,,76.0,Train,Train,Train,Val,Train,TCGA-Q1-A73O-01Z-00-DX1.305629EA-C987-4464-A4AD-730DFEB6CD0C,WITH TUMOR,DX1,
VENHQS1RMS1BNzNQOmNlc2NfdGNnYQ,TCGA-Q1-A73P,cesc_tcga,45.0,MX,N0,2009,T1b,,,,,,,,,,,,Stage IB1,ABSENT,,,,,0.0,146.0,15.87|0,0.0,NOT HISPANIC OR LATINO,,10/31/13,G1,173.0,Endocervical Type of Adenocarcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8384/3,C53.9,YES,2013.0,,ABSENT,YES,0.0,0.0,,17.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,15.87|0,,,,3A3A9B5E-12A1-41F5-A54C-D4C1E0ECCB9E,,,,,,Post-Adjuvant Therapy,NO,,,,5.0,,,6.0,NO,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,,Q1,1.0,,,,82.0,Train,Val,Train,Train,Train,TCGA-Q1-A73P-01Z-00-DX1.2E8DD02B-4F5D-4E13-91DB-D9E2373B645F,WITH TUMOR,DX1,
VENHQS1RMS1BNzNROmNlc2NfdGNnYQ,TCGA-Q1-A73Q,cesc_tcga,46.0,MX,NX,2009,TX,2900.0,HDR,,,Once weekly,40mg/m2,5,,,Cisplatin,,Stage I,,,,,,0.0,179.0,9.33|0,0.0,NOT HISPANIC OR LATINO,,10/31/13,GX,158.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8071/3,C53.9,YES,2013.0,Keratinizing squamous cell carcinoma,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,9.33|0,,,,5C72BDA2-2EC0-455F-AB27-7247FD5FFFF9,,,,,,Post-Adjuvant Therapy,YES,,1.0,,1.0,,,2.0,NO,YES,WHITE,,,YES,,NO,,,,1,Female,Cervical,3.3,13.0,,YES,Q1,2.0,,,,87.0,Train,Train,Train,Train,Val,TCGA-Q1-A73Q-01Z-00-DX1.E39029C5-48EE-466B-A11B-B884A83250F5,WITH TUMOR,DX1,
VENHQS1RMS1BNzNSOmNlc2NfdGNnYQ,TCGA-Q1-A73R,cesc_tcga,45.0,MX,NX,2009,TX,,,,,,,,,,,,Stage I,,,,,,0.0,190.0,18.63|0,0.0,,,10/31/13,GX,155.0,Endocervical Type of Adenocarcinoma,,,No,No,,,,,,C53.9,8384/3,C53.9,YES,2013.0,,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,18.63|0,,,,D9B0AC5A-811D-4305-BB1C-A965BD389CE4,,,,,,Post-Adjuvant Therapy,NO,,,,,,,,NO,YES,WHITE,,,NO,,NO,,,,1,Female,Cervical,,,,,Q1,1.0,,,,95.0,Train,Val,Train,Train,Train,TCGA-Q1-A73R-01Z-00-DX1.1BF1893C-AC21-4FB2-A568-F71B75350374,WITH TUMOR,DX1,
VENHQS1RMS1BNzNTOmNlc2NfdGNnYQ,TCGA-Q1-A73S,cesc_tcga,33.0,MX,N1,2009,T1b1,,,,,Once weekly,40mg/m2,6,,,Cisplatin,,Stage IB1,PRESENT,,,,,0.0,316.0,22.6|0,0.0,NOT HISPANIC OR LATINO,,10/31/13,G2,160.0,Adenosquamous,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8560/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,2.0,0.0,,18.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",Hysterectomy,NO,22.6|0,,,,B0F63819-FC86-4981-9D92-0115C6DE3BCE,Obturator,,,,,Post-Adjuvant Therapy,YES,"Other Location, specify",,,2.0,,,4.0,NO,YES,WHITE,,,YES,,NO,,,,1,Female,Cervical,7.5,19.0,2012.0,YES,Q1,4.0,,,,68.0,Train,Train,Train,Val,Train,TCGA-Q1-A73S-01Z-00-DX1.D74CFF58-A032-45D2-98FA-4B4D9AB90069,WITH TUMOR,DX1,
VENHQS1SQS1BNzQxOmNlc2NfdGNnYQ,TCGA-RA-A741,cesc_tcga,34.0,,,2009,,5500.0,HDR,,,Once weekly,40 MG/M2,6,,,Cisplatin,,Stage IIB,,[Not Available]|[Not Available]|[Not Available]|[Not Available]|Pelvic Nodes Absent|[Not Available],-15.0,14.0,,0.0,0.0,14.59|0,0.0,NOT HISPANIC OR LATINO,,11/13/13,GX,165.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,,YES,0.0,0.0,Bladder Absent|[Not Available]|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|[Not Available],4.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,14.59|0,,,,BDAD2F13-EDE2-4AAD-91A4-BF60F8888BF2,,,,,,Preoperative,YES,"Pelvic (external iliac, internal iliac, obturator)",0.0,0.0,0.0,0.0,0.0,0.0,NO,YES,WHITE,,IMRT,YES,,NO,,,4500.0,1,Female,Cervical,10.0,21.0,2013.0,YES,RA,4.0,,,,86.0,Train,Train,Train,Val,Train,TCGA-RA-A741-01Z-00-DX1.E14092BA-D4CE-4AD6-ACD7-D463D7C4DE71,WITH TUMOR,DX1,
VENHQS1VQy1BN1BEOmNlc2NfdGNnYQ,TCGA-UC-A7PD,cesc_tcga,21.0,M0,N0,1995,T1b,,Other,vaginal implant,,,,,,,,,Stage IB,,,,,,0.0,-1.0,6.64|1,1.0,,,2/4/14,G2,,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,1997.0,Keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,11.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",tumor resection,YES,11.66|1,,,perineural space invasion,0F18EF74-019B-478D-AECD-60CC715BFDB7,,Cervical Cancer,,,,Preoperative,NO,,0.0,1.0,4.0,0.0,0.0,5.0,YES,NO,AMERICAN INDIAN OR ALASKA NATIVE,,External beam radiation,YES,,YES,,,,1,Female,Cervical,1.75,13.0,,NO,UC,2.0,Complete Remission/Response,,WITH TUMOR,,Train,Train,Val,Train,Train,TCGA-UC-A7PD-01Z-00-DX1.D4DDF9DF-57A5-4412-95F4-3747579B8DC1,WITH TUMOR,DX1,
VENHQS1VQy1BN1BGOmNlc2NfdGNnYQ,TCGA-UC-A7PF,cesc_tcga,44.0,M0,N1,2009,T1b1,,,,,,,,,,,,Stage IB1,PRESENT,,,,,0.0,,,,,,2/4/14,G2,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,1999.0,,PRESENT,YES,5.0,,,30.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Cone Biopsy / LEEP,,,93.92|1,,,,1451821E-DD49-41FA-A52E-32F8524FFE82,anterior parametrium,,,,,,,"Pelvic (external iliac, internal iliac, obturator)|Other Location, specify",2.0,0.0,2.0,0.0,0.0,4.0,NO,NO,,,,,,YES,,,,1,Female,Cervical,,,,,UC,2.0,,,,210.0,Train,Train,Train,Val,Train,TCGA-UC-A7PF-01Z-00-DX1.05A08571-76FC-4AD1-B4EA-C6C8D3D0F64E,WITH TUMOR,DX1,
VENHQS1VQy1BN1BHOmNlc2NfdGNnYQ,TCGA-UC-A7PG,cesc_tcga,44.0,MX,N1,1995,T3b,4400.0,HDR,,,Once weekly,,6,,,Cisplatin,,Stage IIIB,,[Not Available]|[Not Available]|[Not Available]|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,-54.0,,,0.0,-10.0,,1.0,,,7/17/14,G1,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2003.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,8.0,0.0,,9.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,12.16|1,,,,53D99A89-6EBD-4637-91DB-7CE43EBC6B8B,,Cervical Cancer,,,,Preoperative,YES,"Pelvic (external iliac, internal iliac, obturator)|Common iliac",0.0,2.0,3.0,0.0,0.0,5.0,NO,NO,WHITE,,Other,YES,external beam and bilateral parametrial boost,YES,,,5400.0,2,Female,Cervical,52.0,18.0,,YES,UC,2.0,Progressive Disease,,WITH TUMOR,82.0,Val,Train,Train,Train,Train,TCGA-UC-A7PG-01Z-00-DX1.1E355FB4-AE5D-490E-91C2-6CFF5BB75165,WITH TUMOR,DX1,
VENHQS1VQy1BN1BJOmNlc2NfdGNnYQ,TCGA-UC-A7PI,cesc_tcga,44.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,ABSENT,[Not Available]|Extra-Pelvic Metastatic Disease Absent|[Not Available]|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,25.0,,,0.0,27.0,53.81|1,1.0,NOT HISPANIC OR LATINO,,7/17/14,G1,,Endometrioid Adenocarcinoma of Endocervix,Former User,,No,No,,,,,Radical Hysterectomy,C53.0,8380/3,C53.0,YES,2009.0,,ABSENT,YES,0.0,,,47.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,YES,69.45|0,,,,C659F1C9-F3B4-4CFE-8627-2BB716C62B96,,,,,,Preoperative,NO,,0.0,1.0,0.0,0.0,0.0,1.0,NO,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,,,,,UC,1.0,Complete Remission/Response,,TUMOR FREE,64.0,Train,Train,Val,Train,Train,TCGA-UC-A7PI-01Z-00-DX1.4DAADDC6-B5F3-4509-943C-8D62771882FA,WITH TUMOR,DX1,
VENHQS1WUy1BOEVCOmNlc2NfdGNnYQ,TCGA-VS-A8EB,cesc_tcga,41.0,M1,NX,2009,T3b,,,,,Once weekly,,4,,,Cisplatin,,Stage IIIB,,,,,,0.0,28.0,,1.0,,,4/22/14,GX,153.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,10.02|1,,,,2C736C5C-9D32-4522-ACFD-6620BC291ACE,,Cervical Cancer,,,,Pre-Adjuvant Therapy,NO,,,,3.0,1.0,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,2.0,Progressive Disease,,WITH TUMOR,64.0,Test,Test,Test,Test,Test,TCGA-VS-A8EB-01Z-00-DX1.1272EB5E-4A07-4F3B-B8DA-2574DEC130C5,WITH TUMOR,DX1,
VENHQS1WUy1BOEVDOmNlc2NfdGNnYQ,TCGA-VS-A8EC,cesc_tcga,55.0,M0,NX,2009,T3b,,,,,,,,,,,,Stage IIIB,,,,,,0.0,46.0,46.48|0,1.0,,,4/22/14,G2,154.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,46.48|0,,,,AFB5442E-0249-475B-8F82-CAE4E0268AD1,,,,,,,YES,,,,3.0,1.0,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,NO,VS,,Complete Remission/Response,,TUMOR FREE,46.0,Train,Train,Train,Train,Val,TCGA-VS-A8EC-01Z-00-DX1.5548FB5F-FA6B-47AB-A572-356084B93FF1,WITH TUMOR,DX1,
VENHQS1WUy1BOEVHOmNlc2NfdGNnYQ,TCGA-VS-A8EG,cesc_tcga,36.0,M0,NX,2009,T1b1,2800.0,HDR,,,,,,,,,,Stage IB1,,,,,,0.0,76.0,45.53|0,0.0,,,4/22/14,GX,160.0,Cervical Squamous Cell Carcinoma,Current User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,45.53|0,,,,B0B293C1-BD7E-4BA8-9F44-47398488EF2C,,,,,,Pre-Adjuvant Therapy,NO,,,,4.0,1.0,,5.0,NO,NO,,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,NO,VS,1.0,Complete Remission/Response,,TUMOR FREE,66.0,Test,Test,Test,Test,Test,TCGA-VS-A8EG-01Z-00-DX1.B7697DF5-A36B-43A3-B043-A0CC174AFA78,WITH TUMOR,DX1,
VENHQS1WUy1BOEVIOmNlc2NfdGNnYQ,TCGA-VS-A8EH,cesc_tcga,56.0,M0,NX,2009,T3b,2400.0,HDR,,,Once weekly,,4,Adverse event/ complications,,Cisplatin,,Stage IIIB,,,,,,0.0,41.0,32.39|0,2.0,,,4/22/14,G2,157.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,32.39|0,,,,05026179-B1DA-411E-A286-89727B1AE380,,,,,,Pre-Adjuvant Therapy,YES,,,,4.0,,,4.0,NO,NO,,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,3.0,39.0,,YES,VS,2.0,Complete Remission/Response,,TUMOR FREE,44.0,Train,Train,Train,Val,Train,TCGA-VS-A8EH-01Z-00-DX1.4AB67191-5014-4728-A4D8-C12B5A7F0A42,WITH TUMOR,DX1,
VENHQS1WUy1BOEVJOmNlc2NfdGNnYQ,TCGA-VS-A8EI,cesc_tcga,38.0,M0,NX,2009,T3b,2800.0,HDR,,,Once weekly,,6,,,Cisplatin,,Stage IIB,,,,,,0.0,-1.0,23.95|0,1.0,,,4/22/14,GX,158.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,23.95|0,,,,7B228C3B-E604-41A1-9B76-8DD3D5A59FFE,,,,,,Pre-Adjuvant Therapy,YES,,,,4.0,,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,58.0,Test,Test,Test,Test,Test,TCGA-VS-A8EI-01Z-00-DX1.8DD9CBFB-C3B2-48D0-ADEE-046197F481A7,WITH TUMOR,DX1,
VENHQS1WUy1BOEVKOmNlc2NfdGNnYQ,TCGA-VS-A8EJ,cesc_tcga,60.0,M1,NX,2009,T2b,2700.0,HDR,,,Once weekly,,4,,,Cisplatin,,Stage IIB,,,,,,0.0,0.0,,0.0,,,4/22/14,G3,167.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2008.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,19.94|1,,,,2E08A89E-4035-4782-B54F-F98EEF5DB80D,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,3.0,,,3.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Progressive Disease,,WITH TUMOR,113.0,Train,Val,Train,Train,Train,TCGA-VS-A8EJ-01Z-00-DX1.B220891F-4475-4199-A3C4-02F15E89FD9D,WITH TUMOR,DX1,
VENHQS1WUy1BOEVLOmNlc2NfdGNnYQ,TCGA-VS-A8EK,cesc_tcga,65.0,M0,NX,2009,T4,,,,,Once weekly,,7,,,Cisplatin,,Stage IVA,,,,,,0.0,58.0,,0.0,,,4/22/14,G2,153.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2008.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,27.23|1,,,,D9C2CA21-F1A6-4CF4-BE28-6C2492DD38E5,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,5.0,1.0,,6.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,,Partial Remission/Response,,WITH TUMOR,50.0,Val,Train,Train,Train,Train,TCGA-VS-A8EK-01Z-00-DX1.DF077538-660B-4EE1-8626-EF925401B48C,WITH TUMOR,DX1,
VENHQS1WUy1BOEVMOmNlc2NfdGNnYQ,TCGA-VS-A8EL,cesc_tcga,38.0,M0,NX,2009,T2b,2800.0,HDR,,,Once weekly,,5,,,Cisplatin,,Stage IIB,,,,,,0.0,-9.0,65.44|0,1.0,,,4/22/14,G3,166.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2009.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,65.44|0,,,,E0A5D99B-B58B-4301-B2DC-A767D90059B1,,,,,,Preoperative,YES,,,,3.0,,,3.0,NO,NO,BLACK OR AFRICAN AMERICAN,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,78.0,Test,Test,Test,Test,Test,TCGA-VS-A8EL-01Z-00-DX1.EF7B6F23-A566-4E2F-9935-28643B7E5357,WITH TUMOR,DX1,
VENHQS1WUy1BOFE4OmNlc2NfdGNnYQ,TCGA-VS-A8Q8,cesc_tcga,26.0,MX,N0,2009,T1b,,,,,,,,,,,,Stage IB,,,,,,0.0,-84.0,16.69|1,0.0,,,3/31/14,G2,166.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Other,C53.9,8070/3,C53.9,YES,2010.0,,ABSENT,YES,0.0,,,11.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",Surgery,YES,32.13|1,Radical trachelectomy and pelvic lymphadenectomy,,,6C3C8219-74AB-4E54-81F5-84D4D5884252,,Cervical Cancer,,,,Preoperative,NO,,,,,,,0.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,,1,Female,Cervical,,,,NO,VS,1.0,Progressive Disease,,WITH TUMOR,92.0,Test,Test,Test,Test,Test,TCGA-VS-A8Q8-01Z-00-DX1.F47487F3-799F-4701-A066-8167E41F78C9,WITH TUMOR,DX1,
VENHQS1WUy1BOFE5OmNlc2NfdGNnYQ,TCGA-VS-A8Q9,cesc_tcga,79.0,MX,NX,2009,TX,2700.0,HDR,,,,,,,,,,Stage IB1,,,,,,0.0,90.0,53.55|0,1.0,,,3/30/14,G2,150.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,53.55|0,,,,5798D741-C198-4C14-BCC2-E3B17CAF1BE3,,,,,,Pre-Adjuvant Therapy,NO,,,,8.0,4.0,,12.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,NO,VS,1.0,Complete Remission/Response,,TUMOR FREE,49.0,Val,Train,Train,Train,Train,TCGA-VS-A8Q9-01Z-00-DX1.0F8698B6-8698-4698-87CC-ECD4C1C4AF0B,WITH TUMOR,DX1,
VENHQS1WUy1BOFFBOmNlc2NfdGNnYQ,TCGA-VS-A8QA,cesc_tcga,44.0,MX,N0,2009,T1b1,,,,,,,,,,,,Stage IB1,,,,,,0.0,0.0,36.1|0,0.0,,,3/30/14,GX,160.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2011.0,,,YES,0.0,0.0,,26.0,Positive vaginal margin,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,36.1|0,,,,1A3D5555-7013-4F06-878A-98944F075B63,,,,,,Preoperative,NO,,,,2.0,,,2.0,NO,NO,,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,NO,VS,1.0,Complete Remission/Response,,TUMOR FREE,67.0,Train,Val,Train,Train,Train,TCGA-VS-A8QA-01Z-00-DX1.9102E5FD-BD2E-403F-8C36-BB9D7110FE18,WITH TUMOR,DX1,
VENHQS1WUy1BOFFDOmNlc2NfdGNnYQ,TCGA-VS-A8QC,cesc_tcga,51.0,MX,NX,2009,TX,,,,,Once weekly,,5,,,Cisplatin,,Stage IVA,,,,,,0.0,-1.0,8.64|1,2.0,,,3/30/14,G2,152.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2009.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,YES,11.5|1,,,,CB695FDD-381E-4C00-836E-0BA27E32176B,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,7.0,,,7.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,2.0,Progressive Disease,,WITH TUMOR,90.0,Train,Train,Val,Train,Train,TCGA-VS-A8QC-01Z-00-DX1.D9F4062C-0438-4D76-9BB2-674138A949BD,WITH TUMOR,DX1,
VENHQS1WUy1BOFFGOmNlc2NfdGNnYQ,TCGA-VS-A8QF,cesc_tcga,42.0,MX,NX,2009,TX,2800.0,HDR,,,Once weekly,,4,Adverse event/ complications,,Cisplatin,,Stage IIB,,,,,,0.0,92.0,59.13|0,0.0,,,3/30/14,G2,159.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,59.13|0,,,,21254CB0-68F3-4ECC-8D9A-73FB0E994C5B,,,,,,Pre-Adjuvant Therapy,YES,,,,5.0,,,5.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,12.0,2010.0,YES,VS,4.0,Complete Remission/Response,,TUMOR FREE,68.0,Train,Train,Val,Train,Train,TCGA-VS-A8QF-01Z-00-DX1.D8DB41E0-8C0F-4394-A2A2-8721BE35644B,WITH TUMOR,DX1,
VENHQS1WUy1BOFFIOmNlc2NfdGNnYQ,TCGA-VS-A8QH,cesc_tcga,76.0,MX,NX,2009,TX,,HDR,,,Once weekly|Once weekly,[Not Available]|[Not Available],3|3,Adverse event/ complications,,Other|Other,Cisplatin|Gemcitabine,Stage IB1,,,,,,0.0,-1.0,,0.0,,,3/30/14,G2,159.0,Mucinous Adenocarcinoma of Endocervical Type,,,No,No,,,,,,C53.9,8482/3,C53.9,YES,2010.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,39.75|1,,,,C4F61715-EE58-4799-A5F4-0F5E27C4093D,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,3.0,1.0,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Partial Remission/Response,,WITH TUMOR,73.0,Train,Train,Val,Train,Train,TCGA-VS-A8QH-01Z-00-DX1.FE72CE6D-0140-4A57-83CC-38F5EAD09FE5,WITH TUMOR,DX1,
VENHQS1WUy1BOFFNOmNlc2NfdGNnYQ,TCGA-VS-A8QM,cesc_tcga,47.0,M1,NX,2009,TX,,,,,Once weekly|Once weekly,[Not Available]|[Not Available],3|3,Adverse event/ complications,,Cisplatin|Other,[Not Applicable]|Fluorouracil,Stage IVB,,,,,,0.0,-334.0,,0.0,,,4/1/14,GX,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2009.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,31.24|1,,,,27D2B645-F1BF-4486-B0B5-273681B58625,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,3.0,1.0,,4.0,NO,NO,,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,16.0,15.0,,YES,VS,2.0,Progressive Disease,,WITH TUMOR,53.0,Train,Val,Train,Train,Train,TCGA-VS-A8QM-01Z-00-DX1.F226D97A-0262-406E-BA4C-722A0732B22F,WITH TUMOR,DX1,
VENHQS1WUy1BOTRXOmNlc2NfdGNnYQ,TCGA-VS-A94W,cesc_tcga,39.0,MX,N1,2009,T2b,2800.0,HDR,,,Once weekly,,5,Adverse event/ complications,,Cisplatin,,Stage IIB,,,,,,0.0,0.0,40.83|0,0.0,,,10/17/14,G2,156.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,,YES,1.0,,,47.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,40.83|0,,,,2F6A0E87-1E6C-41F3-93E0-3E505FA654B0,,,,,,Preoperative,YES,"Pelvic (external iliac, internal iliac, obturator)",,,2.0,,,2.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,79.0,Test,Test,Test,Test,Test,TCGA-VS-A94W-01Z-00-DX1.AC2E482E-E12A-4FB5-9956-B9B7F7120576,WITH TUMOR,DX1,
VENHQS1WUy1BOTRYOmNlc2NfdGNnYQ,TCGA-VS-A94X,cesc_tcga,40.0,MX,NX,2009,T2b,2800.0,HDR,,,Once weekly,,5,,,Cisplatin,,Stage IIB,,,,,,0.0,0.0,,0.0,,,5/21/14,G2,158.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,NO,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,16.62|1,,,,240EF385-DECC-48F7-A798-A81B4AB0410E,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,3.0,,,3.0,NO,NO,BLACK OR AFRICAN AMERICAN,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Partial Remission/Response,,WITH TUMOR,42.0,Train,Val,Train,Train,Train,TCGA-VS-A94X-01Z-00-DX1.2AA0960D-88B0-46CC-B57C-B423BA524527,WITH TUMOR,DX1,
VENHQS1WUy1BOTRZOmNlc2NfdGNnYQ,TCGA-VS-A94Y,cesc_tcga,47.0,MX,NX,2009,T2b,,,,,,,,Adverse event/ complications,,,,Stage IIB,,,,,,0.0,1.0,,1.0,,,5/27/14,GX,154.0,Cervical Squamous Cell Carcinoma,Current User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,4.73|1,,,,0E7F79CD-D188-42EA-BF96-4BA9E9B8606B,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,1.0,,,1.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,1.0,44.0,,NO,VS,2.0,Progressive Disease,,WITH TUMOR,44.0,Train,Train,Train,Val,Train,TCGA-VS-A94Y-01Z-00-DX1.0A4D4E4D-DD01-4692-BE70-1D08CC648361,WITH TUMOR,DX1,
VENHQS1WUy1BOTRaOmNlc2NfdGNnYQ,TCGA-VS-A94Z,cesc_tcga,38.0,MX,NX,2009,T2b,2800.0,HDR,,,Once weekly,,5,,,Cisplatin,,Stage IIB,,,,,,0.0,39.0,33.34|0,1.0,,,5/21/14,G2,162.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,33.34|0,,,,69BABA9F-19C2-4947-95DC-0DD3412929BA,,,,,,Pre-Adjuvant Therapy,YES,,,,3.0,1.0,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,2.0,27.0,2010.0,YES,VS,4.0,Complete Remission/Response,,TUMOR FREE,96.0,Train,Train,Val,Train,Train,TCGA-VS-A94Z-01Z-00-DX1.D185E8BA-35AF-445F-9708-FA5B84C7E5B7,WITH TUMOR,DX1,
VENHQS1WUy1BOTU0OmNlc2NfdGNnYQ,TCGA-VS-A954,cesc_tcga,67.0,MX,NX,2009,T3b,2700.0,HDR,,,Once weekly,,5,,,Cisplatin,,Stage IIIB,,,,,,0.0,92.0,56.31|0,1.0,,,5/21/14,G2,160.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,NO,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,56.31|0,,,,9BA72A77-AEF0-4788-8072-60C28902E55D,,,,,,Pre-Adjuvant Therapy,YES,,,,10.0,,,10.0,NO,NO,,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,58.0,Test,Test,Test,Test,Test,TCGA-VS-A954-01Z-00-DX1.256F0EB9-E7C2-40FF-9A75-25BA1A590556,WITH TUMOR,DX1,
VENHQS1WUy1BOTU3OmNlc2NfdGNnYQ,TCGA-VS-A957,cesc_tcga,64.0,MX,NX,2009,T1b1,,,,,Once weekly,,4,Adverse event/ complications,,Cisplatin,,Stage IB1,,,,,,0.0,118.0,55.45|0,0.0,,,5/27/14,G3,156.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,55.45|0,,,,CB31B3CE-8595-4D75-9436-BB59E95C3A19,,,,,,Pre-Adjuvant Therapy,YES,,,,4.0,,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,91.0,Train,Train,Val,Train,Train,TCGA-VS-A957-01Z-00-DX1.FE01C75F-EAF4-4421-A250-E083BC1AFB14,WITH TUMOR,DX1,
VENHQS1WUy1BOTU4OmNlc2NfdGNnYQ,TCGA-VS-A958,cesc_tcga,46.0,MX,NX,2009,T2b,2800.0,HDR,,,Once weekly,,4,Adverse event/ complications,,Cisplatin,,Stage IIB,,,,,,0.0,0.0,50.1|0,1.0,,,5/21/14,G2,151.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2010.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,50.1|0,,,,97CF3268-9756-4659-9E98-F200F96A91F4,,,,,,Pre-Adjuvant Therapy,YES,,,,4.0,,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,61.0,Train,Val,Train,Train,Train,TCGA-VS-A958-01Z-00-DX1.A1210E5C-5F29-450B-A1A8-FE79DA8194B2,WITH TUMOR,DX1,
VENHQS1WUy1BOTU5OmNlc2NfdGNnYQ,TCGA-VS-A959,cesc_tcga,76.0,MX,NX,2009,T2b,2700.0,HDR,,,,,,,,,,Stage IIB,,,,,,0.0,,51.28|0,,,,5/27/14,G3,145.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,51.28|0,,,,F2BEA37E-0D19-49E1-91A0-A4DE4DFA2D35,,,,,,,NO,,,,11.0,,,11.0,NO,NO,,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,,VS,1.0,Complete Remission/Response,,TUMOR FREE,47.0,Train,Train,Train,Val,Train,TCGA-VS-A959-01Z-00-DX1.80E1CBEA-86F9-473B-8788-0D7D1B5A923C,WITH TUMOR,DX1,
VENHQS1WUy1BOTUwOmNlc2NfdGNnYQ,TCGA-VS-A950,cesc_tcga,42.0,MX,NX,2009,T3a,2600.0,HDR,,,,,,,,,,Stage IIIA,,,,,,0.0,0.0,40.11|0,0.0,,,10/1/14,G3,165.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,40.11|0,,,,3D190F07-2F79-4EE6-9F63-0B563DC05C74,,,,,,Pre-Adjuvant Therapy,NO,,,,3.0,,,3.0,NO,NO,,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,NO,VS,1.0,Partial Remission/Response,,WITH TUMOR,57.0,Train,Train,Train,Train,Val,TCGA-VS-A950-01Z-00-DX1.F46A6D25-A35B-459E-A28C-246F4204ED3B,WITH TUMOR,DX1,
VENHQS1WUy1BOTUyOmNlc2NfdGNnYQ,TCGA-VS-A952,cesc_tcga,66.0,MX,N0,2009,T1b,,,,,,,,,,,,Stage IB1,,,,,,0.0,0.0,58.41|0,0.0,,,5/21/14,G2,155.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8482/3,C53.9,YES,2010.0,,ABSENT,YES,0.0,0.0,,15.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,58.41|0,,,,9FA42FE6-CCD0-4850-B08B-97B20ECEB8DF,,,,,,Preoperative,NO,,,,3.0,,,3.0,NO,NO,WHITE,,,NO,,YES,,,,1,Female,Cervical,,,,,VS,1.0,Complete Remission/Response,,TUMOR FREE,65.0,Val,Train,Train,Train,Train,TCGA-VS-A952-01Z-00-DX1.3C30EAEB-6231-4913-B63D-A06954BB717F,WITH TUMOR,DX1,
VENHQS1WUy1BOTUzOmNlc2NfdGNnYQ,TCGA-VS-A953,cesc_tcga,63.0,MX,NX,2009,T4,,,,,,,,Adverse event/ complications,,,,Stage IVA,,,,,,0.0,0.0,,0.0,,,10/17/14,GX,155.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,15.67|1,,,,DA901E97-3A1D-4952-8254-9C4E60D2812C,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,11.0,,,11.0,NO,NO,,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,NO,VS,1.0,Partial Remission/Response,,WITH TUMOR,47.0,Train,Train,Train,Val,Train,TCGA-VS-A953-01Z-00-DX1.95BEC6B5-866C-4F17-B8C6-9BB53730F73E,WITH TUMOR,DX1,
VENHQS1WUy1BOVU1OmNlc2NfdGNnYQ,TCGA-VS-A9U5,cesc_tcga,57.0,MX,NX,2009,T2b,2800.0,HDR,,,Once weekly,,5,,,Cisplatin,,Stage IIB,,,,,,0.0,-3.0,50.43|0,0.0,,,8/11/14,G3,162.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,50.43|0,,,,939ABCA1-8BD0-4271-9A9B-666764EEB3B6,,,,,,Pre-Adjuvant Therapy,YES,,,,3.0,,,3.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,74.0,Val,Train,Train,Train,Train,TCGA-VS-A9U5-01Z-00-DX1.ADBFF095-CCA3-4F70-B708-B6D840ADDF14,WITH TUMOR,DX1,
VENHQS1WUy1BOVU2OmNlc2NfdGNnYQ,TCGA-VS-A9U6,cesc_tcga,52.0,M1,NX,2009,T4,2600.0,HDR,,,Once weekly,,4,,,Cisplatin,,Stage IVB,,,,,,0.0,0.0,43.07|1,1.0,,,8/11/14,GX,156.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2011.0,Non-keratinizing squamous cell carcinoma,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,YES,43.36|0,,,,98784BBE-E286-48DF-838D-1A88040658BF,,,,,,Preoperative,YES,,,,1.0,1.0,,2.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,,VS,1.0,Stable Disease,,WITH TUMOR,66.0,Test,Test,Test,Test,Test,TCGA-VS-A9U6-01Z-00-DX1.8F1DA05E-6EDD-4B5E-B4A0-2A307A89E66F,WITH TUMOR,DX1,
VENHQS1WUy1BOVU3OmNlc2NfdGNnYQ,TCGA-VS-A9U7,cesc_tcga,30.0,M0,N1,2009,T1b,2800.0,HDR,,,Once weekly,,5,,,Cisplatin,,Stage IB1,,,,,,0.0,0.0,48.36|0,0.0,,,8/11/14,G3,157.0,Cervical Squamous Cell Carcinoma,Current User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,,YES,3.0,0.0,,18.0,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,48.36|0,,,,6D01421E-D533-4967-8422-97FBC0FB0895,,,,,,Preoperative,YES,"Pelvic (external iliac, internal iliac, obturator)",,,1.0,2.0,,3.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,82.0,Test,Test,Test,Test,Test,TCGA-VS-A9U7-01Z-00-DX1.D89A63FB-BA2A-4A04-B89D-CD986B173C7F,WITH TUMOR,DX1,
VENHQS1WUy1BOVVBOmNlc2NfdGNnYQ,TCGA-VS-A9UA,cesc_tcga,60.0,MX,NX,2009,T3,2400.0,HDR,,,Once weekly,,4,,,Cisplatin,,Stage IIIA,,,,,,0.0,0.0,28.48|0,2.0,,,8/11/14,G3,134.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,28.48|0,,,,60117B70-36C0-41BB-A9FC-85DB8FA10102,,,,,,Pre-Adjuvant Therapy,YES,,,,2.0,,,2.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,88.0,Val,Train,Train,Train,Train,TCGA-VS-A9UA-01Z-00-DX1.0D99930B-9559-4C54-AA22-29ABB0972577,WITH TUMOR,DX1,
VENHQS1WUy1BOVVCOmNlc2NfdGNnYQ,TCGA-VS-A9UB,cesc_tcga,54.0,MX,N0,2009,T2b,2800.0,HDR,,,Once weekly,,6,,,Cisplatin,,Stage IIB,,,,,,0.0,0.0,29.93|0,1.0,,,10/1/14,G3,166.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,,,YES,0.0,,,51.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,29.93|0,,,,CA242B4C-B879-4E13-A1E7-84C984067189,,,,,,Preoperative,YES,,,,11.0,,,11.0,NO,NO,,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,79.0,Test,Test,Test,Test,Test,TCGA-VS-A9UB-01Z-00-DX1.4BC3DADC-AFDA-4F7B-A518-83C4DC6A2669,WITH TUMOR,DX1,
VENHQS1WUy1BOVVDOmNlc2NfdGNnYQ,TCGA-VS-A9UC,cesc_tcga,32.0,MX,NX,2009,T2b,,,,,Once weekly,,5,,,Cisplatin,,Stage IIB,,,,,,0.0,-2.0,27.1|0,1.0,,,8/11/14,G2,153.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,27.1|0,,,,CCA23650-1B06-4977-91E8-F35E73E70C48,,,,,,Pre-Adjuvant Therapy,YES,,,,4.0,,,4.0,NO,NO,,,3D conformal,YES,,YES,,,3240.0,1,Female,Cervical,,,,YES,VS,1.0,Stable Disease,,WITH TUMOR,76.0,Val,Train,Train,Train,Train,TCGA-VS-A9UC-01Z-00-DX1.59D79CEB-4157-4956-8C2D-781AA375A43D,WITH TUMOR,DX1,
VENHQS1WUy1BOVVEOmNlc2NfdGNnYQ,TCGA-VS-A9UD,cesc_tcga,73.0,MX,NX,2009,T3a,2400.0,HDR,,,Once weekly,,6,,,Cisplatin,,Stage IIIA,,,,,,0.0,-1.0,24.28|0,0.0,,,8/11/14,G2,161.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,Keratinizing squamous cell carcinoma,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,24.28|0,,,,60CFA29F-4770-4EE4-AA37-787F53155662,,,,,,Pre-Adjuvant Therapy,YES,,,,9.0,5.0,,14.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,64.0,Test,Test,Test,Test,Test,TCGA-VS-A9UD-01Z-00-DX1.9B341391-177B-46A3-AC50-C287FFAE8A3F,WITH TUMOR,DX1,
VENHQS1WUy1BOVVIOmNlc2NfdGNnYQ,TCGA-VS-A9UH,cesc_tcga,53.0,MX,NX,2009,T4,,,,,Once weekly,,5,,,Cisplatin,,Stage IVA,,,,,,0.0,139.0,46.88|0,2.0,,,8/20/14,GX,,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,46.88|0,,,,6949C03E-067A-49A5-B48D-E9380A1B0B27,,,,,,Pre-Adjuvant Therapy,YES,,,,3.0,,,3.0,NO,NO,BLACK OR AFRICAN AMERICAN,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,,Test,Test,Test,Test,Test,TCGA-VS-A9UH-01Z-00-DX1.CB6C2531-2041-477C-9524-3DB427BB3B23,WITH TUMOR,DX1,
VENHQS1WUy1BOVVJOmNlc2NfdGNnYQ,TCGA-VS-A9UI,cesc_tcga,76.0,MX,NX,2009,T2b,2800.0,HDR,,,,,,,,,,Stage IIB,,,,,,0.0,62.0,,1.0,,,8/11/14,GX,,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,45.07|1,,,,9C516D28-BEF2-4334-BDDA-97950BD95AC0,,,,,,Pre-Adjuvant Therapy,NO,,,,5.0,,,5.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,NO,VS,1.0,Complete Remission/Response,,TUMOR FREE,70.0,Train,Train,Train,Val,Train,TCGA-VS-A9UI-01Z-00-DX1.271BEF13-444B-42F5-86C3-FF30D7BFD9E0,WITH TUMOR,DX1,
VENHQS1WUy1BOVVKOmNlc2NfdGNnYQ,TCGA-VS-A9UJ,cesc_tcga,55.0,MX,NX,2009,T2b,,,,,,,,,,,,Stage IIB,,,,,,0.0,0.0,,1.0,,,9/9/14,GX,,Cervical Squamous Cell Carcinoma,Current User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,1.71|1,,,,78C62970-4B48-4DC4-9042-5F48F42818EC,,Cervical Cancer,,,No treatment performed,Other,NO,,,,,,,0.0,,NO,,,,NO,,YES,,,,1,Female,Cervical,,,,,VS,1.0,,,WITH TUMOR,,Train,Train,Val,Train,Train,TCGA-VS-A9UJ-01Z-00-DX1.6B3D2EB0-9B0B-4B38-ADFB-AB88E69273D6,WITH TUMOR,DX1,
VENHQS1WUy1BOVVMOmNlc2NfdGNnYQ,TCGA-VS-A9UL,cesc_tcga,79.0,MX,NX,2009,T3b,2800.0,HDR,,,,,,,,,,Stage IIIB,,,,,,0.0,-1.0,11.04|1,1.0,,,9/5/14,G3,149.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2010.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,YES,14.52|1,,,,7ABACA8F-962E-4F9D-B63F-26C131BF5961,,Cervical Cancer,,,,Pre-Adjuvant Therapy,NO,,,,5.0,,,5.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,,VS,1.0,Progressive Disease,,WITH TUMOR,56.0,Train,Val,Train,Train,Train,TCGA-VS-A9UL-01Z-00-DX1.4348D92F-0EA0-4A98-8F5E-D52E49AF71F4,WITH TUMOR,DX1,
VENHQS1WUy1BOVVNOmNlc2NfdGNnYQ,TCGA-VS-A9UM,cesc_tcga,39.0,MX,NX,2009,T3b,2000.0,HDR,,,Once weekly,,,,,Cisplatin,,Stage IVB,,,,,,0.0,0.0,,0.0,,,9/9/14,G2,160.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2011.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,27.23|1,,,,EE2C9743-EAA1-4F0D-8D35-E96686AC3913,,,,,,Pre-Adjuvant Therapy,YES,,,,5.0,,,5.0,NO,NO,BLACK OR AFRICAN AMERICAN,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,75.0,Test,Test,Test,Test,Test,TCGA-VS-A9UM-01Z-00-DX1.D921E19D-7C09-4543-9940-09B3FBA3624B,WITH TUMOR,DX1,
VENHQS1WUy1BOVVPOmNlc2NfdGNnYQ,TCGA-VS-A9UO,cesc_tcga,43.0,MX,N0,2009,T2b,2800.0,HDR,,,Once weekly,,3,,,Cisplatin,,Stage IIB,,,,,,0.0,0.0,47.83|0,1.0,,,8/11/14,G2,159.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,,C53.9,8482/3,C53.9,YES,2011.0,,,YES,0.0,,,45.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,47.83|0,,,,4DA121DA-9193-4AC5-8206-03CB1F7C2C14,,,,,,Preoperative,YES,,,,1.0,,,1.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,40.0,Train,Train,Train,Train,Val,TCGA-VS-A9UO-01Z-00-DX1.7498BCE3-5878-47B3-A1E5-196C189C62DC,WITH TUMOR,DX1,
VENHQS1WUy1BOVVQOmNlc2NfdGNnYQ,TCGA-VS-A9UP,cesc_tcga,43.0,MX,NX,2009,T2a,2800.0,HDR,,,Once weekly,,6,,,Cisplatin,,Stage IIA,,,,,,0.0,54.0,44.68|1,1.0,,,8/11/14,G3,155.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,,C53.9,8482/3,C53.9,YES,2011.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,YES,47.44|0,,,,F0CFAACC-30E5-4E54-B33A-F0FD5DAD620E,,,,,,Pre-Adjuvant Therapy,YES,,,,4.0,,,4.0,NO,NO,,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,1.0,34.0,,YES,VS,2.0,Complete Remission/Response,,WITH TUMOR,68.0,Val,Train,Train,Train,Train,TCGA-VS-A9UP-01Z-00-DX1.D5A56C98-7E32-47B5-B918-98A5D730C276,WITH TUMOR,DX1,
VENHQS1WUy1BOVVROmNlc2NfdGNnYQ,TCGA-VS-A9UQ,cesc_tcga,32.0,MX,N0,2009,T1b,2000.0,HDR,,,,,,,,,,Stage IB,,,,,,0.0,,32.46|1,,,,8/11/14,G2,160.0,Mucinous Adenocarcinoma of Endocervical Type,Current User,,No,No,,,,,Other,C53.9,8482/3,C53.9,YES,2011.0,,,YES,0.0,,,22.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,YES,41.49|0,Wertheim Meiggs,,,2C600A58-98ED-4572-9B6F-EDBA2719790C,,,,,,,NO,,,,,4.0,,4.0,NO,NO,,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,NO,VS,1.0,Complete Remission/Response,,TUMOR FREE,72.0,Train,Train,Val,Train,Train,TCGA-VS-A9UQ-01Z-00-DX1.E2705EAE-0836-44FA-B7F8-BF4BBE56C539,WITH TUMOR,DX1,
VENHQS1WUy1BOVVSOmNlc2NfdGNnYQ,TCGA-VS-A9UR,cesc_tcga,53.0,MX,NX,2009,T2a,2800.0,HDR,,,Once weekly,,6,,,Cisplatin,,Stage IIA,,,,,,0.0,0.0,22.17|1,1.0,,,8/11/14,GX,161.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,,C53.9,8482/3,C53.9,YES,2013.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,26.05|0,,,,ADC60720-AC20-4E73-9C37-3AD3119C07D6,,,,,,Pre-Adjuvant Therapy,YES,,,,5.0,,,5.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,64.0,Train,Train,Train,Train,Val,TCGA-VS-A9UR-01Z-00-DX1.8475AB5B-6699-4F92-B5F8-7B8A7DF61942,WITH TUMOR,DX1,
VENHQS1WUy1BOVVUOmNlc2NfdGNnYQ,TCGA-VS-A9UT,cesc_tcga,72.0,MX,N1,2009,T1b1,,,,,,,,,,,,Stage IB,,,,,,0.0,-1.0,15.83|0,1.0,,,10/1/14,G3,144.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8482/3,C53.9,YES,2013.0,,ABSENT,YES,1.0,,,14.0,"Other Location, specify",Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,15.83|0,,,Uninvolved margins,A945FD96-FFB3-4787-BACD-60DA4560C8A5,,,,,,Pre-Adjuvant Therapy,,"Pelvic (external iliac, internal iliac, obturator)",,,3.0,,,3.0,NO,NO,ASIAN,,,,,YES,,,,1,Female,Cervical,,,,,VS,1.0,Complete Remission/Response,,TUMOR FREE,42.0,Val,Train,Train,Train,Train,TCGA-VS-A9UT-01Z-00-DX1.A3044F45-36C0-492C-BCB4-56903A2DAF78,WITH TUMOR,DX1,
VENHQS1WUy1BOVVVOmNlc2NfdGNnYQ,TCGA-VS-A9UU,cesc_tcga,42.0,MX,NX,2009,T2b,2800.0,HDR,,,Once weekly,,3,,,Cisplatin,,Stage IIB,,,,,,0.0,26.0,14.52|0,0.0,,,10/1/14,G1,162.0,Cervical Squamous Cell Carcinoma,Current User,HIV,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,14.52|0,,,,4770EC81-9174-4D2A-AF54-70C00696FB0B,,,,,,Pre-Adjuvant Therapy,YES,,,,7.0,,,7.0,NO,NO,,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,2.0,23.0,,YES,VS,2.0,Complete Remission/Response,,TUMOR FREE,67.0,Test,Test,Test,Test,Test,TCGA-VS-A9UU-01Z-00-DX1.BA1B42BF-2D2F-4167-83FF-D6C7F20AE918,WITH TUMOR,DX1,
VENHQS1WUy1BOVVWOmNlc2NfdGNnYQ,TCGA-VS-A9UV,cesc_tcga,74.0,MX,NX,2009,T4,,,,,,,,,,,,Stage IVA,,,,,,0.0,-2.0,,1.0,,,8/11/14,GX,152.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,3.42|1,,,,C9E4BAC6-0CAC-4FCA-A548-527DEAC5B880,,Cervical Cancer,,,The patient did not perform treatment,Other,NO,,,,5.0,,,5.0,NO,NO,,,,NO,,YES,,,,1,Female,Cervical,,,,,VS,1.0,,,WITH TUMOR,31.0,Train,Train,Train,Val,Train,TCGA-VS-A9UV-01Z-00-DX1.D54DF95F-F73D-45F4-A291-6F001004119F,WITH TUMOR,DX1,
VENHQS1WUy1BOVVZOmNlc2NfdGNnYQ,TCGA-VS-A9UY,cesc_tcga,29.0,MX,NX,2009,T1b2,2800.0,HDR,,,Once weekly,,5,,,Cisplatin,,Stage IVB,,,,,,0.0,0.0,13.53|1,2.0,,,9/5/14,G2,163.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,YES,18.23|1,,,,A1B99260-8643-4CEF-95A0-3853D64762B7,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,,,,,NO,NO,,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Progressive Disease,,WITH TUMOR,46.0,Train,Train,Train,Train,Val,TCGA-VS-A9UY-01Z-00-DX1.6EB5B19F-98C8-4B9C-8FF4-F53ACD163BE5,WITH TUMOR,DX1,
VENHQS1WUy1BOVVaOmNlc2NfdGNnYQ,TCGA-VS-A9UZ,cesc_tcga,61.0,MX,N0,2009,T1b,3600.0,HDR,,,,,,,,,,Stage IB1,,,,,,0.0,,67.15|0,,,,8/20/14,G2,149.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,Other,C53.9,8482/3,C53.9,YES,2009.0,,,YES,0.0,,,26.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,67.15|0,Wertheim Meiggs,,,6817BB3E-1F8A-457C-9AB0-31CCDA8B6868,,,,,,,NO,,,,4.0,,,4.0,NO,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,,,,NO,VS,1.0,Complete Remission/Response,,TUMOR FREE,54.0,Test,Test,Test,Test,Test,TCGA-VS-A9UZ-01Z-00-DX1.D8E51585-4DBA-47CA-B78F-33E139F18CD9,WITH TUMOR,DX1,
VENHQS1WUy1BOVY0OmNlc2NfdGNnYQ,TCGA-VS-A9V4,cesc_tcga,63.0,MX,NX,2009,T4,,,,,Once weekly,,4,,,Cisplatin,,Stage IVA,,,,,,0.0,-1.0,3.29|1,2.0,,,10/1/14,G2,161.0,Mucinous Adenocarcinoma of Endocervical Type,,,No,Yes,,,,,,C53.9,8482/3,C53.9,YES,2013.0,,,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,YES,4.34|1,,,,778389BA-C2E9-47D4-B133-6F4D0E689B34,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,3.0,,,3.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,30.0,15.0,2013.0,YES,VS,4.0,,,WITH TUMOR,52.0,Test,Test,Test,Test,Test,TCGA-VS-A9V4-01Z-00-DX1.F71A69E3-050E-4CA9-A074-BAA03739D542,WITH TUMOR,DX1,
VENHQS1WUy1BOVY1OmNlc2NfdGNnYQ,TCGA-VS-A9V5,cesc_tcga,50.0,MX,NX,2009,T2b,,,,,Once weekly,,6,,,Carboplatin,,Stage IIB,,,,,,0.0,0.0,,1.0,,,10/1/14,G2,157.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,,C53.9,8482/3,C53.9,YES,2011.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,16.23|1,,,,D3FF2AEB-46BE-4F54-8A8F-178EB921FBB6,,,,,,Pre-Adjuvant Therapy,YES,,,,1.0,,,1.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,YES,VS,1.0,Progressive Disease,,WITH TUMOR,98.0,Test,Test,Test,Test,Test,TCGA-VS-A9V5-01Z-00-DX1.F6E5CA78-4A76-44CD-A003-B055237E50E8,WITH TUMOR,DX1,
VENHQS1WUy1BOVYwOmNlc2NfdGNnYQ,TCGA-VS-A9V0,cesc_tcga,58.0,MX,NX,2009,T1b,2800.0,HDR,,,Once weekly,,4,,,Cisplatin,,Stage IB,,,,,,0.0,,15.6|1,,,,10/1/14,G3,158.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,,C53.9,8482/3,C53.9,YES,2013.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,YES,18.82|0,,,,A5885835-9473-455A-BAC0-6FA43FA8A866,,,,,,,YES,,,,7.0,,,7.0,NO,NO,,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,4.5,27.0,2012.0,YES,VS,4.0,Complete Remission/Response,,WITH TUMOR,76.0,Train,Train,Train,Train,Val,TCGA-VS-A9V0-01Z-00-DX1.880F6655-0F7A-4D47-A6E0-1065BA008C2A,WITH TUMOR,DX1,
VENHQS1WUy1BOVYxOmNlc2NfdGNnYQ,TCGA-VS-A9V1,cesc_tcga,46.0,MX,NX,2009,T3b,,,,,Once weekly,,5,,,Cisplatin,,Stage IVB,,,,,,0.0,,1.91|1,,,,9/5/14,G2,155.0,Mucinous Adenocarcinoma of Endocervical Type,Never Used,,No,No,,,,,,C53.9,8482/3,C53.9,YES,2013.0,,,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,YES,5.16|1,,,,A6A07BC7-AB1B-429D-81ED-D7A890C88E51,,Cervical Cancer,,,,,YES,,,,3.0,1.0,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,2.4,24.0,,YES,VS,2.0,Progressive Disease,,WITH TUMOR,45.0,Train,Train,Val,Train,Train,TCGA-VS-A9V1-01Z-00-DX1.BEA16277-7AE1-4149-90BA-E4FDAEF4235F,WITH TUMOR,DX1,
VENHQS1WUy1BOVYyOmNlc2NfdGNnYQ,TCGA-VS-A9V2,cesc_tcga,29.0,MX,N0,2009,T1b,,,,,,,,,,,,Stage IB1,,,,,,0.0,-1.0,18.23|0,1.0,,,9/5/14,G2,156.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Other,C53.9,8070/3,C53.9,YES,2013.0,,,YES,0.0,0.0,,26.0,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,18.23|0,Wertheim Meiggs,,,03804F9B-DF7C-462C-8984-8EB3A5ED4999,,,,,,Preoperative,NO,,,,2.0,,,2.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,4500.0,1,Female,Cervical,,,,NO,VS,1.0,Complete Remission/Response,,TUMOR FREE,49.0,Train,Train,Val,Train,Train,TCGA-VS-A9V2-01Z-00-DX1.61AD73DF-4A1D-4398-9558-00ADAF82952A,WITH TUMOR,DX1,
VENHQS1WUy1BOVYzOmNlc2NfdGNnYQ,TCGA-VS-A9V3,cesc_tcga,62.0,MX,NX,2009,T4,2600.0,HDR,,,Once weekly,,6,,,Cisplatin,,Stage IVB,,,,,,0.0,-2.0,19.74|1,1.0,,,8/11/14,G3,164.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,NO,17.74|0,,,,1CB1D2CA-DFA6-4C42-9DA9-C711DC5AAB5D,,,,,,Pre-Adjuvant Therapy,YES,,,,,,,0.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Complete Remission/Response,,TUMOR FREE,60.0,Test,Test,Test,Test,Test,TCGA-VS-A9V3-01Z-00-DX1.6625C7BA-2F8A-41E9-871B-EF8C96999A74,WITH TUMOR,DX1,
VENHQS1WUy1BQTYyOmNlc2NfdGNnYQ,TCGA-VS-AA62,cesc_tcga,51.0,MX,NX,2009,T2b,2800.0,HDR,,,Once weekly,,5,,,Cisplatin,,Stage IIB,,,,,,0.0,-1.0,,0.0,,,11/13/14,G2,156.0,Cervical Squamous Cell Carcinoma,Current User,,No,No,,,,,,C53.9,8070/3,C53.9,YES,2009.0,,,,,,,,,Peri (6-12 months since last menstrual period),Biopsy (cervical / CT-guided / Other),,NO,15.41|1,,,,173174F8-9D95-40B0-9F88-A4BF4CCB521B,,Cervical Cancer,,,,Pre-Adjuvant Therapy,YES,,,,4.0,,,4.0,NO,NO,WHITE,,3D conformal,YES,,YES,,,5400.0,1,Female,Cervical,,,,YES,VS,1.0,Progressive Disease,,WITH TUMOR,67.0,Train,Train,Train,Val,Train,TCGA-VS-AA62-01Z-00-DX1.8DC8A4E5-7999-4CAC-ABBA-CDD2B7CA409F,WITH TUMOR,DX1,
VENHQS1XTC1BODM0OmNlc2NfdGNnYQ,TCGA-WL-A834,cesc_tcga,57.0,,N1,,T1b1,,,,,,,,,,,,,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,0.0,0.0,,0.0,,25.99|0,,NOT HISPANIC OR LATINO,,3/6/14,G3,162.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8070/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,4.0,,Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,28.0,Microscopic parametrial involvement,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,25.99|0,,,,48D81B1E-CD75-4B55-A0B2-C331BE2A88AE,,,,,,,YES,"Pelvic (external iliac, internal iliac, obturator)",,,2.0,,,3.0,NO,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,6.5,43.0,2012.0,,WL,4.0,,,TUMOR FREE,79.0,Train,Train,Val,Train,Train,TCGA-WL-A834-01Z-00-DX1.F39447F7-0C68-435B-864E-1C5EAB3DC767,WITH TUMOR,DX1,
VENHQS1YUy1BOFRKOmNlc2NfdGNnYQ,TCGA-XS-A8TJ,cesc_tcga,41.0,M0,N1,2009,T1b1,,,,,Once weekly,,1,Participant refusal,,Cisplatin,,Stage IB1,ABSENT,,,,,0.0,0.0,29.24|0,0.0,HISPANIC OR LATINO,,7/28/14,G2,146.0,Cervical Squamous Cell Carcinoma,Former User,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2012.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,5.0,0.0,,20.0,"Other Location, specify",Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,29.24|0,,,FREE MARGINS,FFD8D31F-BC4B-4E19-BBAF-0E26E9F3A107,,,,,,Preoperative,YES,"Pelvic (external iliac, internal iliac, obturator)",1.0,,1.0,,,2.0,NO,YES,BLACK OR AFRICAN AMERICAN,,,YES,,NO,Participant refusal,,,1,Female,Cervical,,,,YES,XS,5.0,Complete Remission/Response,,TUMOR FREE,51.0,Train,Train,Val,Train,Train,TCGA-XS-A8TJ-01Z-00-DX1.3CB10EF8-8A92-472B-8B5D-6CA88C8A70D5,WITH TUMOR,DX1,
VENHQS1aSi1BOFFPOmNlc2NfdGNnYQ,TCGA-ZJ-A8QO,cesc_tcga,73.0,,,,,,,,,,,,,,,,,,,,,,0.0,,0.0|0,,,,12/19/14,,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2007.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,EB3BA1FB-8254-4C02-A982-507F075CBAC1,,,,,,,,,,,,,,,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,ZJ,,,,,,Test,Test,Test,Test,Test,TCGA-ZJ-A8QO-01Z-00-DX1.A70D772D-689C-4924-8A91-54D5CCF5DD4B,WITH TUMOR,DX1,
VENHQS1aSi1BOFFROmNlc2NfdGNnYQ,TCGA-ZJ-A8QQ,cesc_tcga,24.0,M0,N0,1995,T1b2,3000.0,HDR,,,Once weekly,40mg/m2,6,,,Cisplatin,,Stage IIB,,,,,,0.0,845.0,67.54|0,0.0,NOT HISPANIC OR LATINO,,2/25/14,GX,158.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2007.0,Non-keratinizing squamous cell carcinoma,,NO,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,NO,67.54|0,,,,B12DEB95-6AA1-49CB-A3C5-A711D42D6FB9,,,,,,Preoperative,YES,,,,,,,0.0,NO,NO,WHITE,,,YES,,YES,,,,1,Female,Cervical,20.0,11.0,,YES,ZJ,2.0,Complete Remission/Response,,TUMOR FREE,71.0,Train,Val,Train,Train,Train,TCGA-ZJ-A8QQ-01Z-00-DX1.E0D248C2-EDE1-4CDD-AF31-79A596B7CFC0,WITH TUMOR,DX1,
VENHQS1aSi1BOFFSOmNlc2NfdGNnYQ,TCGA-ZJ-A8QR,cesc_tcga,38.0,MX,NX,2009,TX,,,,,,,,,,,,Stage I,,,,,,0.0,-2.0,,0.0,NOT HISPANIC OR LATINO,,2/25/14,GX,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8071/3,C53.9,YES,2007.0,Keratinizing squamous cell carcinoma,,NO,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Biopsy (cervical / CT-guided / Other),,NO,19.12|1,,,,DB44488E-4ED0-4082-BCA0-BBFD22FF0537,,,,,,Preoperative,,,,,,,,,NO,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,,,,,YES,,,,1,Female,Cervical,0.4,36.0,2009.0,,ZJ,2.0,,,,58.0,Train,Train,Train,Train,Val,TCGA-ZJ-A8QR-01Z-00-DX1.93187552-A4A9-4A48-BDED-C7B8EE8197DC,WITH TUMOR,DX1,
VENHQS1aSi1BQVg0OmNlc2NfdGNnYQ,TCGA-ZJ-AAX4,cesc_tcga,85.0,M0,N0,2009,T2,,,,,,,,,,,,Stage II,,,,,,0.0,,0.69|0,,NOT HISPANIC OR LATINO,,12/19/14,G3,170.0,Cervical Squamous Cell Carcinoma,Never Used,,No,Yes,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2008.0,Non-keratinizing squamous cell carcinoma,PRESENT,YES,0.0,0.0,,26.0,Positive vaginal margin,,Biopsy (cervical / CT-guided / Other),,,0.69|0,,,,13D72130-604C-4D79-95CC-53C2E25D91B0,,,,,,,,,,,3.0,,,3.0,,NO,WHITE,,,,,YES,,,,1,Female,Cervical,0.57,23.0,1949.0,,ZJ,4.0,,,,77.0,Train,Train,Val,Train,Train,TCGA-ZJ-AAX4-01Z-00-DX1.CD3F654C-40AB-4216-B35C-7CCD0BE34500,WITH TUMOR,DX1,
VENHQS1aSi1BQVg4OmNlc2NfdGNnYQ,TCGA-ZJ-AAX8,cesc_tcga,58.0,M0,N1,2009,T3b,,,,,,,,,,,,Stage IIIB,,,,,,0.0,,0.0|0,,,,12/19/14,G2,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2009.0,Non-keratinizing squamous cell carcinoma,,YES,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,B5F0E361-D67D-4FA9-9916-43623DAFB10F,,,,,,,,,,,,,,,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,ZJ,,,,,,Val,Train,Train,Train,Train,TCGA-ZJ-AAX8-01Z-00-DX1.CE816E37-988E-4969-A8A8-F2DA0FB8F704,WITH TUMOR,DX1,
VENHQS1aSi1BQVhBOmNlc2NfdGNnYQ,TCGA-ZJ-AAXA,cesc_tcga,64.0,MX,N0,2009,T1b,,,,,,,,,,,,Stage IB1,,,,,,0.0,,1.41|0,,NOT HISPANIC OR LATINO,,12/30/14,G2,155.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,Radical Hysterectomy,C53.9,8072/3,C53.9,YES,2009.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Cone Biopsy / LEEP,,,1.41|0,,,,E8DE2228-3AAA-48AD-A2E4-2940280AF6FD,,,,,,,,,,,4.0,,,4.0,,NO,WHITE,,,,,YES,,,,1,Female,Cervical,26.0,18.0,1989.0,,ZJ,3.0,,,,78.0,Train,Train,Train,Val,Train,TCGA-ZJ-AAXA-01Z-00-DX1.D8B65F94-452F-44CB-9EAD-74695FD92B78,WITH TUMOR,DX1,
VENHQS1aSi1BQVhCOmNlc2NfdGNnYQ,TCGA-ZJ-AAXB,cesc_tcga,42.0,M0,N0,2009,T1b2,,,,,,,,,,,,Stage IB2,,,,,,0.0,,0.0|0,,NOT HISPANIC OR LATINO,,12/31/14,G3,163.0,Endocervical Adenocarcinoma of the Usual Type,,,No,No,,,,,,C53.9,8384/3,C53.9,YES,2009.0,,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,88F0AA4A-6BFD-4573-B136-58F84F867F10,,,,,,,,,,,3.0,,,3.0,,NO,WHITE,,,,,YES,,,,1,Female,Cervical,,,,,ZJ,1.0,,,,97.0,Train,Val,Train,Train,Train,TCGA-ZJ-AAXB-01Z-00-DX1.F4167F85-902B-4E2F-B8BC-B749A53B9796,WITH TUMOR,DX1,
VENHQS1aSi1BQVhEOmNlc2NfdGNnYQ,TCGA-ZJ-AAXD,cesc_tcga,35.0,M0,N0,2009,T3b,,,,,,,,,,,,Stage IIIB,,,,,,0.0,,0.0|0,,,,12/30/14,G2,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,AF33DF2E-9737-4F63-952C-858A70AA589C,,,,,,,,,,,,,,,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,ZJ,,,,,,Train,Train,Train,Val,Train,TCGA-ZJ-AAXD-01Z-00-DX1.D180F04D-27E4-466D-8A59-3540CCA3A065,WITH TUMOR,DX1,
VENHQS1aSi1BQVhGOmNlc2NfdGNnYQ,TCGA-ZJ-AAXF,cesc_tcga,62.0,M0,N0,2009,T2b,,,,,,,,,,,,Stage IIB,,,,,,0.0,,0.0|0,,,,1/28/15,G3,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8071/3,C53.9,YES,2010.0,Keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,0ACD1E47-1099-469B-A6D4-E00DB47F57A9,,,,,,,,,,,,,,,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,ZJ,,,,,,Test,Test,Test,Test,Test,TCGA-ZJ-AAXF-01Z-00-DX1.C8EBDF13-499A-4560-B7E6-8F22A6B8DCB4,WITH TUMOR,DX1,
VENHQS1aSi1BQVhJOmNlc2NfdGNnYQ,TCGA-ZJ-AAXI,cesc_tcga,67.0,M0,NX,2009,T2b,,,,,,,,,,,,Stage IIB,,,,,,0.0,,0.0|0,,,,12/31/14,G2,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,40A86987-E77F-4977-92B1-8217796E1938,,,,,,,,,,,,,,,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,ZJ,,,,,,Train,Train,Train,Train,Val,TCGA-ZJ-AAXI-01Z-00-DX1.F71550C8-8947-4677-9592-D78122E97C72,WITH TUMOR,DX1,
VENHQS1aSi1BQVhKOmNlc2NfdGNnYQ,TCGA-ZJ-AAXJ,cesc_tcga,43.0,MX,N0,2009,T2b,,,,,,,,,,,,Stage IIB,,,,,,0.0,,0.0|0,,,,12/31/14,,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8071/3,C53.9,YES,2010.0,Keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,6B60BF8E-29A1-4C6B-9EAD-AEA4DDC99064,,,,,,,,,,,,,,,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,ZJ,,,,,,Val,Train,Train,Train,Train,TCGA-ZJ-AAXJ-01Z-00-DX1.7B11EC69-0FFB-4EDE-A4B5-C90B6A0E5959,WITH TUMOR,DX1,
VENHQS1aSi1BQVhOOmNlc2NfdGNnYQ,TCGA-ZJ-AAXN,cesc_tcga,34.0,M0,N1,2009,T1b2,,,,,,,,,,,,Stage IB2,,,,,,0.0,,0.0|0,,NOT HISPANIC OR LATINO,,12/31/14,,173.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,5F22E050-C172-4F2D-A1F9-6CB749B6EF98,,,,,,,,,,,1.0,,,1.0,,NO,WHITE,,,,,YES,,,,1,Female,Cervical,2.1,21.0,,,ZJ,2.0,,,,59.0,Train,Train,Train,Train,Val,TCGA-ZJ-AAXN-01Z-00-DX1.47F380CB-458E-45C9-BE7F-E4A02D384FFC,WITH TUMOR,DX1,
VENHQS1aSi1BQVhUOmNlc2NfdGNnYQ,TCGA-ZJ-AAXT,cesc_tcga,54.0,M0,N1,2009,T3b,,,,,,,,,,,,Stage IIIB,,,,,,0.0,,0.0|0,,NOT HISPANIC OR LATINO,,12/31/14,G2,165.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2009.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,5916AF71-0262-42CF-AF4B-EAC830A8B419,,,,,,,,,,,3.0,,,3.0,,NO,WHITE,,,,,YES,,,,1,Female,Cervical,0.2,20.0,1982.0,,ZJ,4.0,,,,76.0,Test,Test,Test,Test,Test,TCGA-ZJ-AAXT-01Z-00-DX1.75149994-F297-4DAA-9E71-87FDA73740AF,WITH TUMOR,DX1,
VENHQS1aSi1BQVhVOmNlc2NfdGNnYQ,TCGA-ZJ-AAXU,cesc_tcga,51.0,M0,N0,2009,T2b,,,,,,,,,,,,Stage IIB,,,,,,0.0,,0.16|0,,NOT HISPANIC OR LATINO,,12/19/14,G2,165.0,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2010.0,Non-keratinizing squamous cell carcinoma,,,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.16|0,,,,DDD4B6D2-5BE0-4EDD-977A-A795EEA3C738,,,,,,,,,,,,,,0.0,,NO,WHITE,,,,,YES,,,,1,Female,Cervical,52.86,15.0,,,ZJ,2.0,,,,70.0,Train,Train,Val,Train,Train,TCGA-ZJ-AAXU-01Z-00-DX1.A692FCB2-F9FC-4328-9E81-60C7D44094EB,WITH TUMOR,DX1,
VENHQS1aSi1BQjBIOmNlc2NfdGNnYQ,TCGA-ZJ-AB0H,cesc_tcga,48.0,M0,N1,2009,T3b,,,,,,,,,,,,Stage IIIB,,,,,,0.0,,0.0|0,,,,12/19/14,,,Cervical Squamous Cell Carcinoma,,,No,No,,,,,,C53.9,8072/3,C53.9,YES,2006.0,Non-keratinizing squamous cell carcinoma,,YES,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,F0DAF315-8909-4CDA-886D-A2770B08DB94,,,,,,,,,,,,,,,,NO,,,,,,YES,,,,1,Female,Cervical,,,,,ZJ,,,,,,Train,Train,Val,Train,Train,TCGA-ZJ-AB0H-01Z-00-DX1.1F0584E3-1E50-4755-BF3D-EB62502CB975,WITH TUMOR,DX1,
VENHQS1aSi1BQjBJOmNlc2NfdGNnYQ,TCGA-ZJ-AB0I,cesc_tcga,25.0,MX,N1,1995,T2b,,,,,,,,,,,,Stage IIB,,,,,,0.0,,0.0|0,,NOT HISPANIC OR LATINO,,12/19/14,,173.0,Cervical Squamous Cell Carcinoma,Never Used,,No,No,,,,,Radical Hysterectomy,C53.9,8071/3,C53.9,YES,2006.0,Keratinizing squamous cell carcinoma,,YES,,,,,,,Biopsy (cervical / CT-guided / Other),,,0.0|0,,,,A4F13656-A941-498A-9AC9-F020ED559B35,,,,,,,,,,,4.0,,,4.0,,NO,WHITE,,,,,YES,,,,1,Female,Cervical,13.0,13.0,2006.0,,ZJ,4.0,,,,78.0,Val,Train,Train,Train,Train,TCGA-ZJ-AB0I-01Z-00-DX1.32F22BAF-2A26-456D-80B8-423824E9EDC7,WITH TUMOR,DX1,
VENHQS1aWC1BQTVYOmNlc2NfdGNnYQ,TCGA-ZX-AA5X,cesc_tcga,64.0,MX,NX,2009,TX,,,,15.8,,,,Participant refusal,,,,Stage IIIB,,Bladder Present|[Not Available]|[Not Available]|[Not Available]|[Not Available]|[Not Available],-2.0,,52.0,0.0,7.0,3.91|0,1.0,NOT HISPANIC OR LATINO,[Not Available]|Extra-Pelvic Metastatic Disease Absent|[Not Available]|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent,11/24/14,G2,157.0,Cervical Squamous Cell Carcinoma,,"Other, specify",No,No,,,,,,C53.9,8070/3,C53.9,YES,2013.0,Non-keratinizing squamous cell carcinoma,ABSENT,NO,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Biopsy (cervical / CT-guided / Other),,,3.91|0,,Positive for Hepatitis A,,4756ACC0-4E96-44D4-B359-04D64DC7EB84,,,,Bilateral pelvic wall involvement on imaging,,Pre-Adjuvant Therapy,,,0.0,0.0,2.0,0.0,0.0,2.0,NO,YES,WHITE,,,,,NO,Participant refusal,,,1,Female,Cervical,,,,NO,ZX,1.0,,,WITH TUMOR,56.0,Train,Val,Train,Train,Train,TCGA-ZX-AA5X-01Z-00-DX1.8C4B54F5-409B-4A62-AA88-B079606D2D45,WITH TUMOR,DX1,
